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Medicaid Discontinuity among Adults with Cardiovascular Disease or High Risk
Conditions: Associations with Medication Adherence and Health Care Utilization
Abstract
BACKGROUND: Medicaid coverage among adults is often characterized by discontinuity – loss of
Medicaid coverage, and churning, or entering and exiting Medicaid – over short durations. Little is known
about the impact of having discontinuous Medicaid coverage on access to care, preventive care,
pharmacotherapy, primary care, and hospitalizations, among non-elderly adults with cardiovascular
disease (CVD) or high-risk conditions.
OBJECTIVES: This dissertation employed a three empirical research papers approach to pursue the
following aims: (1) characterize the adult subpopulations with CVD or conditions placing them at high risk
for CVD who lack continuous Medicaid coverage, and examine the characteristics associated with
Medicaid discontinuity, (2) examine associations between Medicaid discontinuity, medication adherence
and medication utilization, and (3) examine the associations between Medicaid discontinuity, access to
care, preventive care, primary care visits, and hospitalizations.
METHODS: This was a retrospective comparative analysis of the 2002–2011 Medical Expenditure Panel
Survey employing a repeated cross-sectional study design. Study sample included adults aged 18–64
years diagnosed with ≥1 CVD (defined as acute myocardial infarction, coronary artery disease,
congestive heart failure, peripheral and visceral atherosclerosis, or stroke) or high-risk conditions for CVD
(defined as hypertension, lipid disorders, diabetes, or chronic kidney disease) who reported having
Medicaid coverage any time during survey year. Individuals having continuous, full-year Medicaid
coverage (Continuous Medicaid) were compared to those with(Discontinuous–Uninsured), and separately
to those with(Discontinuous–Insured). Associations between Medicaid discontinuity, access to care, and
preventive care were estimated using multivariate logistic regression. Medication adherence, measured
as medication possession ratio (MPR) with adequate adherence being considered at MPR>0.8, was
estimated using multivariate logistic regression. Medication utilization, measured as the number of allcause, and disease-specific prescription drug fills, was estimated using multivariate negative binomial
regression. Four health care services utilization outcomes – inpatient, emergency room (ER), hospital
outpatient, and office-based physician visits – measured as both, number of all-cause and number of
disease-specific visits, were estimated using either zero-inflated negative binomial regression or negative
binomial regression depending on the distribution of the outcome of interest.
RESULTS: Overall, 31.8% of adults with CVD or high-risk conditions for CVD hadcoverage, majority of
whom (23.5%) belonged to the Discontinuous– Uninsured group. Of those who had Medicaid at the
beginning of the year, only 21.9% of the Discontinuous–Uninsured, and 8% of the Discontinuous–Insured
still had Medicaid by the year end. Male gender, minority race/ethnicity, receiving disability benefits or
participating in a federal assistance program, Medicaid managed care enrollment, and diagnosis of
respiratory illnesses were the characteristics associated with lower odds of Medicaid discontinuity,
whereas being married, residing in the South, having higher income, or education, being employed, and
having fair to poor perceived health status were associated with higher odds of Medicaid discontinuity.
Overall adherence to commonly prescribed therapeutic medication classes, measured as average MPR,
was not significantly different between the Continuous Medicaid and the two discontinuous coverage
groups, whereas examination of class-specific adherence yielded mixed results. Discontinuous Medicaid
coverage was associated with significantly lower allcause and disease-specific prescription drug
utilization among both the discontinuous Medicaid groups. Medicaid discontinuity was associated with
poor access to care, and higher diseasespecific inpatient and ER hospitalizations among both the
discontinuous Medicaid coverage groups. Additionally, among the Discontinuous–Uninsured, Medicaid
discontinuity was associated with lower odds of routine medical checkup, lower all-cause primary care

office visits, and higher disease-specific hospital outpatient visits.
CONCLUSION: Among non-elderly adults with CVD or high-risk conditions, for CVD having discontinuous
Medicaid coverage was found to be associated with poor access to care and preventive care, poor
adherence to certain medication classes and lower utilization of prescription medications, higher
hospitalizations for CVD or associated conditions, and lower primary care office visits. Disruptions in and
loss of Medicaid coverage among adults with CVD or high-risk conditions may lead to negative health
outcomes due to the disruptions in continuity of care and inability to appropriately manage these disease
conditions. This research provides strong support for implementation of policies to stabilize Medicaid
coverage and reduce Medicaid discontinuity among individuals with CVD or high-risk conditions for CVD,
such as the 12 month continuous Medicaid eligibility provisions currently in place for low-income
children. Such policies will greatly improve some of the adverse access to care, preventive care,
pharmacotherapy, and medical care outcomes observed in this study. Vulnerable populations with
chronic, debilitating conditions may benefit from such policies to a greater extent compared to the overall
low-income adult population. Simultaneously, reenrollment and outreach strategies may need to be more
efficiently implemented to ensure individuals who are eligible for Medicaid, continue to remain enrolled in
Medicaid. Such enabling strategies employed by Medicaid managed care organizations may be adopted
by State Medicaid agencies to ensure greater continuity in Medicaid coverage for low-income vulnerable
populations with chronic and debilitating diseases.
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ABSTRACT
BACKGROUND: Medicaid coverage among adults is often characterized by
discontinuity – loss of Medicaid coverage, and churning, or entering and exiting
Medicaid – over short durations. Little is known about the impact of having
discontinuous Medicaid coverage on access to care, preventive care, pharmacotherapy,
primary care, and hospitalizations, among non-elderly adults with cardiovascular disease
(CVD) or high-risk conditions.
OBJECTIVES: This dissertation employed a three empirical research papers
approach to pursue the following aims: (1) characterize the adult subpopulations with
CVD or conditions placing them at high risk for CVD who lack continuous Medicaid
coverage, and examine the characteristics associated with Medicaid discontinuity, (2)
examine associations between Medicaid discontinuity, medication adherence and
medication utilization, and (3) examine the associations between Medicaid discontinuity,
access to care, preventive care, primary care visits, and hospitalizations.
METHODS: This was a retrospective comparative analysis of the 2002–2011
Medical Expenditure Panel Survey employing a repeated cross-sectional study design.
Study sample included adults aged 18–64 years diagnosed with ≥1 CVD (defined as
acute myocardial infarction, coronary artery disease, congestive heart failure, peripheral
and visceral atherosclerosis, or stroke) or high-risk conditions for CVD (defined as
hypertension, lipid disorders, diabetes, or chronic kidney disease) who reported having
Medicaid coverage any time during survey year. Individuals having continuous, full-year
Medicaid coverage (Continuous Medicaid) were compared to those with <12 months of
Medicaid coverage with no other insurance reported during the year (Discontinuous–
Uninsured), and separately to those with <12months of Medicaid along with other
sources of health insurance during the year (Discontinuous–Insured). Associations
between Medicaid discontinuity, access to care, and preventive care were estimated using
multivariate logistic regression. Medication adherence, measured as medication
possession ratio (MPR) with adequate adherence being considered at MPR>0.8, was
estimated using multivariate logistic regression. Medication utilization, measured as the
number of all-cause, and disease-specific prescription drug fills, was estimated using
multivariate negative binomial regression. Four health care services utilization outcomes
– inpatient, emergency room (ER), hospital outpatient, and office-based physician visits –
measured as both, number of all-cause and number of disease-specific visits, were
estimated using either zero-inflated negative binomial regression or negative binomial
regression depending on the distribution of the outcome of interest.
RESULTS: Overall, 31.8% of adults with CVD or high-risk conditions for CVD
had <12 months of Medicaid coverage, majority of whom (23.5%) belonged to the
Discontinuous–Uninsured group. Of those who had Medicaid at the beginning of the
year, only 21.9% of the Discontinuous–Uninsured, and 8% of the Discontinuous–Insured
still had Medicaid by the year end. Male gender, minority race/ethnicity, receiving
disability benefits or participating in a federal assistance program, Medicaid managed
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care enrollment, and diagnosis of respiratory illnesses were the characteristics associated
with lower odds of Medicaid discontinuity, whereas being married, residing in the South,
having higher income, or education, being employed, and having fair to poor perceived
health status were associated with higher odds of Medicaid discontinuity. Overall
adherence to commonly prescribed therapeutic medication classes, measured as average
MPR, was not significantly different between the Continuous Medicaid and the two
discontinuous coverage groups, whereas examination of class-specific adherence yielded
mixed results. Discontinuous Medicaid coverage was associated with significantly lower
all-cause and disease-specific prescription drug utilization among both the discontinuous
Medicaid groups. Medicaid discontinuity was associated with poor access to care, and
higher disease-specific inpatient and ER hospitalizations among both the discontinuous
Medicaid coverage groups. Additionally, among the Discontinuous–Uninsured, Medicaid
discontinuity was associated with lower odds of routine medical checkup, lower all-cause
primary care office visits, and higher disease-specific hospital outpatient visits.
CONCLUSION: Among non-elderly adults with CVD or high-risk conditions,
for CVD having discontinuous Medicaid coverage was found to be associated with poor
access to care and preventive care, poor adherence to certain medication classes and
lower utilization of prescription medications, higher hospitalizations for CVD or
associated conditions, and lower primary care office visits. Disruptions in and loss of
Medicaid coverage among adults with CVD or high-risk conditions may lead to negative
health outcomes due to the disruptions in continuity of care and inability to appropriately
manage these disease conditions. This research provides strong support for
implementation of policies to stabilize Medicaid coverage and reduce Medicaid
discontinuity among individuals with CVD or high-risk conditions for CVD, such as the
12 month continuous Medicaid eligibility provisions currently in place for low-income
children. Such policies will greatly improve some of the adverse access to care,
preventive care, pharmacotherapy, and medical care outcomes observed in this study.
Vulnerable populations with chronic, debilitating conditions may benefit from such
policies to a greater extent compared to the overall low-income adult population.
Simultaneously, reenrollment and outreach strategies may need to be more efficiently
implemented to ensure individuals who are eligible for Medicaid, continue to remain
enrolled in Medicaid. Such enabling strategies employed by Medicaid managed care
organizations may be adopted by State Medicaid agencies to ensure greater continuity in
Medicaid coverage for low-income vulnerable populations with chronic and debilitating
diseases.
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CHAPTER 1.

INTRODUCTION

INSTABILITY IN HEALTH INSURANCE
The health care system in the United States (U.S.) has widely recognized to be
“fragmented”.1 The systemic misalignment of incentives, and lack of coordination
between physician, and hospitals, leading to poor care coordination, inefficient allocation
of resources, contribute to this narrative. This in turn greatly hampers the quality of care
that patients receive. Likewise, the health insurance system in the U.S. too is fragmented
with most individuals covered by employer-sponsored private health insurance (48%),
and the poor, elderly, and disabled population groups being covered by governmentsponsored public health insurance (roughly 31%), with the remaining either purchasing
individual private health plans (just 5% of the total population), or remaining uninsured,
which estimates peg at 15% of the total population, roughly the same as those on
Medicaid and Medicare.2 Rules and regulations are set separately for both private health
insurance by employers, and for public health insurance by government, regarding
eligibility for the insurance plans paid for, the specific covered benefits and cost sharing.
The principal requirement for employer-sponsored insurance is employment.
Losing employment, changing jobs, moving to different geographic regions, and starting
one’s own venture, are circumstances that can lead to losing employer-sponsored
insurance coverage or gaps in insurance coverage. The number of individuals that lose
insurance resulting from loss of employment increased significantly during times of
economic recession.3,4 As a cost-cutting measure, employers may change the benefit
structure of the plans by requiring their employees to pay more through higher premiums,
deductibles or co-pays, and also by cutting the numbers and/or types of services covered.
Such measures may make health insurance expensive for low-income employees and
those who cannot afford such plan structures. When an individual employee receives
employment-sponsored coverage, his/her entire family is covered under the insurance
plan. Thus, employee spouses and children of may also experience insurance instability
as well due to circumstances such as changes in benefit structure where spouse coverage
is dropped, loss of coverage or employment, retirement, death or other circumstances.
Government-sponsored public health insurance too has its own set of eligibility
criteria and enrollment procedures, and requires individuals to be aware of them to
determine whether they are eligible or not, and if they are, to provide the appropriate
documentation to enroll for these insurance plans, and maintain eligibility; this is
especially true for Medicaid and Children’s Health Insurance Plan (CHIP) that are also
referred to as means-tested public health insurance programs.5 The eligibility
requirements and enrollment procedures for Medicaid and CHIP differ from state-tostate, and so any change in residence across states may lead to loss of insurance coverage
resulting from either ineligibility or failure to enroll successfully. Traditionally, before
the passage of the 2010 Patient Protection and Affordable Care Act (PPACA), not only
did the income eligibility thresholds vary greatly between the states, but they were also
different for different population groups, such as more generous coverage limits for

1

children and pregnant women, less generous coverage limits for non-elderly adults with
children, and no coverage for non-elderly adults without any children.6 Small fluctuations
in income levels for covered non-elderly adults would end up disqualifying individuals
with incomes at or near eligibility thresholds. As with employer-sponsored health
insurance, changes or loss in Medicaid coverage for one member of the family impacted
the continuity in Medicaid for the entire family. Also, changes in family size and
compositions would also impact eligibility for these public insurance programs, since
yearly poverty levels that are established take into account these factors. The rules and
regulations for eligibility and enrollment between public and private health insurance are
different, and therefore, individuals who have to transition between one system to another
also experience gaps in insurance coverage, either due to failure to follow enrollment
procedures, or being unaware of such an option, or even due to the stigma of enrolling for
Medicaid or other low-income public programs.6 It is broadly due to these diverse factors
in this fragmented health insurance system, that individuals and families experience
insurance instability and continue to swing into and out of various types of health
insurance coverage.
INSTABILITY IN MEDICAID AMONG LOW-INCOME ADULT POPULATION
Medicaid, the nation’s primary public health insurance program for the lowincome population, provides much-needed health insurance coverage to an estimated 67
million individuals who meet the eligibility criteria, which include having incomes and
assets below a certain threshold level determined by each State.7 These include lowincome children, adults, elderly, and disabled who do not have access to private health
insurance, and many of whom are not eligible for any other source of coverage. Medicaid
however, has been described as a leaky sieve. Inefficient administrative hurdles and
ponderous periodic paperwork requirements, result in discontinuity in Medicaid
coverage, characterized by either loss of coverage or “churning” – frequent transitions
into and out of various sources of coverage.8,9 Such instability often plagues Medicaideligible individuals, leading to both gaps in coverage and interruptions in the continuity
of care. Families may have to find new providers or change their existing health
treatments due to different provider networks or different services covered in their new
health plans, or may end up forgoing needed care after becoming uninsured. Some
research has been conducted to examine Medicaid instability and its impact on various
outcomes, although the research in this area is not exhaustive.
Harman and colleagues examined Utah Medicaid claims data from 1990-1994 to
study the impact of Medicaid interruptions on inpatient psychiatric services use. They
found that interruptions in Medicaid were associated with an average of 0.63 more
psychiatric hospitalizations per beneficiary, and 8.3 more psychiatric hospitalization days
over the study period.10 Using the Ohio Medicaid claims from 1992-1999 Koroukian
examined the impact of length of enrollment in Medicaid on use of screening
mammography among women aged 40-64 years. They found that with each additional
year of Medicaid enrollment, the proportion of women receiving screening
mammography increased significantly, and [Odds Ratio (OR): 1.59; 95% Confidence
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Interval (CI): 1.57–1.60], and the mean number of annual mammography exams
increased from 0.08/year among women enrolled for less than a year to 0.26/year among
women enrolled for more than 7 years.11 Continuous Medicaid enrollment also was
shown to have a positive impact on cervical cancer prevention.12 Harman and colleagues
analyzed Florida Medicaid claims data from 1999-2002 to examine the impact of
Medicaid interruption on depressed beneficiaries’ health care utilization and
expenditures. They found that inpatient episodes, the length of inpatient stay, number of
emergency department (ED) visits, and total Medicaid expenditures increased
significantly (P<0.001) in the three-month period after an interruption in coverage of
more than one month, indicating a significant negative impact of Medicaid instability
among low-income elderly with mental illness.13 More recently, studies that have
examined the impact of interruptions in Medicaid using state-specific data have found
that instability in Medicaid is associated with higher risk for hospitalization for
ambulatory care-sensitive conditions, and increase in overall program expenditures due to
higher inpatient and ED utilization.14 In the only study using nationally representative
data, Banerjee and colleagues (2010) examined the Medical Expenditure Panel Survey
(MEPS) 2000-2004 to study the impact of Medicaid instability on health care utilization,
and found that individuals with discontinuous Medicaid coverage had higher inpatient
and ED utilization, but lower prescription drug utilization annually.15
The literature examining the impact of lack of insurance on health care outcomes
in general, and disease-specific outcomes in particular is exhaustive with studies
highlighting the adverse impact of lacking health insurance. The literature examining the
impact of gaps in health insurance is less comprehensive, however, for the most part this
literature has established that even short gaps in insurance coverage may lead to negative
outcomes among individuals with chronic conditions. Although these studies have
assessed the impact of insurance gaps on patients with numerous conditions including
cancer, depression/anxiety and schizophrenia, and diabetes, fewer studies have focused
on patient with cardiovascular disease (CVD) and CVD-associated conditions. Studies
using more advanced statistical analyses such as zero-inflated linear models, differencein-differences analyses, and instrumental variable regression analyses need to be
conducted more to account for endogeneity problems that may confound the association
between continuation and discontinuation in Medicaid and other insurance programs and
major clinical outcomes. Studies examining Medicaid instability have mostly been
conducted using data on a single state’s Medicaid program, and there is a paucity of
studies (could also be due to lack of national data) that examine nationally representative
estimates of churning in Medicaid and its impact on health care outcomes, especially
among individuals diagnosed with chronic disease conditions. Although medication
adherence/compliance as an area of research has been thoroughly examined with several
high-quality robust analyses of adherence, and its impact of health care utilization,
research examining the impact of churning in insurance in general and Medicaid in
particular is lacking. It is imperative therefore, to examine the impact of Medicaid
discontinuity on pharmacotherapy outcomes, such as medication adherence and
medication utilization.

3

CARDIOVASCULAR DISEASE OR ASSOCIATED HIGH-RISK CONDITIONS
AMONG LOW-INCOME POPULATIONS
CVD is the leading cause of death in the U.S. accounting for approximately 1 in
every 4 deaths being attributed to them.16 Cardiovascular complications resulting from
high blood pressure, lipid disorders, and other risk factors have been known to exert a
substantial burden leading to disability, morbidity, and mortality.17,18 The economic
burden due to CVD has been estimated to exceed $300 billion.19 Estimates peg the
prevalence of cardiovascular disease (CVD), including heart failure and stroke, among
low-income adult population at 28%.20 Additionally, many individuals with CVD that
have resulted from worsening of other chronic conditions such as hypertension, diabetes,
and hyperlipidemia. High blood pressure (24%), high cholesterol (17%), and high blood
sugar level (9%) are some of the prevalent risk factors or high-risk conditions for
CVD.21,22 For instance, 82% of low-income diabetic adults, and 74% of low-income
adults with CVD reported one or more additional chronic condition, which indicates the
complex disease burden and health care needs in the CVD or high risk population.
Additionally, spending for nonelderly adult Medicaid enrollees with CVD and many of
the high-risk conditions for CVD ranged from $9,694 - $13,490 per capita, which was
significantly higher than their counterparts without these chronic conditions, and once
again reflected the complex chronic disease burden among these diseased
subpopulations.20
Low-income populations with CVD or conditions placing them at high risk for
CVD, such as acute myocardial infarction, congestive heart failure, coronary artery
disease, peripheral and visceral atherosclerosis, stroke, hypertension, diabetes,
hyperlipidemia, and chronic kidney disease, would face tremendous challenges in
managing these complex chronic conditions. CVD and CVD-associated conditions
require appropriate and uninhibited access to medical care, preventive care, prescription
medications, and periodic primary and specialty care visits for prevention and treatment.
Failure to appropriately manage these chronic conditions may exacerbate the symptoms
and lead to worsening of health leading, resulting in unplanned hospitalizations and
emergency room admissions. Insurance coverage is a critical component and an
important factor in ensuring access to and utilization of needed medical care for
appropriate disease management. Medicaid, as mentioned above is a critical safety-net
health insurance program for low-income populations that provides these vulnerable
populations the ability to seek needed medical care. Interruptions and discontinuity in
Medicaid coverage may especially have a lead to significantly poor health outcomes
among these vulnerable populations, and therefore policies to stabilize Medicaid
coverage among low-income populations with CVD or high-risk conditions for CVD
may be even more critical to ensuring continuity of care and appropriate disease
management among these individuals. While need appropriate medical care,
pharmacotherapy is also an important component of disease management for these
individuals. Prescribed medicines not only need to be filled in a timely manner as
directed, but adhering to the appropriate prescribed medication regimen is also critical to
observe positive therapeutic effects of these medications. After reviewing the literature
for the definitions for CVD and conditions which are high risk factors, and in
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consultation with a cardiologist to restrict the number of these conditions to those
requiring appropriate and prolonged disease management in the outpatient and
community settings, the present study has considered the CVD and high-risk conditions
for CVD listed above as the index chronic conditions.17,23-26 The rationale being that
continuity of Medicaid coverage may be even more critical among this subpopulation of
the non-elderly adult Medicaid population, and the adverse outcomes due to Medicaid
discontinuity may be more detrimental among these individuals.
RESEARCH AIMS
Using nationally representative data on non-institutionalized, non-elderly adults
diagnosed with one or more CVD or high-risk conditions for CVD who reported having
Medicaid at any point of time during the year, this dissertation aims to investigate the
associations between instability in Medicaid coverage within a year, and access to care,
preventive care, prescription drug adherence and utilization, primary care visits, and
inpatient and ER hospitalizations.
Aim 1: To Examine the Individual Characteristics Associated with Medicaid
Discontinuity
1) Are the demographic, socioeconomic, Medicaid-, and health-related
characteristics significantly different between those who have continuous
Medicaid coverage and their counterparts with discontinuous Medicaid coverage
during the year?
2) Which characteristics are significantly associated with Medicaid discontinuity in
this study population?
Aim 2: To Examine the Associations between Medicaid Discontinuity, Medication
Adherence and Medication Utilization
x
x

Hypothesis 2a: Medicaid discontinuity is associated with poor adherence to
commonly prescribed therapeutic classes of medications used to treat CVD or
high-risk conditions for CVD
Hypothesis 2b: Medicaid discontinuity is associated with lower all-cause and
disease-specific prescription drug utilization

Aim 3: To Examine the Associations between Medicaid Discontinuity, Access to
Care, Preventive Services Use, and Utilization of Health Care Services
x
x

Hypothesis 3a: Medicaid discontinuity is associated with poor access to care
Hypothesis 3b: Medicaid discontinuity is associated with a lower likelihood of
adequate preventive services use
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x
x

Hypothesis 3c: Medicaid discontinuity is associated with lower all-cause and
disease-specific hospital outpatient visits, and office-based physician visits
Hypothesis 3d: Medicaid discontinuity is associated with higher all-cause and
disease-specific inpatient hospitalizations and ER hospitalizations
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CHAPTER 2. CHARACTERISTICS ASSOCIATED WITH MEDICAID
DISCONTINUITY IN ADULTS WITH CARDIOVASCULAR DISEASE OR
ASSOCIATED HIGH-RISK CONDITIONS
BACKGROUND
Cardiovascular disease (CVD) and CVD associated conditions (e.g. hypertension,
lipid disorders, and diabetes) exert substantial burden due to disability, morbidity, and
mortality. CVD is the major cause of death in the U.S., accounting for 1 in 4 deaths being
attributed to them.16 Economic burden due to these debilitating chronic conditions is
estimated to exceed $300 billion annually.19 Continuity of care is essential to for
appropriate management of these disease conditions, and having uninterrupted access to
health insurance is critical to ensure this continuity of care.27,28 Medicaid, the nation’s
primary public health insurance program for the low-income population, provides muchneeded health insurance coverage to an estimated 67 million individuals at any given
point in time.7 Estimates indicate that over 28% of the Medicaid population at or below
138 percent of the federal poverty level (FPL) are diagnosed with CVD or high-risk
conditions for CVD.29,30
Medicaid however, has been described as a leaky sieve.8 Inefficient administrative
hurdles and ponderous periodic paperwork requirements, result in discontinuity in
Medicaid coverage, characterized by wither loss of coverage or “churning” – frequent
transitions into and out of various sources of coverage.8,9 Such instability often plagues
Medicaid-eligible individuals, leading to both gaps in coverage and interruptions in the
continuity of care. Families may have to find new providers or change their existing
health treatments due to different provider networks or different services covered in their
new health plans, or may end up forgoing needed care after becoming uninsured.
The consequences of lack of insurance have been well-documented. Ayanian and
colleagues reported that Americans who were uninsured for one year or more were more
likely to have foregone routine clinical checkup in the past 2 years, and this pattern was
observed among individuals diagnosed with several chronic conditions such as
hypertension, hyperlipidemia, HIV/AIDS, among others. Long-term and short-term
uninsured (uninsured for less than one year), also did not receive recommended cancer
screening, and diabetes care among others.31 Recent estimates indicate that these trends
have continued into the first decade of the 21st century. Fields and colleagues analyzed
the Medical Expenditure Panel Survey (MEPS) data from 2006-2010 to examine the
impact of insurance stability and residence on several health care utilization measures.
They found that discontinuously insured individuals had more ED visits, fewer physician
office visits, and fewer prescription drug fills among others, compared to those with
continuous insurance coverage.32 Several other studies examining Medicaid data have
also reported adverse impacts on access to care, and health outcomes due to gaps in
Medicaid coverage.2,10-14
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Medicaid discontinuity, due to either becoming ineligible or “drop-out” despite
meeting the eligibility criteria, has been well documented in children.33-35 Some research
has been conducted to examine Medicaid instability among adults, although this area of
research is not exhaustive. For instance, estimates peg the rate of adult disenrollment
from Medicaid to range from 21–33% annually.36-38 Sommers examined the predictors of
loss of Medicaid and found that young age, male gender, and Hispanic ethnicity were
significant risk factors for coverage discontinuity.38 However, there have been no
estimates of Medicaid instability among non-elderly adults with CVD or high-risk
conditions for CVD among whom, the impact of such coverage discontinuity could be
detrimental. Including population groups diagnosed with and managing these chronic
conditions in policy discussions to improve Medicaid retention among adults is
important, as these groups could benefit the most from coverage stability and the
resulting continuity in disease management.
The present study aims to: 1) obtain national estimates of Medicaid coverage
transitions and discontinuity among non-elderly adults with CVD or high-risk conditions
for CVD, 2) characterize the population groups that have continuous and discontinuous
Medicaid coverage within a year, and 3) examine the individual characteristics associated
with Medicaid discontinuity in this study population.
METHODS
The present study is a retrospective cross-sectional analysis designed to compare
the characteristics of non-elderly adults diagnosed with CVD or high-risk conditions for
CVD with continuous full-year Medicaid coverage versus those with discontinuous
Medicaid coverage. The study seeks to determine the individual characteristics associated
with Medicaid discontinuity in this CVD population. Medicaid, being a means tested
source of public health insurance, is not a permanent source of insurance coverage. As
discussed earlier, the requirements of periodic reporting of income, assets, family status
and residence, apart from changes in one or more of these circumstances are the major
sources of instability in Medicaid coverage which may impact access to care and
preventive services use for individuals with CVD or high-risk conditions for CVD. In
order to capture this instability in the study population, we first describe the prevalence of
these chronic conditions in this study population. We then examine in detail, the
demographic, socioeconomic, Medicaid-, and health-related characteristics associated
with Medicaid discontinuity in this study, and control for these covariates in the
multivariate models to determine the individuals characteristics associated with Medicaid
discontinuity in this CVD population.
Data Source
This study analyzed the Medical Expenditure Panel Survey (MEPS). MEPS is a
set of large-scale surveys of families, individuals, their medical providers and employers
across the United States. It is jointly sponsored by the Agency for Healthcare Research
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and Quality (AHRQ) and the National Center for Health Statistics (NCHS), and has been
conducted annually since 1996. It has two major components; the Household Component
(HC), and the Insurance Component, with data on medical providers in the HC being
supplemented by the Medical Provider Component. MEPS collects detailed information
from a nationally representative sample of the civilian noninstitutionalized population of
the U.S. on health services utilization and health expenditures, insurance coverage, and
sources of payment.39
When obtaining national estimates from surveys such as MEPS, appropriate
sample size is critical to obtain reliable estimates, since estimates of some population
subgroups may vary from year to year. AHRQ suggests a minimum of 100 unweighted
participants per cell for producing reliable national estimates. The advantage of survey
such as MEPS is that they allow for several years’ of data to be pooled together in order
to increase the sample size and improve the precision of estimates. The pooling of the
different years of data was conducted in accordance with the guidelines provided by
MEPS, and data for the years 2002 – 2011 were pooled together to allow for a
sufficiently large sample size to ensure reliable estimates.
MEPS Sampling Plan
MEPS has an overlapping panel design. Two separate panels of respondents are
interviewed simultaneously during a calendar year. A new panel of sample households is
selected each year, and data for each panel are collected for two calendar years. The two
years of data for each panel are collected in five rounds of interviews that take place over
a two and a half year period. This provides continuous and current estimates of health
care expenditures at both the person and household level for two panels for each calendar
year. Figure 2-1 illustrates this overlapping panel design in detail with an example of
Panels 15 and 16.
Study Population
The study population consisted of individuals diagnosed with CVD or high-risk
conditions for CVD. CVD was defined as any diagnosis of acute myocardial infarction
(Clinical Classification code (CCC): 100), coronary artery disease (CCC: 101),
congestive heart failure (CCC: 108), peripheral and visceral atherosclerosis (CCCs: 114,
115, 116), stroke (CCCs: 109, 112). High-risk conditions for CVD were defined as
hypertension (CCC: 098), lipid disorders (CCC: 053), diabetes (CCC: 049, 050), and
chronic kidney disease (CCC: 158). CCC aggregates conditions and procedures into
mutually exclusive and clinically homogeneous categories, using Clinical Classification
Software.40 The study population included respondents who were: (1) aged 18 to 64
years, (2) self-reported either being diagnosed with CVD or high-risk conditions for CVD
in their first round of the MEPS survey, or reported having an event (an inpatient,
emergency, outpatient, or office-based provider visits, or a prescription medication)
associated with one or more of the aforementioned disease conditions at any point of time
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Figure 2-1.

MEPS Overlapping Panel Design

Reprinted with permission. MEPS-HC Sample Design and Collection Process. Agency
for Healthcare Research and Quality, Rockville, Md.
http://www.meps.ahrq.gov/survey_comp/hc_data_collection.jsp. Accessed on April 6,
2015.41
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during the survey, (3) reported having had Medicaid coverage at any point of time during
the survey year, and (4) had positive person weights, and were interviewed for all five
rounds of the 2-year MEPS survey interviews. Events associated with any particular
disease conditions were self-reported and coded by the MEPS data reviewers
accordingly. A portion of the self-reported data were verified by contacting the health
care providers associated with the events reported and coded accordingly.42 Selection of
individuals in the study population on the basis of a medical event associated with the
disease condition of interest is a valid approach to ensure that the study sample is not
impacted by misreporting of chronic conditions diagnoses.43 Respondents who reported
having Medicare, or pregnancy were excluded from this study.
A major goal of this study was to characterize Medicaid discontinuity among
individuals with CVD or high-risk conditions for CVD. Unlike previous studies, this
study accounted for presence of other sources of health coverage among the
discontinuous Medicaid coverage groups.15 This was done since individuals who do not
report having continuous full-year Medicaid coverage and have no other health insurance
during the year may be different from those with other sources of health insurance
coverage, in terms of characteristics and health care utilization. Individuals in the study
population who reported having Medicaid coverage during all 12 months of a survey year
were classified as having continuous Medicaid coverage, which was the comparison
group and designated as ‘Continuous Medicaid’ in this study. Individuals who reported
having <12 months of Medicaid coverage during a survey year were divided into two
groups: (1) individuals with <12 months of Medicaid coverage who did not report any
other sources of health insurance during the survey year, designated in this study as
‘Discontinuous–Uninsured’, and (2) individuals with <12 months of Medicaid coverage
who also reported having other source(s) of health insurance during the survey year
(either private, Tricare, or any hospital- or physician group-based health insurance),
designated in this study as ‘Discontinuous–Insured’.
Study Variables
Our primary outcomes of interest are an indicator for Medicaid discontinuity
without other health insurance coverage (Discontinuous–Uninsured), and an indicator for
Medicaid discontinuity with other sources of health insurance coverage (Discontinuous–
Insured). The measures of comparison between the three groups, which were also
adjusted for in the regression models included the following covariates:
1) Demographic covariates: age (in years), gender (female vs. male), race/ethnicity
(Non-Hispanic White vs. Non-Hispanic Black, Hispanic, and other races), marital
status (not married vs. married), family size (N), and geographic residence
(Northeast vs. Midwest, South, and West).
2) Socioeconomic covariates: education (less than high school vs. high school/GED,
and Bachelor’s or higher), income as a percentage of the federal poverty level
(FPL) (<100% FPL vs. 100 - <125% FPL, and >125% FPL), employment (always
unemployed vs. intermittent employment, and always employed), binary indicator
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for Metropolitan Statistical Area (MSA) residence.
3) Medicaid-related covariates: binary indicator for Supplementary Security Income
(SSI) for disability receipt or participation in the Temporary Assistance for Needy
Families (TANF) program, and a binary indicator for Medicaid HMO/Managed
Care participation.
4) Health-related covariates: perceived health status (excellent/very good/good vs.
fair/poor), perceived mental health status (excellent/very good/good vs. fair/poor),
number of CVD or high-risk conditions for CVD (N), binary indicator for mental
illness/substance abuse diagnosis, binary indicator for respiratory diseases
diagnosis, binary indicator for arthritis/joint pain diagnosis, and Charlson
Comorbidity Index (CCI) score.
All regression models included the year fixed effects to capture any macro-level
variations during the study period.
Statistical Analysis
Survey-weighted proportions of prevalence of CVD or high-risk conditions for
CVD were calculated. Chi-square tests and t-tests were conducted as part of the initial
bivariate statistics to compare characteristics across the groups in the study population.
Survey-weighted multivariate logistic regression analyses were then conducted to
determine the predictors of Medicaid discontinuity in the study population. As denoted in
Equation 2-1 and Equation 2-2,


Pr[DU=1|x] = F-1(ߙො  ୀଵ ߚመ ܺ )

(Eq. 2-1)


Pr[DI=1|x] = F-1(ߙො  ୀଵ ߚመ ܺ )

(Eq. 2-2)

In the logistic regression analyses, both Discontinuous–Uninsured (denoted by
DU) and Discontinuous–Insured (denoted by DI) were modeled as dichotomous outcome
variables as a function of the demographic, socioeconomic, Medicaid eligibility and
health-related covariates. F-1 denotes the inverse of the cumulative standard logistic
distribution function that relates the outcome on the probability scale to the covariates.
Pr[ ] denotes the population average probability of Medicaid discontinuity (for both with
and without other sources of insurance coverage models) conditional on the covariates. X
denotes the vector of aforementioned individual characteristics that predict Medicaid
discontinuity in the two population groups of interest. The proportion of missing data was
approximately 6% for the study. As a result, the listwise deletion approach was used to
account for missing values. Multicollinearity was assessed for all the regression models,
and the variance inflation factor was found to be less than 5, which was lower than the
widely accepted threshold of 10 for existence of multicollinearity. The HosmerLemeshow tests for goodness-of-fit were highly insignificant for all the logistic
regression models indicating no significant difference between the observed and
predicted values of the response variables, and that the model fit the data. All data
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analyses were conducted using SAS 9.3 and STATA 13 to account for the complex
survey design of MEPS.
RESULTS
Figure 2-2 is a schematic representation of the process employed for deriving the
unweighted, unadjusted study sample. Of the 344,933 individuals in the ten-year period
between 2002 and 2011, 328,135 had positive MEPS person-level weights. After
excluding individuals with Medicare (44,921), those who reported pregnancy (17), and
those respondents who were not in-scope throughout the survey period (7,359), 275,838
non-institutionalized study respondents remained. Of these, 231,675 respondents who did
not report being diagnosed with CVD or high-risk conditions for CVD were excluded,
resulting in a total of 41,163 individuals being selected who either reported being
diagnosed with, or having an event (prescribed medicine, inpatient, ER, outpatient, or
office-based provider visits) associated with CVD or high-risk conditions for CVD,
which were the index chronic conditions considered in this study. Of these, a total of
38,186 individuals were further excluded as they either did not have Medicaid coverage
at any point of time during the study period, or they were less than 18 or more than 64
years of age, resulting in a total overall sample of 5,977 individuals aged 18-64 years
who had Medicaid at any given point in time during the study period.
The overall study sample (5,977) was divided further into groups: the continuous
Medicaid coverage group consisting of 3,926 individuals (65.7%) who had uninterrupted
Medicaid coverage throughout the year (hereby referred to as Continuous Medicaid), and
the discontinuous Medicaid coverage group consisting of 1,900 individuals (31.8%) who
had less than 12 months of Medicaid coverage. There were 151 individuals (2.5%) who
reported both full-year Medicaid coverage along with other sources of health insurance,
which were excluded in the main analyses and included in the sensitivity analyses. In
order to capture the heterogeneity in the discontinuous Medicaid subpopulation due to
presence of other sources of health insurance coverage, this group was further divided
into two groups: the Discontinuous–Uninsured, which consisted of 1,407 individuals
(74.1% of the discontinuous Medicaid subpopulation, 23.5% of the total study sample)
who did not report any other form of health insurance during the year, and the
Discontinuous–Insured, consisting of 493 individuals (25.9% of the discontinuous
Medicaid subpopulation, 8.3% of the total study sample) who reported some other form
of health insurance during the year (either, private, Tricare, or other forms of hospital- or
physician group-based health insurance). Thus, all outcome models were analyzed
separately; comparing Continuous Medicaid and the Discontinuous–Uninsured
populations, and separately comparing the Continuous Medicaid vs. the Discontinuous–
Insured population groups. This was done to capture the variability among the population
group of interest, those with Discontinuous Medicaid. Individuals who do not report
having continuous full-year Medicaid coverage and have no other health insurance during
the year may have significant differences, not only in sociodemographic characteristics
and health status, but may also have different health care utilization patterns and health
behaviors.
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MEPS 2002-2011
N = 344,933

Exclusion: Non-positive person weights
N = 16,798

N = 328,135

Exclusion: Medicare enrollees
N = 44,921

N = 283,214

Exclusion: Pregnancy
N = 17

N = 283,197
Exclusion: Dropped out of survey
N = 7,359
N = 275,838
Exclusion: Individuals without CVD or
high-risk conditions
N = 231,675

Individuals with CVD or highrisk conditions
N = 44,163

Individuals aged 18-64 years,
ever had Medicaid
N = 5,977

Continuous Medicaid
(12 months)
N = 3,926

Exclusion: Age <18 or >64 years,
never had Medicaid
N = 38,186

Exclusion for Main Analysis: Continuous
Medicaid & Other insurance
N = 151
(Included in sensitivity analyses)

Discontinuous Medicaid
(<12 months)
N = 1,900

Discontinuous–Uninsured
(<12 months & No other insurance)
N = 1,407
Figure 2-2.

Discontinuous–Insured
(<12 months & Other insurance)
N = 493

Schematic Representation of the Study Sample Derivation Process
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Table 2-1 depicts the distribution of the various diagnosis and utilization
components or criteria which were considered in this study for sample selection. From an
overall sample of 5,997, 3,997 reported being diagnosed with one or more of the CVD or
high-risk conditions for CVD examined in this study, 5,332 reported taking on or more
prescription medicines associated with these index chronic conditions, and 3,713 had
reported having one or more office-based provider visits for one or more of the index
chronic conditions examined in this study.
Prevalence of CVD or High-Risk Conditions for CVD
Table 2-2 shows the prevalence of CVD or high-risk conditions for CVD in the
study population. The prevalence of the index disease conditions was fairly even between
the Continuous and Discontinuous–Uninsured groups with hypertension being the most
prevalent disease (49.9% vs. 52.7%, P=0.179), followed by lipid disorders (34.1% vs.
31.3%, P=0.139), and diabetes (28.3% vs. 28.5%, P=0.918). The prevalence of coronary
artery disease (8.1% vs. 7.3%, P=0.407), MI (4.3% vs. 4.0%, P=0.739), stroke (4.4% vs.
3.8%, P=0.572), CHF (3.3% vs. 3.1%, P=0.856), peripheral and visceral atherosclerosis
(1.6% vs. 0.9%, P=0.082), and chronic kidney disease (0.8% vs. 0.4%, P=0.293) had
lower prevalence in these groups. Distribution of the index conditions when comparing
the Continuous with the Discontinuous–Insured groups was similar. The mean number of
index chronic conditions was higher among the Continuous Medicaid group compared to
the Discontinuous–Uninsured (P=0.028), and the Discontinuous–Insured groups
(P=0.008). When comparing the raw numbers of cardiovascular disease and associated
comorbidities in this study population, this study found that 18.7% of individuals in the
Continuous group had 3 or more chronic conditions, compared to 17.7% in the
Discontinuous–Uninsured (P=0.792), and 13.6% in the Discontinuous–Insured groups
(P=0.096).
Among individuals with MI, the most prevalent chronic comorbid index driving
diagnosis was hypertension, followed by lipid disorders, coronary artery disease,
diabetes, stroke, and congestive heart failure. In this subgroup, the prevalence of stroke
was significantly different between the Continuous and Discontinuous–Insured groups
(P=0.027). When examining individuals with CHF, the most prevalent chronic comorbid
index driving diagnosis was found to be hypertension, followed by lipid disorders,
diabetes, coronary artery disease, myocardial infarction, and stroke. Finally, among
individuals with coronary artery disease, hypertension was again the most prevalent
comorbidity, followed by lipid disorders, diabetes, myocardial infarction, and congestive
heart failure (results not shown).
Medicaid Enrollment among the Two Discontinuous Medicaid Groups
Table 2-3 shows the summary statistics for Medicaid enrollment among the
discontinuous Medicaid insurance groups. The average duration of enrollment for the
undivided discontinuous Medicaid population was 6.0 months. The Discontinuous–
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Table 2-1.

Diagnosis and Event Components Used to Select the Study Population
Components

Frequency (N)

CVD or High-Risk Conditions
for CVD

3,997

Weighted
Frequency (N)
2,638,024

% (SE)

Rx for CVD or High-Risk
Conditions for CVD

5,332

3,474,117

89.3 (0.6)

Inpatient Visit for CVD or HighRisk Conditions for CVD

372

260,990

6.7 (0.4)

ER Visit for CVD or High-Risk
Conditions for CVD

463

304,458

7.8 (0.5)

Outpatient Visit for CVD or
High-Risk Conditions for CVD

480

324,800

8.3 (0.6)

Office-Based Visit for CVD or
High-Risk Conditions for CVD

3,713

2,379,045

61.1 (0.9)

Study Population

5,977

3,892,363

--

67.8 (0.9)

CVD: Cardiovascular disease; Rx: Prescription medication; ER: Emergency room.
CVD include myocardial infarction, coronary artery disease, congestive heart failure,
peripheral and visceral atherosclerosis, stroke. High-risk conditions for CVD include
hypertension, lipid disorders, and diabetes, chronic kidney disease.
Study Population includes individuals reporting one or more of at least one of the study
components listed in the table.
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Table 2-2.

Prevalence of CVD or High-Risk Conditions for CVD in the Study Population
Continuous Medicaid

Prevalence

Mean Index
Diseases (SE)
No. of Index
Diseases
1
2
>3

Index
Diseases
MI
CAD
CHF
PVA
Stroke
Hypertension
Lipid Disorders
Diabetes
CKD

Weighted N
or Mean
109,746
207,594
83,275
40,962
111,114
1,273,888
870,818
723,694
19,144

Discontinuous–Uninsured

% (SE)
or SE
4.3 (0.5)
8.1 (0.6)
3.3 (0.5)
1.6 (0.3)
4.4 (0.5)
49.9 (1.2)
34.1 (1.1)
28.3 (1.1)
0.8 (0.2)

1.73

0.01

951,993
462,928
325,033

54.7 (1.4)
26.6 (1.1)
18.7 (1.1)

Weighted N
or Mean
36,811
66,361
28,341
8,511
35,051
481,202
285,706
260,672
4,046
1.70

351,268
163,062
110,621

Discontinuous–Insured

% (SE)
or SE
4.0 (0.6)
7.3 (0.9)
3.1 (0.8)
0.9 (0.3)
3.8 (0.8)
52.7 (1.8)
31.3 (1.7)
28.5 (1.8)
0.4 (0.2)

Weighted N
or Mean
10,903
25,846
5,709
7,810
13,361
196,635
133,370
113,299
1,323

0.01*

1.56

56.2 (2.2)
26.1 (1.8)
17.7 (1.8)

170,538
65,581
37,000

% (SE)
or SE
2.6 (0.9)
6.1 (1.2)
1.4 (0.7)
1.8 (0.7)
3.2 (1.1)
46.4 (2.7)
31.4 (2.5)
26.7 (2.2)
0.3 (0.2)
0.06**

62.4 (3.2)
24.0 (3.2)
13.6 (2.4)

CVD: Cardiovascular disease; MI: myocardial infarction; CAD: coronary artery disease; CHF: congestive heart failure; PVA: peripheral vascular
disease; CKD: chronic kidney disease; SE: standard error
***P<0.001; **P<0.01; *P<0.05 for difference from the Continuous Medicaid group. Index diseases include the CVD or its associated risk factor
comorbidities considered in this study. Sample consists of 3,003997 individuals or weighted sample of 2,638,024 who reported being diagnosed
with one or more index diseases.
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Table 2-3.

Medicaid Enrollment among the Discontinuous Medicaid Groups

Coverage
Components
Mean Duration of
Medicaid
Mean Duration of
No Insurance

Discontinuous–Uninsured
Mean or
SE or %
Weighted N
(SE)
6.5 months
0.1
5.5 months

0.1

Discontinuous–Insured
Mean or
SE or %
Weighted N
(SE)
***
5.0 months
0.2
1.2 months***

0.1

Insurance Status
After 12 Months†
Still in Medicaid
Uninsured
Other Insurance

83,125
297,045
--

21.9 (2.2)
78.1 (2.2)
--

11,647***
10,058***
147,896

8.0 (2.0)
6.0 (2.0)
86.0 (2.0)

Medicaid
Coverage
Transitions
1
>2

752,311
161,615

82.3 (1.4)
17.7 (1.4)

350,803
73,462

82.7 (2.0)
17.3 (2.0)

Sample consisted of 380,171 individuals in the Discontinuous–Uninsured group and 169,600
individuals in the Discontinuous–Insured group who either reported being diagnosed with or
having an event (prescription medication, or inpatient, emergency, hospital outpatient, or officebased provider visits) associated with CVD or high-risk conditions for CVD, and who reported
having Medicaid at the beginning of the year.
***P<0.001; **P<0.01; *P<0.05 for difference from the Discontinuous–Uninsured group.
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Uninsured group was enrolled in Medicaid for a longer period on average compared to
the Discontinuous–Insured group (6.5 vs. 5.0 months, P<0.001). Additionally, this study
examined the average duration of no insurance and found individuals in the
Discontinuous–Insured group were uninsured for a little over a month (5.5 vs. 1.2
months, P<0.001). This study also examined Medicaid enrollment status after 12 months
of initial Medicaid enrollment. Overall, a total of 4,898 individuals were enrolled in the
month of January of the survey year, of which 85.3% were still enrolled in Medicaid
during the month of December in the survey year, 3.5% had some other form of
insurance coverage, and 10.2% were uninsured (results not shown). Of the 621
individuals in the Discontinuous–Uninsured group who had Medicaid in the beginning of
the year, 78.1% were uninsured while 21.9% still had Medicaid coverage at the end of the
year. Of the 200 individuals in the Discontinuous–Insured group who had Medicaid in the
beginning of the survey year, only 8.0% still had Medicaid, 6.0% were uninsured, and the
remaining 86% had some other source of health insurance coverage at the end of the year.
Finally, when examining the number of transitions into and/or out of Medicaid coverage,
this study found that overall 17.6% of individuals in this study population had more than
one transitions, and the proportion of multiple transitions was similar between the two
discontinuous Medicaid subgroups (17.7% vs. 17.3%, P=0.875).
Characteristics of the Study Population
Table 2-4 displays the demographic, socioeconomic, eligibility, and healthrelated characteristics of the study population. The mean age of the full sample was 46.5
years (not displayed). In comparison to the Continuous Medicaid group, those in the
Discontinuous–Uninsured group were less likely to belong to other races [5.5%
(Discontinuous–Insured) vs. 9.5% (Continuous), P<0.001], were more likely to be
married (37.7% vs. 29.9%, P<0.001), and were more likely to belong to the South (34.5%
vs. 29.8%, P=0.035). When examining the socioeconomic characteristics, this study
found that the Discontinuous–Uninsured were more likely to have completed high
school/GED (54.9% vs. 50.4%, P=0.004) or college (12.2% vs. 9.4%, P=0.004), were
more likely to have incomes >125% FPL (43.0% vs. 33.9%, P<0.001), and were more
likely to have intermittent (25.0% vs. 12.4%, P<0.001), as well as continuous full-year
employment (20.7% vs. 15.1%, P<0.001). Among the Medicaid eligibility variables, the
Discontinuous–Uninsured were less likely to be eligible for SSI due to disability or
participate in TANF (16.9% vs. 41.5%, P<0.001), and were less likely to report Medicaid
HMO/managed care (50.6% vs. 61.3%, P<0.001). Finally, when examining the healthrelated covariates, they were less likely to report having mental /substance abuse illnesses
(24.9% vs. 30.8%, P=0.003), respiratory illnesses (12.9% vs. 19.7%, P<0.001), or
arthritis/joint pain diagnosis (29.3% vs. 34.1%, P=0.015), and were less likely to report
having fair or poor perceived mental health status (25.7% vs. 33.7%, P<0.001) when
compared to the Continuous Medicaid group. The mean CCI score was not significantly
different between the two groups (P=0.078).
When comparing the Discontinuous–Insured group to the Continuous Medicaid
group (Table 2-4), this study found that when examining the demographic covariates,
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Table 2-4.

Characteristics of the Study Population

Characteristics
DEMOGRAPHIC

Continuous Medicaid
Weighted N
% (SE)

Discontinuous–Uninsured
Weighted N
% (SE)
P-value†

Discontinuous–Insured
Weighted N
% (SE)
P-value††

0.621

0.027

Age
18 – 34 years

388,425

15.9 (1.0)

165,340

18.1 (1.3)

98,188

23.1 (2.3)

35 – 49 years

875,809

35.9 (1.2)

324,653

35.5 (1.8)

141,109

33.3 (2.7)

50 – 64 years

1,173,144

48.2 (1.3)

423,933

46.4 (2.0)

184,968

43.6 (3.0)

0.359

Gender
Female

1,632,006

67.0 (1.2)

624,410

68.3 (1.8)

Race/Ethnicity

0.223
267,502

63.1 (2.8)

<0.001

<0.001

Non-Hispanic White

1,094,002

44.9 (1.8)

442,534

48.4 (2.1)

256,231

60.4 (3.2)

Non-Hispanic Black

666,358

27.3 (1.5)

219,033

24.0 (1.6)

799,36

18.8 (2.0)

Hispanic

445,601

18.3 (1.2)

202,106

22.1 (1.5)

50,704

12.0 (1.6)

Others

231,416

9.5 (0.9)

50,253

5.5 (0.9)

37,393

8.8 (1.7)

Marital Status
Married

<0.001
727,457

29.9 (1.3)

344,150

37.7 (1.8)

Region

<0.001
184,414

43.5 (3.2)

0.035

0.034

Northeast

608,070

25.0 (1.6)

187,785

20.5 (1.7)

104,394

24.6 (2.9)

Midwest

477,401

19.6 (1.4)

184,710

20.2 (1.7)

115,146

27.2 (3.2)

South

727,520

29.8 (1.6)

315,073

34.5 (1.8)

98,072

23.1 (2.3)

West

624,386

25.6 (1.7)

226,358

24.8 (1.9)

106,652

25.1 (3.0)
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Table 2-4.

(Continued)

Characteristics
Family Size Mean (SE)

Continuous Medicaid
Weighted
% (SE)
N
2.8 (0.1)

Discontinuous–Uninsured
Weighted N
% (SE)
P-value†
2.9 (0.1)

0.481

Discontinuous–Insured
Weighted N
% (SE)
P-value††
2.8 (0.1)

0.900

SOCIOECONOMIC
Education
<High School
High School/GED
College Degree

0.004
971,041

40.2 (1.4)

298,300

32.9 (1.8)

67,896

16.0 (1.9)

1,215,968

50.4 (1.4)

498,289

54.9 (2.0)

232,334

54.9 (3.2)

227,668

9.4 (0.7)

111,300

12.2 (1.4)

123,109

29.1 (3.2)

Income
<100% FPL

<0.001

<0.001

<0.001

1,384,551

56.8 (1.2)

428,540

46.9 (1.7)

104,719

24.7 (2.3)

100 – <125% FPL

227,591

9.3 (0.6)

91,940

10.1 (1.1)

28,783

6.8 (1.3)

>125% FPL

825,236

33.9 (1.1)

393,445

43.0 (1.8)

290,763

68.5 (2.6)

Employment

<0.001

<0.001

Always Unemployed

1,767,234

72.5 (1.2)

496,282

54.3 (1.8)

112,490

26.5 (2.2)

Unstable Employment

301,597

12.4 (0.8)

228,246

25.0 (1.6)

129,583

30.6 (2.5)

Always Employed

368,547

15.1 (0.9)

189,398

20.7 (1.4)

182,191

42.9 (2.9)

1,931,797

79.3 (1.8)

721,532

78.9 (1.9)

0.854

344,287

81.1 (2.7)

0.503

SSI/TANF

1,012,240

41.5 (1.3)

154,157

16.9 (1.3)

<0.001

41,212

9.7 (1.6)

<0.001

Medicaid HMO/MCO

1,424,726

61.3 (1.5)

459,330

50.5 (2.0)

<0.001

233,429

55.0 (3.0)

0.064

MSA
MEDICAID-RELATED
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Table 2-4.

(Continued)

Characteristics
HEALTH-RELATED

Continuous Medicaid
Weighted N
% (SE)

Discontinuous–Uninsured
Weighted N
% (SE)
P-value†

Discontinuous–Insured
Weighted N % (SE) P-value††

0.144

<0.001

Perceived Health Status
Fair to Poor

1,314,794

53.9 (1.2)

467,555

51.2 (1.9)

Perceived Mental Health
Fair to Poor

40.2 (2.5)

<0.001
821,318

33.7 (1.2)

234,931

25.7 (1.7)

<0.001
84,716

20.0 (2.2)

0.775

CVD or High-Risk
Conditions for CVD
<1

170,598

0.037

1,678,222

68.9 (1.1)

640,242

70.1 (1.8)

321,685

75.8 (2.3)

2

444,995

18.2 (0.8)

163,062

17.8 (1.4)

65,581

15.5 (2.2)

>3

314,160

12.9 (0.8)

110,621

12.1 (1.3)

37,000

8.7 (1.5)

Mental/Substance Abuse
Illnesses

751,357

30.8 (1.2)

227,885

24.9 (1.6)

0.003

115,891

27.3 (2.4)

0.176

Respiratory Illnesses

479,702

19.7 (1.1)

117,992

12.9 (1.1)

<0.001

39,380

9.3 (1.5)

<0.001

Arthritis/Joint Pain

830,408

34.1 (1.3)

267,358

29.3 (1.7)

0.015

107,575

25.4 (2.4)

0.002

CCI Score Mean (SE)

1.2 (0.0)

0.078

0.9 (0.1)

Population Size

2,437,378

1.1 (0.1)
64.6 (1.0)

913,926
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24.2 (0.8)

424,265

0.003
11.2 (0.7)

Table 2-4.

(Continued)

Study population includes MEPS respondents from the years 2002-2011, aged 18-64 years, who either reported being diagnosed with, or
reported having an event (prescription medication, or inpatient, emergency, outpatient, or office-based provider visits) associated with, 1 or
more cardiovascular disease or associated risk factor comorbidities considered in this study.
†
P-value for the difference between Discontinuous–Uninsured and Continuous Medicaid groups. ††P-value for the difference between
Discontinuous–Insured and Continuous Medicaid groups. P-values in bold indicate statistically significant difference below the threshold
value of P<0.05.
SE: Standard error; GED: General educational development; FPL: Federal poverty level; MSA: Metropolitan Statistical Area; SSI:
Supplementary Security Income due to disability; TANF: Temporary Assistance to Needy Families program participation; HMO: Health
maintenance organization; MCO: Managed care organization; CCI: Charlson Comorbidity Index score (D’Hoore adapted CCI score was
calculated in this study using the 3-digit ICD-9-CM codes in MEPS).
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individuals in the Discontinuous–Insured group were more likely to be younger (23.1%
vs. 15.9% in the 18-34 years age group, P=0.027), less likely to be Non-Hispanic Black
(18.8% vs. 27.3%, P<0.001) or Hispanic (12.0% vs. 18.3%, P<0.001), more likely to be
married (43.5% vs. 30.4%, P<0.001), and more likely to reside in the Midwest (27.2%
vs. 19.6%, P=0.034). Among the socioeconomic characteristics, the Discontinuous–
Insured were more likely to have a college degree (29.1% vs. 9.4%, P<0.001), were more
likely to have family incomes >125% FPL (68.5% vs. 33.9%, P<0.001), were more likely
to have intermittent (30.5% vs. 12.4%, P<0.001), or continuous full-year employment
(42.9% vs. 15.1%, P<0.001). Among the Medicaid eligibility variables it was found that
the Discontinuous–Insured were less likely to be eligible for SSI due to disability or
participate in TANF (9.7% vs. 41.5%, P<0.001), however, Medicaid managed care
enrollment was not statistically significant. When examining the health-related
characteristics, the Discontinuous–Insured were less likely to report having fair to poor
health status (40.2% vs. 53.9%, P<0.001), or fair to poor mental health status (20.0% vs.
33.7%, P<0.001), more likely to have fewer CVD or high-risk conditions for CVD
(P=0.037) less likely to have respiratory illnesses (9.3% vs. 19.7%, P<0.001), or
arthritis/joint pain diagnosis (25.4% vs. 34.1%, P=0.002), and had a lower mean CCI
score [Mean (SE): 0.9 (0.07) vs. 1.2 (0.04), P=0.003] in comparison to the Continuous
Medicaid group.
Characteristics Associated with Medicaid Discontinuity
The final study sample with non-missing values on all variables, after undergoing
the listwise deletion process, was 5,738, comprising of 3,859 individuals in the
Continuous Medicaid group, 1,388 individuals in the Discontinuous–Uninsured group,
and 491 individuals in the Discontinuous–Insured group. Table 2-5 shows the results of
the multivariate logistic regression analyses to determine the predictors of Medicaid
discontinuity among non-elderly adults with CVD or high-risk conditions for CVD.
Discontinuous–Uninsured
When comparing individuals with discontinuous Medicaid coverage with no other
sources of health coverage (Discontinuous–Uninsured) to those with continuous
Medicaid coverage (Continuous) group, this study found that among the demographic
predictors, male respondents had 18% lower odds than females [Odds Ratio (OR): 0.82;
95% Confidence Interval (CI): 0.68 – 0.98], Non-Hispanic Blacks had a 21% lower odds
(OR: 0.79, 95% CI: 0.64 – 0.98), and individuals belonging other races had a 43% lower
odds compared to Non-Hispanic Whites (OR: 0.57, 95% CI: 0.40 – 0.81), married
individuals had 26% higher odds than respondents who were not married (OR: 1.26, 95%
CI: 1.03 – 1.55), and individuals living in the South had about 65% higher odds
compared to the Northeast residents (OR: 1.65, 95% CI: 1.29 – 2.10), of experiencing
Medicaid discontinuity with no subsequent (or concurrent) sources of health coverage.
Among the socioeconomic predictors of Medicaid discontinuity, this study found
that individuals with family income levels of >125% FPL had about 23% higher odds
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Table 2-5.

Characteristics Associated with Medicaid Discontinuity in the Study Population

Characteristics

Discontinuous–Uninsured
Odds Ratio (95% Confidence Interval)

Discontinuous–Insured
Odds Ratio (95% Confidence Interval)

DEMOGRAPHIC
Age
18 – 34 years

1.00 (Reference)

1.00 (Reference)

35 – 49 years

1.10 (0.83 – 1.45)

1.12 (0.75 – 1.67)

50 – 64 years

1.25 (0.92 – 1.69)

0.85 (0.62 – 1.16)

Female

1.00 (Reference)

1.00 (Reference)

Male

0.82 (0.68 – 0.98)*

0.94 (0.73 – 1.21)

Non-Hispanic White

1.00 (Reference)

1.00 (Reference)

Non-Hispanic Black

0.79 (0.64 – 0.98)*

0.59 (0.43 – 0.82)**

Hispanic

1.09 (0.85 – 1.38)

0.65 (0.44 – 0.96)*

Others

0.57 (0.40 – 0.81)**

1.01 (0.60 – 1.71)

Not Married

1.00 (Reference)

1.00 (Reference)

Married

1.26 (1.03 – 1.55)*

1.50 (1.09 – 2.06)*

Northeast

0.86 (0.66 – 1.11)

1.00 (Reference)

Midwest

1.15 (0.87 – 1.52)

1.46 (0.97 – 2.18)

South

1.40(1.09 – 1.80)**

1.13 (0.78 – 1.63)

Gender

Race/Ethnicity

Marital Status

Region
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Table 2-5.

(Continued)

Characteristics
West

Discontinuous–Uninsured
Odds Ratio (95% Confidence Interval)
1.00 (Reference)

Discontinuous–Insured
Odds Ratio (95% Confidence Interval)
0.99 (0.67 – 1.48)

0.94 (0.89 – 1.00)*

0.86 (0.76 – 0.96)*

<High School

1.00 (Reference)

1.00 (Reference)

High School/GED

1.22 (1.00 – 1.49)

1.77 (1.26 – 2.49)***

College Degree

1.05 (0.76 – 1.45)

3.13 (2.16 – 4.53)***

<100% FPL

1.00 (Reference)

1.00 (Reference)

100 – <125% FPL

1.06 (0.80 – 1.41)

1.21 (0.77 – 1.92)

>125% FPL

1.23 (1.01 – 1.50)*

2.52 (1.89 – 3.36)***

Always Unemployed

1.00 (Reference)

1.00 (Reference)

Unstable Employment

1.92 (1.49 – 2.47)***

3.97 (2.86 – 5.51)***

Always Employed

1.23 (0.96 – 1.56)

3.52 (2.47 – 5.01)***

Non-MSA

1.00 (Reference)

1.00 (Reference)

MSA

1.08 (0.85 – 1.37)

1.28 (0.85 – 1.92)

Family Size
SOCIOECONOMIC
Education

Income

Employment

MSA
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Table 2-5.

(Continued)

Characteristics

Discontinuous–Uninsured
Odds Ratio (95% Confidence Interval)

Discontinuous–Insured
Odds Ratio (95% Confidence Interval)

MEDICAID-RELATED
SSI/TANF
No

1.00 (Reference)

1.00 (Reference)

Yes

0.33 (0.27 – 0.41)***

0.33 (0.21 – 0.51)***

No

1.00 (Reference)

1.00 (Reference)

Yes

0.61 (0.52 – 0.73)***

0.70 (0.53 – 0.92)*

Excellent/Very Good/Good

1.00 (Reference)

1.00 (Reference)

Fair to Poor

1.25 (1.04 – 1.51)*

1.09 (0.83 – 1.42)

Excellent/Very Good/Good

1.00 (Reference)

1.00 (Reference)

Fair to Poor

0.83 (0.67 – 1.02)

0.84 (0.60 - 1.17)

<1

1.00 (Reference)

1.00 (Reference)

2

1.05 (0.84 – 1.32)

0.80 (0.54 – 1.17)

>3

0.97 (0.69 – 1.36)

0.84 (0.50 – 1.41)

Medicaid HMO/MCO

HEALTH-RELATED
Perceived Health Status

Perceived Mental Health

CVD or High-Risk Conditions for
CVD
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Table 2-5.

(Continued)

Characteristics

Discontinuous–Uninsured
Odds Ratio (95% Confidence Interval)

Discontinuous–Insured
Odds Ratio (95% Confidence Interval)

Mental/Substance Abuse Illnesses
No

1.00 (Reference)

1.00 (Reference)

Yes

0.91 (0.73 – 1.15)

1.23 (0.90 – 2.18)

No

1.00 (Reference)

1.00 (Reference)

Yes

0.72 (0.56 – 0.91)**

0.66 (0.44 – 1.00)*

No

1.00 (Reference)

1.00 (Reference)

Yes

0.97 (0.79 – 1.19)

0.92 (0.67 – 1.27)

CCI Score

0.99 (0.93 – 1.06)

1.07 (0.98 – 1.18)

Respiratory Illnesses

Arthritis/Joint Pain

Study population includes MEPS respondents from the years 2002-2011, aged 18-64 years, who either reported being diagnosed with, or reported
having an event (prescription medication, or inpatient, emergency, outpatient, or office-based provider visits) associated with, 1 or more
cardiovascular disease or associated risk factor comorbidities considered in this study.
***P-value<0.001, **P<0.01, *P<0.05 for the difference between Continuous Medicaid vs Discontinuous–Uninsured and Continuous Medicaid
vs Discontinuous–Insured groups
SE: Standard error; GED: General educational development; FPL: Federal poverty level; MSA: Metropolitan Statistical Area; SSI: Supplementary
Security Income due to disability; TANF: Temporary Assistance to Needy Families program participation; HMO: Health maintenance
organization; MCO: Managed care organization; CCI: Charlson Comorbidity Index score (D’Hoore adapted CCI score was calculated in this study
using the 3-digit ICD-9-CM codes in MEPS).
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(OR: 1.23, 95% CI: 1.01 – 1.50), and individuals with intermittent employment had
almost two times higher odds compared to the unemployed (OR: 1.92, 95% CI: 1.49 –
2.47) of belonging to the Discontinuous–Uninsured group. When examining the
Medicaid-related variables, this study found that SSI due to disability or TANF
participation was associated with about 67% lower odds (OR: 0.33, 95% CI: 0.27 – 0.41),
and Medicaid HMO/managed care participation was associated with 39% lower odds
(OR: 0.61, 95% CI: 0.52 – 0.73) of experiencing Medicaid discontinuity. When
examining health-related variables, this study found that individuals with respiratory
illnesses had about 28% lower odds (OR: 0.72, 95% CI: 0.56 – 0.91), and those reporting
fair to poor health status had about 25% higher odds (OR: 1.25, 95% CI: 1.04 – 1.51) of
belonging to the Discontinuous–Uninsured group.
Discontinuous–Insured
When examining the predictors of discontinuous Medicaid coverage who also
reported having other sources of health insurance coverage (Discontinuous–Insured), this
study found that among the demographic characteristics, Non-Hispanic Blacks had 41%
lower odds (OR: 0.59, 95% CI: 0.43 – 0.82), Hispanics had 35% higher odds (OR: 0.65,
95% CI: 0.44 – 0.96), and married individuals had about 48% higher odds (OR: 1.48,
95% CI: 1.07 – 2.05) of belonging of the Discontinuous–Insured group. In addition, as
the number of family members increased by one, the odds of experiencing Medicaid
discontinuity decreased by about 15% (OR: 0.85, 95% CI: 0.75 – 0.96).
Among the socioeconomic variables, this study found that individuals with higher
education had higher odds compared to individuals with no high school education [OR
(95% CI) for high school/GED: 1.75 (1.25 – 2.46), and OR (95% CI) for College degree:
3.05 (2.10 – 4.44)], individuals with higher family income had higher odds compared to
low-income group [OR (95% CI) for >125% FPL: 2.55 (1.91 – 3.41)], and those with
partial or full-year employment had higher odds [OR (95% CI) for intermittent
employment: 3.98 (2.87 – 5.54), and OR (95% CI) for always employed: 3.46 (2.42 –
4.94)] compared to unemployed individuals of belonging to the Discontinuous–Insured
group. Both the Medicaid-related variables were significant predictors with individuals
who reported receiving SSI due to disability or TANF participation having 67% lower
odds (OR: 0.33, 95% CI: 0.21 – 0.51), and those reporting Medicaid HMO/managed care
participation having about 30% lower odds (OR: 0.70, 95% CI: 0.53 – 0.92) of
experiencing Medicaid discontinuity. Finally, among the health-related variables,
individuals who reported having respiratory illnesses had about 35% lower odds (OR:
0.65, 95% CI: 0.43 – 0.98) of being in the Discontinuous–Insured group.
DISCUSSION
The present study findings highlight the high prevalence of Medicaid
discontinuity among non-elderly adults with CVD or high-risk conditions for CVD.
National estimates indicate that of the roughly 4 million individuals who reported having
CVD or an associated comorbidity in the first round of the MEPS survey and Medicaid at
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any point in time during the year, a little over 1.3 million had less than full-year Medicaid
coverage, over 900,000 (or 68.3%) of which did not have any other health insurance
during the year. To our knowledge, no previous study has stratified the discontinuous
Medicaid group based on presence (Discontinuous–Insured) or absence (Discontinuous–
Uninsured) other sources of health insurance coverage. On average, the Discontinuous–
Uninsured group in this study was enrolled for about 6.5 months in Medicaid during a
year. The instability in Medicaid coverage is further highlighted by the finding that of the
3.1 million individuals (Unweighted frequency = 4,898) who had Medicaid at the
beginning of the year, a little over 300,000 (or 10%) of these individuals were uninsured
at the end of the year. When this end-of-the-year insurance status was examined among
individuals with family income level of <100% of FPL, this study found that of the 1.6
million individuals who had Medicaid as the year began, over 130,000 (or 8%) of these
individuals were uninsured as the year ended. Churning in Medicaid, or multiple
transitions into and out of Medicaid coverage, especially to a state of having no health
insurance, are a major concern among policymakers and health policy researchers.8,44
Churning is especially concerning when it results in loss of health insurance. This study
found that about 17% of the non-elderly adult population with CVD or high-risk
conditions for CVD experienced more than one transition into or out of Medicaid
coverage.
Hypertension, lipid disorders and diabetes, conditions considered significant risk
factors for CVD, were the most prevalent chronic conditions in this population. Among
the core CVD conditions, coronary artery disease, MI, and stroke – conditions that exert
significant morbidity and mortality – were the most prevalent chronic conditions in this
study.18,21 Hypertension has been well-established as a significant high-risk condition for
CVD.17,21 This study found hypertension to be the most prevalent chronic condition
among low-income individuals with CVD or high-risk conditions for CVD. Although
estimates in the literature indicate the prevalence of CVD in the Medicaid population to
be over 16 million as mentioned earlier, the lower numbers in this study may indicate
differences in data source and inclusion criteria of first round-disease reporting to capture
the chronicity of CVD and associated risk factors. The distribution of these index
diseases was similar between the continuous Medicaid coverage, and both the
discontinuous Medicaid groups indicating that Medicaid discontinuity, both with or
without other sources of health insurance, may be predicted by factors other than
differences in CVD burden.
Of the two major public health insurance programs in the U.S., Medicaid
enrollees are more likely to experience discontinuity in their health care coverage in
comparison to Medicare enrollees, and the prevalence and duration of coverage
discontinuity are as high as private employer-sponsored insurance among the low-income
groups.45 Being the primary, means-tested health insurance program for the low-income
population, small increases in family incomes and assets often render individuals and
families ineligible for Medicaid based on their state’s Medicaid eligibility criteria.
However, research has shown that several individuals and families lose Medicaid
coverage despite being eligible, mainly due to the inability to periodically report changes
in their income, assets, and residential status, among other information, and often not
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being able to understand the state Medicaid reenrollment procedures.37,46,47 As shown in
this study a significant proportion of the discontinuous Medicaid coverage group did not
report having any other source of health insurance coverage. Overwhelmingly, empirical
literature suggests uninsured individuals have poor access to care, utilization of health
care services, unplanned inpatient admissions, and often have poor health outcomes
compared to the insured populations.10-14,31,32
Among the characteristics significantly associated with discontinuity, NonHispanic Whites had a higher likelihood of experiencing discontinuity compared to
minorities, which is similar to previous findings. This may be due to the fact that
minorities are more likely to be eligible for Medicaid due to differential income and
assets. This is further bolstered by additional findings in this study that those with higher
education, income levels, and some form of employment during the year; indicators of
better socioeconomic status; have a higher likelihood of experiencing Medicaid
discontinuity, which may indicate that race/ethnicity may be impacting discontinuity in
conjunction with socioeconomic characteristics. Individuals residing in the southern
geographic region were more likely to report having discontinuous Medicaid coverage
and no other form of health insurance, which may reflect regional differences in
Medicaid eligibility criteria and reenrollment procedures.48 Respondents who reported
having Medicaid through managed care organizations had significantly lower likelihood
of experiencing discontinuity in their Medicaid coverage which may be due to better
outreach efforts to ensure continued enrollment among their plan members compared to
the traditional state fee-for-service Medicaid programs.38
As of April 2015, thirty states, including the district of Columbia (D.C.) have
moved forward to expand their state Medicaid programs in accordance with the
regulations under the 2014 Patient Protection and Affordable Care Act (ACA), that
stipulate States to provide Medicaid coverage to residents with incomes at or below 138
percent of FPL, irrespective of marital or parenthood status.49 In addition, the health law
stipulated the creation of health insurance marketplaces in each state, known as the health
exchanges, as a one-stop shop for state residents and employers to purchase health
insurance plans. Individuals with incomes between 138 – 400 percent of FPL, who do not
meet the Medicaid eligibility criteria under the expansion provision (in states not
expanding Medicaid, the range is 100 – 400 percent of FPL) would receive subsidies to
purchase private plans from the health exchanges.50 These measures intended to expand
coverage to hitherto uninsured and underinsured individuals and families may decrease
the uninsured rate, but research suggests that the problems of Medicaid coverage
transitions may continue to persist. Research suggests that among states not expanding
Medicaid, the problems of losing Medicaid coverage to become uninsured will continue
to exist, since upward income mobility would need to be significant for individuals to
qualify for private insurance subsidies that will kick in above the 138 percent of FPL
threshold. However, among states that do expand Medicaid, the problems of transitions
from Medicaid to subsidized private insurance exchanges and/or back will also exist.51,52
When individuals lose Medicaid coverage to become uninsured, and especially
when they are eligible for Medicaid, it is considered a policy failure, and the resulting
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lack of insurance may have significant adverse health outcomes.34 However, when
individuals transition from one source of coverage to another, continuity of care may still
be impacted, especially since different insurance plans have different network of
providers, and differing benefit structures, and may cover different classes of medications
and services. This study showed that over a quarter of the CVD population with
discontinuous Medicaid coverage belonged to the Discontinuous–Insured group who
reported having less than six months of Medicaid coverage, and were uninsured for a
little over a month, on average. This may exert additional burden on individuals and
families of taking out time and effort to sign up for other sources of health care coverage
that includes providing the necessary documents for enrollment and may also temporarily
disrupt continuity of care in this population.
Policymakers debating measures to ensure continuity in Medicaid among nonelderly adults should especially include populations with chronic and debilitating
conditions such as CVD and associated risk factors in all such discussions, since the
detrimental effects of coverage discontinuity and resultant disruptions in continuity of
care may be amplified in such population groups. Moreover, outreach and reenrollment
strategies employed by Medicaid managed care organizations can be adopted by
traditional state Medicaid plans. In addition, expanding the penetration of managed care
in Medicaid can also be an alternative to enable states to strike a balance between tight
fiscal spending and increased and continued Medicaid enrollment. Health care providers
and their staff in the meanwhile can play a major role by informing, encouraging, and if
possible assisting, low-income patients with CVD, their risk factors, or disability, to signup and maintain their enrollment in Medicaid through periodic reporting as per the state’s
requirements. In a survey conducted for the Centers for Medicare and Medicaid Services
(CMS), more than half of the respondents indicated that they would trust a doctor when
making a decision to enroll in Medicaid or CHIP, and about 50 percent preferred getting
Medicaid/CHIP-related information at the doctor’s office.53
As with all observational research, this study is not without its limitations. Statelevel Medicaid eligibility data was not available to explore the complex and dynamic
patterns of discontinuity that may differ based on the state’s eligibility and reporting
criteria. Nonetheless, the finding of individuals residing in the south having greater
likelihood of discontinuity may have captured some of the regional variations in
Medicaid policies, and future research with state-level data may better account for these
differences. This study only explored associations between individual characteristics and
Medicaid discontinuity, and not causality, and the findings only explore predictors of
within-year discontinuous Medicaid coverage and may not capture risk factors for secular
trends in Medicaid discontinuity. The regression analyses may not have adjusted for
unobserved covariates that may have confounded the impact of certain risk factors on the
likelihood of belonging to the Discontinuous–Uninsured or the Discontinuous–Insured
groups.
Limitations of small sample size due to the focus of this study on individuals with
CVD or high-risk conditions for CVD, and not the entire Medicaid population, prevented
us from imputing Medicaid eligibility and obtaining robust estimates of Medicaid
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discontinuity predictors in this imputed subpopulation. Nonetheless, these findings have
highlighted significant prevalence of overall discontinuous Medicaid coverage, and future
studies with higher sample sizes of the CVD population can further explore predictors of
Medicaid discontinuity separately among those losing eligibility due to upward income
mobility, and those dropping out of Medicaid despite being eligible. Data in MEPS are
self-reported, so the estimates may not exactly reflect the national estimates of Medicaid
discontinuity. Researchers have speculated that most surveys underestimate the number
of Medicaid enrollees due to a variety of reasons including stigma of public insurance.
However, such misreporting is less of a problem for MEPS compared to other federal
health surveys.54 Finally, findings from this study are representative of the noninstitutionalized civilian population and may not be applicable to individuals with
prolonged hospitalizations or admitted to long-term care facilities.
CONCLUSION
The present study highlights the prevalence of Medicaid discontinuity among
non-elderly adults with CVD or high-risk conditions for CVD and finds that a high
proportion of individuals with less than full-year Medicaid coverage do not have any
other source of health insurance. Women, individuals with higher education and income,
those residing in the South census region, and those perceiving their health to be fair or
poor may be at higher risk for Medicaid discontinuity. Medicaid managed care enrollees
may have lower risk for Medicaid discontinuity. Outreach and reenrollment strategies
employed by such managed care organizations can be adopted by state Medicaid agencies
to improve Medicaid uptake, continuity and reenrollment, especially for enrollees with
chronic conditions such as CVD or high-risk conditions for CVD. Discussions regarding
policies to improve retention of and continuity in Medicaid must include individuals
suffering from these chronic and debilitating disease conditions whose continuity of care
may be adversely impacted due to such coverage instability. Low-income adults
managing chronic conditions, especially in regions with stringent Medicaid eligibility
regulations, must be encouraged to ensure continuity of Medicaid coverage.
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CHAPTER 3. ASSOCIATIONS BETWEEN MEDICAID DISCONTINUITY,
MEDICATION ADHERENCE AND MEDICATION UTILIZATION AMONG
ADULTS WITH CARDIOVASCULAR DISEASE OR ASSOCIATED HIGH-RISK
CONDITIONS
BACKGROUND
Cardiovascular disease (CVD) along with conditions that are risk factors for
CVD, such as diabetes and chronic kidney disease, are some of the most common causes
of death, both regionally and globally.16,17,55 Randomized studies and guidelines have
established the importance of lowering blood pressure, cholesterol, or blood sugar levels,
along with lifestyle changes such as smoking cessation, in order to reduce morbidity and
mortality associated with CVD or high-risk conditions for CVD.56,57 Nevertheless,
management of the chronic risk factor conditions has been suboptimal.58-60
Pharmacotherapy is essential to appropriately treat these chronic conditions and achieve
and maintain the guidelines-recommended target levels for blood pressure, blood sugar,
and cholesterol. Inability to obtain or consume medications necessary to avoid risk for
chronic, debilitating conditions such as CVD may have detrimental outcomes among
individuals who are at risk for these conditions.
Medicaid plays a pivotal role in providing access to care for individuals with low
incomes, and disabilities. Among non-elderly adult Medicaid enrollees, the prevalence of
chronic conditions is high and many have complex health care needs due to existing
comorbid conditions, such as mental, and respiratory illnesses.30 Prevalence of CVD or
high-risk conditions for CVD among Medicaid enrollees is high; an estimated 28% of
enrollees are diagnosed with CVD, 24% with high blood pressure, 17% with high
cholesterol, and 9-15% with diabetes.21,22 Due to this high chronic disease burden, adult
Medicaid enrollees have high health care needs, and need the resources to effectively
manage their chronic conditions.30 However, means-tested health insurance programs
such as Medicaid have their own set of eligibility criteria and enrollment procedures,
which vary from state to state,6 and it is critical for individuals and families to be
cognizant of these policies and procedures to enroll in, and maintain eligibility, programs
such as Medicaid. Small fluctuations in income levels for covered non-elderly adults due
to increases in pay or work hours, would end up disqualifying individuals with incomes
at or near eligibility thresholds. The rules and regulations for eligibility and enrollment
between public and private health insurance are different, and therefore, individuals who
have to transition between one system to another also experience gaps in insurance
coverage, either due to failure to follow enrollment procedures, or being unaware of such
an option, or even due to the stigma of enrolling for Medicaid or other low-income public
programs. It is broadly due to these factors in this fragmented health insurance system,
that individuals and families experience insurance instability and they continue to swing
into and out of various types of health insurance coverage.
Instability in Medicaid coverage may not only impact utilization of prescription
medications due to access issues, but may also affect adherence of these medications as
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prescribed by health care providers. Adherence to evidence-based cardiovascular
medications is essential for attaining therapeutic goals, in order to achieve favorable
health outcomes.61-64 Suboptimal adherence may have detrimental consequences even
among non-elderly adults with multiple chronic conditions and comorbidities, who often
require multiple medications to manage their disease conditions.65,66 Policies to ensure
higher retention of Medicaid-eligible needy individuals and continuity in Medicaid
coverage, along with seamless transition from Medicaid to other insurance coverage
sources must be a priority for policymakers and other stakeholders, including health care
providers. Pharmacotherapy may become one of the first casualties of loss of Medicaid
coverage, since out-of-pocket costs have been found to be one of the most significant
barriers to medication adherence and utilization.
Empirical studies examining the impact of lack of insurance coverage continuity
on medication adherence among individuals with CVD or high-risk conditions for CVD
is lacking. Among the few studies examining impact of discontinuous Medicaid coverage
on medication utilization in general, or focusing on other disease conditions, there is a
general agreement that having instability in coverage has an adverse impact on obtaining
needed medications to manage chronic diseases.15,32,67 In intending to strengthen the
literature on Medicaid coverage discontinuity by highlighting the association between
discontinuous Medicaid coverage and pharmacotherapy outcomes among the CVD
population, this study has the following two objectives: (1) examine whether having
discontinuous Medicaid coverage is associated with poor adherence to commonly
prescribed therapeutic drug classes, and (2) examine whether discontinuous Medicaid
coverage is associated with low prescription drug utilization.
METHODS
Data Source
The present study is a retrospective cross-sectional comparative analysis of the
Medical Expenditure Panel Survey (MEPS). MEPS is a set of large-scale surveys of
families, individuals, their medical providers and employers across the United States. It is
jointly sponsored by the Agency for Healthcare Research and Quality (AHRQ) and the
National Center for Health Statistics (NCHS), and has been conducted annually since
1996. It has two major components; the Household Component (HC), the Insurance
Component, with data on medical providers in the HC being supplemented by the
Medical Provider Component. MEPS collects detailed information from a nationally
representative sample of the civilian noninstitutionalized population of the U.S. on health
services utilization and health expenditures, insurance coverage, and sources of payment.
MEPS has an overlapping panel design. Two separate panels of respondents are
interviewed simultaneously during a calendar year. A new panel of sample households is
selected each year, and data for each panel are collected for two calendar years. The two
years of data for each panel are collected in five rounds of interviews that take place over
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a two and a half year period. This provides continuous and current estimates of health
care expenditures at both the person and household level for two panels for each calendar
year. By combining data from the overlapping panels, these annual files provide nearly
double the sample size of individual panels and cover the entire calendar year for each
respondent. Although all MEPS data are reported by respondents during computerassisted personal interviewing, further detailed health service use data, including on
prescription drugs, are collected from a sample of providers with respondents’
permission.39
When obtaining national estimates from surveys such as MEPS, appropriate
sample size is critical to obtain reliable estimates, since estimates of some population
subgroups may vary from year to year. The advantage of survey such as MEPS is that
they allow for several years’ of data to be pooled together in order to increase the sample
size and improve the precision of estimates. The pooling of the different years of data
was conducted in accordance with the guidelines provided by MEPS, and data for the
years 2002 – 2011 were pooled together to allow for a sufficiently large sample size to
ensure reliable estimates.
Study Population
The broad classification of “cardiovascular disease (CVD) and associated
comorbidities” in this study consisted for the following disease conditions: acute
myocardial infarction (Clinical Classification code (CCC): 100), coronary artery disease
(CCC: 101), congestive heart failure (CCC: 108), peripheral and visceral atherosclerosis
(CCCs: 114, 115, 116), stroke (CCCs: 109, 112), hypertension (CCC: 098), lipid
disorders (CCC: 053), and diabetes (CCC: 049, 050). CCC aggregates conditions and
procedures into mutually exclusive and clinically homogeneous categories, using Clinical
Classification Software.40 When examining utilization of prescription medications in the
form of number of medication refills, the study population included respondents who
were: (1) aged 18 to 64 years, (2) reported either being diagnosed with CVD or high-risk
conditions for CVD for CVD in their first round of the MEPS survey, or reported having
an event (an inpatient, emergency, outpatient, or office-based provider visits, or a
prescription medication) associated with one or more of the aforementioned disease
conditions at any point of time during the survey, (3) reported having had Medicaid
coverage at any point of time during the survey year, and (4) had positive person weights,
and were interviewed for all five rounds of the 2-year MEPS survey interviews. When
examining adherence to commonly prescribed medication classes for managing the CVD
and associated risk factor comorbidities listed above, an additional inclusion criteria was
considered: (5) respondents who had one or more fills or refills for the following
therapeutic drug classes – angiotensin converting enzymes inhibitors (ACEI), angiotensin
II receptor blockers (ARB), beta blockers, calcium channel blockers, diuretics, antihypertensive drug combinations, HMG-CoA reductase inhibitors (statins), sulfonylureas,
and biguanides.
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Respondents who reported having Medicare, or pregnancy were excluded from
this study. Pregnant women with incomes at or below 133 percent of the federal poverty
level are eligible for Medicaid coverage throughout the pregnancy; however, the
coverage ceases 60 days postpartum.68 Low-income non-elderly adults with disabilities
are also eligible for Medicare if they have received monthly social security disability
income for two years. Most coverage benefits for prescription drugs for dual eligible
beneficiaries are covered by Medicare Part D, instead of Medicaid. As a result, these two
population groups were excluded from this study.
Individuals who have less than a year of Medicaid coverage and experience
within-year Medicaid discontinuity may not be a homogenous group, especially when
they report having other forms of insurance coverage during the year. In order to account
for these differences, individuals in the study population who reported having <12
months of Medicaid coverage during a survey year were divided into two groups: (1)
individuals with <12 months of Medicaid coverage who did not report any other sources
of health insurance during the survey year, designated in this study as ‘Discontinuous–
Uninsured’, and (2) individuals with <12 months of Medicaid coverage who also reported
having other source(s) of health insurance during the survey year (either private, Tricare,
or any hospital- or physician group-based health insurance), designated in this study as
‘Discontinuous–Insured’. Individuals in the study population who reported having
Medicaid coverage during all 12 months of a survey year were classified as having
continuous Medicaid coverage, which was the comparison group and designated as
‘Continuous Medicaid’ in this study.
Study Variables
Our first objective was to examine whether Medicaid discontinuity was associated
with adherence to commonly prescribed classes of medications among non-elderly adults
with CVD or its associated risk factor comorbidities. The primary outcomes of interest
was the binary indicator for medication adherence measured as the medication possession
ratio (MPR), or the proportion of days during the survey year during which respondents
had medications on hand. In the subsequent section, we describe how adherence was
measured for this study. The second objective was to examine whether Medicaid
discontinuity impacts medication utilization. The primary outcome of interest for this
objective was the raw number of refills for all medications reported by the study
respondents. We divided this utilization measure into all-cause, and disease-specific
medication utilization, i.e. number of refills for all medications reported by the study
respondents in the survey year (all-cause), and the number of refills for medications
specifically prescribed for CVD or high-risk conditions for CVD for CVD that were
examined in this study (disease-specific).
All regression models included the following classes of covariates:1) Demographic covariates: age (in years), gender (female vs. male), race/ethnicity
(Non-Hispanic White vs. Non-Hispanic Black, Hispanic, and other races), marital
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status (not married vs. married), family size (N), and geographic residence
(Northeast vs. Midwest, South, and West).
2) Socioeconomic covariates: education (less than high school vs. high school/GED,
and Bachelor’s or higher), income as a percentage of the federal poverty level
(FPL) (<100% FPL vs. 100 - <125% FPL, and >125% FPL), employment (always
unemployed vs. intermittent employment, and always employed), binary indicator
for Metropolitan Statistical Area (MSA) residence.
3) Medicaid-related covariates: binary indicator for Supplementary Security Income
(SSI) for disability receipt or participation in the Temporary Assistance for Needy
Families program, and a binary indicator for Medicaid HMO/Managed Care
participation.
4) Health-related covariates: perceived health status (excellent/very good/good vs.
fair/poor), perceived mental health status (excellent/very good/good vs. fair/poor)
binary indicator for mental illness/substance abuse diagnosis, binary indicator for
respiratory diseases diagnosis, binary indicator for arthritis/joint pain diagnosis,
and Charlson Comorbidity Index (CCI) score.
When examining medication adherence, the regression models included the
following additional covariates:
5) Medication-related covariates: number of unique prescription medications
reported by the study respondents (N), and a binary indicator for whether
individuals had a 90 days’ supply of medications.
All regression models included the year fixed effects to capture any macro-level
variations during the study period. SAS 9.3 and STATA 13 were used.
Measurement of Adherence
The measurement of adherence in this study involved several intermediate steps.
From the Prescribed Medicines files in MEPS, this study used the drug refill records for
each study respondent, to estimate adherence to each medication class during the year
when the respondents had refills for any medication from that class of medication. Of the
two most common measures of adherence, medication possession ratio (MPR) and
proportion of days covered (PDC), this study used the MPR measure.69,70 Using an
interval-based MPR measure approach, the denominator for this measure was the number
of days between the index date, which was first day of the round in which the first fill or
refill of a class of drug (e.g. beta blockers) was reported, and the last day of the survey
year, i.e. December 31st. The numerator is the total number of days covered by drug fills
during the denominator duration, i.e. the total days’ supply for that particular class of
medication within the follow-up (denominator) period. Equation 3-1 displays the
average MPR estimation:
∑
total Rx days of supplyn
Intervaln (round date for first Rx during year – December 31)
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(Eq. 3-1)

n

As mentioned earlier, the proportion of the total days’ supply for a therapeutic
class of medication was estimated within the follow-up interval reported by an individual.
Depending on the number of therapeutic classes reported by each individual, the MPR
was estimated for each class and summed, and then divided by the number of therapeutic
classes reported by individuals (n) to obtain an average MPR measure for that individual.
This enables capturing non-adherence, since any discontinuation in the drug refill will be
captured in the calculation as it tracks adherence till the end of the duration and not the
last drug refill during the measurement period, as is common with the standard measures
of MPR.69 All MPR measures were expressed as a percentage and capped at 100% (or
1.0). Drugs that were dispensed within a therapeutic class (e.g. switching from carvedilol
to propranolol among beta blockers) were considered interchangeable.69 ACEI and ARBs
were considered a single class for this study.
More than 90% of index refills had occurred in the first two rounds of the
calendar year. The drug class-specific MPRs that were obtained were summed, and an
overall average MPR measure was calculated to summarize adherence to all drug classes
an individual was taking. In order to make policy-relevant conclusions about the impact
of insurance discontinuity on medication adherence, the continuous MPR measure was
transformed into a binary MPR measure, with a cutoff of 80% (0.8) or more signifying
adequate adherence to prescribed medications examined in this study. The main outcome
variable was the overall binary MPR measure. Class-specific MPR adherence measures
were examined in secondary analyses.
Prior to 2010, MEPS did not report data on days’ supply for the prescription
medications reported by the respondents during the survey year. Previous studies have
overcome this shortcoming, by developing algorithms for days’ supply based on the
quantity of drug dispensed using data from administrative claims, or other similar
sources. A similar approach was applied; however, rather than using an external source of
data, the 2010 and 2011 MEPS prescription medication data that had the days’ supply
information was used to develop an algorithm that approximates days’ supply for
previous years in MEPS based on their quantity prescribed/dispensed, which was
available for all the 10 years in MEPS. The most frequent number of supply days
furnished by each level of dispensed quantity was first identified, and found that 30, and
90 days’ supply were the most common patterns observed for most quantities dispensed.
After deriving a method to smoothly approximate the distribution of the days’ supply, the
days of supply were categorized using different sets of categories. The third
categorization algorithm was found to have the highest correlation with the actual MPR
measures, both continuous and binary, which were calculated using the days’ supply
variables from 2011 and 2010 years of MEPS data, separately as displayed in Table 3-1
and Table 3-2. Finally, using this algorithm, the MPR adherence measures for all years
prior to 2010 were calculated to obtain overall estimates of medication adherence.
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Table 3-1.

Refill Days of Supply Algorithms and MPR Validation in 2011 Sample (N= 5,475)

Categorization

Quantity
Dispensed

Corresponding
Days’ Supply
Algorithm

Categorization 1

<75
>75

30
90

Categorization 2

<50
>50 – <80
>80

30
60
90

Categorization 3

<44
45
>45 – <75
>75 – <119
120
>120

30
90
30
90
30
90

Continuous MPR
Measure
Pearson’s
Correlation
0.868

Binary MPR Measure
Observed
κ- Statistic
Agreement (%)
0.925

0.841***

0.881

0.931

0.854***

0.889

0.934

0.864***

MPR: Medication Possession Ratio
***P<0.001. The null hypothesis for estimating kappa statistic is that there is no agreement between the two discrete measures of
MPR.
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Table 3-2.

Refill Days of Supply Algorithms and MPR Validation in 2010 Sample (N= 5,058)

Categorization

Quantity
Dispensed

Corresponding
Days’ Supply
Algorithm

Categorization 1

<75
>75

30
90

Categorization 2

<50
>50 – <80
>80

30
60
90

Categorization 3

<44
45
>45 – <75
>75 – <119
120
>120

30
90
30
90
30
90

Continuous MPR
Measure
Pearson’s
Correlation
0.835

Binary MPR Measure
Observed
κ- Statistic
Agreement (%)
0.918

0.827***

0.856

0.876

0.747***

0.868

0.924

0.841***

MPR: Medication Possession Ratio
***P<0.001. The null hypothesis for estimating kappa statistic is that there is no agreement between the two discrete measures of
MPR.
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Statistical Analysis
Bivariate statistics were conducted when examining the characteristics of the
study population. Survey-weighted proportions of the use of different classes of
medications examined in this study were calculated. When examining medication
adherence, Survey-weighted multivariate logistic regression analyses were conducted.
Equation 3-2 and Equation 3-3 depict the logistic regression models to examine
adherence among both the Discontinuous–Uninsured, and the Discontinuous–Insured
groups relative to the Continuous Medicaid insurance group.


Pr[MPR>0.8|x] = F-1(ߙො  ߚመଵ Ǥ  ݏݑݑ݊݅ݐ݊ܿݏ݅ܦെ ܷ݊݅݊ ݀݁ݎݑݏ ୀଵ ߚመ ܺ ) (Eq. 3-2)


Pr[MPR>0.8|x] = F-1(ߙො  ߚመଵ Ǥ  ݏݑݑ݊݅ݐ݊ܿݏ݅ܦെ  ݀݁ݎݑݏ݊ܫ ୀଵ ߚመ ܺ )

(Eq. 3-3)

Medication adherence is modeled as a dichotomous outcome variable as a
function of Medicaid discontinuity as well as the demographic, socioeconomic,
eligibility, health-related, and medication-related covariates mentioned above. F-1 denotes
the inverse of the cumulative standard logistic distribution function that relates the
outcome on the probability scale to the covariates. Pr[ ] denotes the population average
probability of adherence to medications conditional on the covariates denoted by x.
Discontinuous–Uninsured and Discontinuous–Insured are binary indicator variables for
the main independent variable of interest, that equals one for individuals having
discontinuous annual Medicaid coverage without any other sources of insurance and with
other sources of insurance during the year, respectively, and equals zero for the
comparison group of individuals with continuous Medicaid coverage. X denotes the
vector of aforementioned individual characteristics that predict Medicaid discontinuity in
the two population groups of interest.
When examining all-cause and disease-specific medication utilization using the
number of prescription drug fills as the outcome, the negative binomial regression model
was utilized due to the skeweness in the distribution exhibited by the outcomes measures.
Appendix A, Figures A-1 to A-4, display the distribution in the all-cause and diseasespecific prescription drug utilization outcome measures. It is a type of generalized linear
model where the dependent variable Y is a count of the number of times an event occurs
(in this case, the number of drug fills). A convenient parameterization of the negative
binomial distribution is denoted by Equation 3-4.71
ሺݕሻ ൌ ܲሺܻ ൌ ݕሻ ൌ

భ
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ቀଵାఈஜቁ

௬

(Eq. 3-4)

In Equation 3-4, μ>0 is the mean of Y, which is the count variable indicating the
number of prescription drug fills (either all-cause, or disease-specific) and α>0 is the
heterogeneity parameter. It can be derived as a Poisson-gamma mixture, or as the number
of failures before the (1/α)th success. A simpler depiction of the traditional negative
binomial regression model, the NB2 model is depicted is depicted in Equation 3-5 and
Equation 3-6 as follows:
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 Ɋି௨௦ ൌ ߚ  ߚଵ  ݏݑݑ݊݅ݐ݊ܿݏ݅ܦെ ܷ݊݅݊ ݀݁ݎݑݏ ߚଶ Ǥ ݔଶ   ڮ ߚ Ǥ ݔ (Eq. 3-5)
 Ɋௗ௦௦ି௦ ൌ ߚ  ߚଵ  ݏݑݑ݊݅ݐ݊ܿݏ݅ܦെ ܷ݊݅݊ ݀݁ݎݑݏ ߚଶ Ǥ ݔଶ   ڮ ߚ Ǥ ݔ
(Eq. 3-6)
Apart from the main indicator variables for the Discontinuous–Uninsured group,
the covariates ݔଶ to ݔ are known, and the population regression coefficients ߚ to ߚ are
to be estimated. The two equations above depict the negative binomial regression models
to estimate the differences in all-cause prescription drug utilization (Equation 3-5), and
disease-specific prescription drug utilization (Equation 3-6) between the Continuous
Medicaid, and Discontinuous–Uninsured groups. Similar regression models (not shown
here) were run to estimate differences in prescription drug utilization between the
Continuous Medicaid and Discontinuous–Insured groups. The coefficient of interest for
the Discontinuous–Uninsured is the measure of differences in the utilization of overall,
and disease-specific drug utilization. Because of the functional form of the negative
binomial regression, the effect size of a factor is the antilog of its coefficient. This
estimated coefficients are transformed to obtain the incidence rate ratio (IRR). An IRR of
less than one for the discontinuous Medicaid groups would suggest lower medication
utilization among them when compared to their counterparts with continuous Medicaid
coverage.
In addition to obtaining IRRs, this study further estimated the average marginal
effect to determine the predicted difference in the number of all-cause and diseasespecific prescription drug fills between the continuous and discontinuous Medicaid
groups. The marginal effects measure the discrete change in the outcome variable, i.e. for
a binary independent variable, how do predicted probabilities change as the binary
independent variable changes from 0 (Continuous Medicaid) to 1 (Discontinuous–
Uninsured, or Discontinuous–Insured).72 In order to obtain these marginal effects, after
developing and running the multivariate negative binomial regression model, the
estimated coefficients of the model were used to calculate two predicted prescription drug
fills for all individuals in the study population. The first predicted utilization assumed all
individuals had discontinuous Medicaid coverage (by setting the Medicaid discontinuity
indicator variable to 1), and the second predicted utilization assumed all individual to
have continuous full-year Medicaid coverage (by setting the Medicaid discontinuity
indicator variable to 0). The average per-person difference in prescription drug fills
attributable to Medicaid coverage was estimated by obtaining the difference in predicted
drug utilization for each person and computing the weighted average of the difference
across the entire study sample. All data analyses were conducted using SAS 9.3 and
STATA 13 to account for the complex survey design of MEPS.
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RESULTS
Characteristics of the Study Populations
The characteristics of the study population when examining adherence to
commonly prescribed medications to manage CVD or high-risk conditions for CVD, and
when examining utilization of prescription medications, are displayed in Table 3-3 and
Table 3-4, respectively. The study sample when examining overall medication adherence
included 3,210 respondents in the Continuous Medicaid coverage group (nationally
representative of about 2 million individuals), 1,088 individuals in the Discontinuous–
Uninsured group (nationally representative of over 700,000 individuals), and 388
individuals in the Discontinuous–Insured group (nationally representative of over
300,000 individuals). When examining utilization of prescription medications in the
study population, the study sample included 3,926 respondents in the Continuous
Medicaid coverage group (nationally representative of about 2.4 million individuals),
1,407 individuals in the Discontinuous–Uninsured group (nationally representative of
over 900,000 individuals), and 493 individuals in the Discontinuous–Insured group
(nationally representative of over 400,000 individuals). The difference being, when
examining medication adherence there was an additional inclusion criteria; the study
population consisted of individuals who reported taking one or more of the eight classes
of medications for which adherence was examined.
When examining medication adherence (Table 3-3), in comparison to the
Continuous Medicaid group, individuals in the Discontinuous–Uninsured group were less
likely to belong to other race groups (P=0.016), and more likely to be married (P<0.001),
and were more likely to belong to the South geographic region (P=0.010). Among the
socioeconomic covariates, this study found that respondents were more likely to have
completed high school/GED or college (P=0.006), were more likely to have family
incomes >125% FPL (P<0.001), and more likely to have intermittent, as well as
continuous full-year employment (P<0.001). Respondents were less likely to be eligible
for SSI due to disability or participate in TANF (P<0.001), and less likely to report
Medicaid HMO/managed care (P<0.001). Among the health-related variables,
respondents were less likely to report having fair or poor perceived mental health status
(P=0.001), less likely to report having mental /substance abuse illnesses (P=0.014), and
less likely to report having respiratory illnesses (P<0.001). The mean CCI score was not
significantly different between the two groups (P=0.181). When examining the
medication-related variables, this study found that although the Discontinuous–Uninsured
group on average were prescribed fewer medications than the Continuous Medicaid
group (7.6 vs. 9.1 medications, P<0.001), and both groups had similar proportion of 90
days’ supply for their medications (P=0.242).
When comparing the Discontinuous–Insured group to the Continuous Medicaid
group, this study found that among the demographic covariates, individuals in the
Discontinuous–Insured group were more likely to be younger (P=0.034), were less likely
to belong to minority race/ethnicity groups (P<0.001), more likely to be married
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Table 3-3.

Study Population Characteristics when Examining Medication Adherence

Characteristics
DEMOGRAPHIC

Continuous Medicaid
Weighted N
% (SE)

Discontinuous–Uninsured
Weighted N
% (SE)
P-value†

Discontinuous–Insured
Weighted N
% (SE)
P-value††

0.876

Age

0.014

18 – 34 years

248,650

12.5 (0.9)

93,295

13.1 (1.3)

65,519

19.6 (2.4)

35 – 49 years

669,245

33.8 (1.3)

242,313

34.2 (2.1)

100,718

30.1 (3.0)

50 – 64 years

1,065,905

53.7 (1.4)

373,450

52.7 (2.3)

168,190

50.3 (3.3)

0.939

Gender
Female

1,334,759

67.3 (1.3)

475,870

67.1 (2.0)

Race/Ethnicity

0.190
210,679

63.0 (3.2)

0.016

<0.001

Non-Hispanic White

894,528

45.1 (1.9)

336,390

47.4 (2.3)

211,937

63.4 (3.3)

Non-Hispanic Black

562,325

28.3 (1.5)

183,702

25.9 (1.9)

64,835

19.4 (2.2)

Hispanic

341,418

17.2 (1.2)

145,309

20.5 (1.6)

34,802

10.4 (1.6)

Others

185,529

9.4 (0.9)

43,657

6.2 (1.0)

22,852

6.8 (1.5)

Marital Status
Married

<0.001
602,503

30.4 (1.4)

271,354

38.3 (2.1)

<0.001
154,101

46.1 (3.6)

0.064

Region

0.040

Northeast

481,061

24.3 (1.7)

141,392

19.9 (2.0)

82,125

24.5 (3.1)

Midwest

393,671

19.8 (1.4)

139,468

19.7 (1.8)

92,872

27.8 (4.0)

South

607,916

30.6 (1.7)

255,996

36.1 (2.0)

76,828

23.0 (2.7)

West

501,152

25.3 (1.7)

172,201

24.3 (2.0)

82,602

24.7 (3.4)

Family Size Mean (SE)

2.7 (0.1)

2.8 (0.1)
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0.532

2.8 (0.1)

0.449

Table 3-3.

(Continued)

Characteristics

Continuous Medicaid
Weighted
% (SE)
N

Discontinuous–Uninsured
Weighted N
% (SE)
P-value†

Discontinuous–Insured
Weighted N
% (SE)
P-value††

0.006

<0.001

SOCIOECONOMIC
Education
<High School

776,408

39.5 (1.5)

226,415

32.2 (1.9)

51,716

15.5 (2.1)

High School/GED

997,819

50.7 (1.4)

392,411

55.7 (2.2)

176,153

52.8 (3.6)

College Degree

193,484

9.8 (0.8)

85248

12.1 (1.6)

105,631

31.7 (3.6)

Income
<100% FPL

<0.001

<0.001

1,113,782

56.1 (1.3)

324,544

45.8 (2.0)

74,686

22.3 (2.3)

100 – <125% FPL

185,942

9.4 (0.6)

69,730

9.8 (1.2)

24,692

7.4 (1.5)

>125% FPL

684,076

34.5 (1.2)

314,784

44.4 (2.1)

235,048

70.3 (2.8)

Employment
Always Unemployed

<0.001

<0.001

1,468,299

74.0 (1.3)

399,549

56.3 (2.0)

91,161

27.3 (2.5)

Unstable Employment

231,945

11.7 (0.9)

165,706

23.4 (1.9)

102,142

30.5 (2.9)

Always Employed

283,555

14.3 (1.0)

143,803

20.3 (1.5)

141,123

42.2 (3.2)

1,564,442

78.9 (1.8)

552,171

77.9 (2.0)

0.651

267,784

80.1 (2.7)

0.696

852,158

43.0 (1.5)

127,179

17.9 (1.5)

<0.001

30,671

9.2 (1.8)

<0.001

1,139,857

60.4 (1.6)

354,416

50.3 (2.1)

<0.001

180,662

54.0 (3.4)

0.077

MSA
MEDICAID-RELATED
SSI/TANF
Medicaid HMO/MCO
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Table 3-3.

(Continued)

Characteristics
HEALTH-RELATED

Continuous Medicaid
Weighted N
% (SE)

Discontinuous–Uninsured
Weighted N
% (SE)
P-value†
0.050

Perceived Health Status
Fair to Poor

1,112,169

56.1 (1.4)

366,568

51.7 (2.1)

Perceived Mental Health
Fair to Poor

Discontinuous–Insured
Weighted N % (SE) P-value††
<0.001
140,242

41.9 (2.8)

0.001
670,915

33.9 (1.4)

189,140

26.7 (1.9)

<0.001
62,634

18.7 (2.4)

0.998

CVD or high-risk
conditions for CVD

0.066

<1

1,281,387

64.6 (1.3)

457,590

64.5 (2.0)

240,536

71.9 (2.7)

2

400,899

20.2 (0.9)

144,019

20.3 (1.6)

58,036

17.4 (2.5)

>3

301,513

15.2 (1.0)

107,449

15.2 (1.5)

35,854

10.7 (1.5)

Mental/Substance Abuse
Illnesses

606,104

30.6 (1.4)

177,733

25.1 (1.8)

0.014

94,737

28.3 (2.8)

0.463

Respiratory Illnesses

394,992

19.9 (1.2)

87,482

12.3 (1.2)

<0.001

32,380

9.7 (1.8)

<0.001

Arthritis/Joint Pain

693,646

35.0 (1.4)

221,951

31.3 (1.9)

0.073

97,019

29.0 (3.0)

0.073

CCI Score Mean (SE)

1.2 (0.0)

0.181

1.1 (0.1)

Population Size

1,983,799

1.1 (0.1)
65.5 (1.1)

709,058
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23.4 (0.9)

334,426

0.058
11.1 (0.8)

Table 3-3.

(Continued)

Study population includes MEPS respondents from the years 2002-2011, aged 18-64 years, who either reported being diagnosed with or
having an event (prescription medication, or inpatient, emergency, outpatient, or office-based provider visits) associated with CVD or highrisk conditions for CVD, had <1 month of Medicaid coverage during the survey year, and who consumed one or more medications from the
following therapeutic drug classes: ACEI/ARB, beta blockers, calcium channel blockers, diuretics, anti-HTN combinations, statins,
sulfonylureas, and biguanides.
†
P-value for the difference between Discontinuous–Uninsured and Continuous Medicaid groups. ††P-value for the difference between
Discontinuous–Insured and Continuous Medicaid groups. P-values in bold indicate statistically significant difference below the threshold
value of P<0.05.
SE: Standard error; GED: General educational development; FPL: Federal poverty level; MSA: Metropolitan Statistical Area; SSI:
Supplementary Security Income due to disability; TANF: Temporary Assistance to Needy Families program participation; HMO: Health
maintenance organization; MCO: Managed care organization; CCI: Charlson Comorbidity Index score (D’Hoore adapted CCI score was
calculated in this study using the 3-digit ICD-9-CM codes in MEPS).
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Table 3-4.

Study Population Characteristics when Examining Medication Utilization

Characteristics
DEMOGRAPHIC

Continuous Medicaid
Weighted N
% (SE)

Discontinuous–Uninsured
Weighted N
% (SE) P-value†

Discontinuous–Insured
Weighted N % (SE)
P-value††

0.385

0.013

Age
18 – 34 years

388,425

15.9 (1.0)

165,340

18.1 (1.3)

98,188

23.1 (2.3)

35 – 49 years

875,809

35.9 (1.2)

324,653

35.5 (1.8)

141,109

33.3 (2.7)

50 – 64 years

1,173,144

48.2 (1.3)

423,933

46.4 (2.0)

184,968

43.6 (3.0)

0.491

Gender
Female

1,632,006

67.0 (1.2)

624,410

68.3 (1.8)

Race/Ethnicity

0.169
267,502

63.1 (2.8)

<0.001

<0.001

Non-Hispanic White

1,094,002

44.9 (1.8)

442,534

48.4 (2.1)

256,231

60.4 (3.2)

Non-Hispanic Black

666,358

27.3 (1.5)

219,033

24.0 (1.6)

79,936

18.8 (2.0)

Hispanic

445,601

18.3 (1.2)

202,106

22.1 (1.5)

50,704

12.0 (1.6)

Others

231,416

9.5 (0.9)

50,253

5.5 (0.9)

37,393

8.8 (1.7)

Marital Status
Married

<0.001
727,457

29.9 (1.3)

344,150

37.7 (1.8)

Region

<0.001
184,414

43.5 (3.2)

0.049

0.023

Northeast

608,070

25.0 (1.6)

187,785

20.5 (1.7)

104,394

24.6 (2.9)

Midwest

477,401

19.6 (1.4)

184,710

20.2 (1.7)

115,146

27.2 (3.2)

South

727,520

29.8 (1.6)

315,073

34.5 (1.8)

98,072

23.1 (2.3)

West

624,386

25.6 (1.7)

226,358

24.8 (1.9)

106,652

25.1 (3.0)

Family Size Mean (SE)

2.8 (0.1)

2.9 (0.1)
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0.409

2.8 (0.1)

0.976

Table 3-4.

(Continued)

Characteristics
SOCIOECONOMIC

Continuous Medicaid
Weighted N
% (SE)

Discontinuous–Uninsured
Weighted N % (SE)
P-value†

Education
<High School
High School/GED
College Degree

0.001

<0.001

971,041

40.2 (1.4)

298,300

32.9 (1.8)

67,896

16.0 (1.9)

1,215,968

50.4 (1.4)

498,289

54.9 (2.0)

232,334

54.9 (3.2)

227,668

9.4 (0.7)

111,300

12.2 (1.4)

123,109

29.1 (3.2)

Income
<100% FPL

Discontinuous–Insured
Weighted N % (SE)
P-value††

<0.001

<0.001

1,384,551

56.8 (1.2)

428,540

46.9 (1.7)

104,719

24.7 (2.3)

100 – <125% FPL

227,591

9.3 (0.6)

91,940

10.1 (1.1)

28,783

6.8 (1.3)

>125% FPL

825,236

33.9 (1.1)

393,445

43.0 (1.8)

290,763

68.5 (2.6)

Employment
Always Unemployed

<0.001

<0.001

1,767,234

72.5 (1.2)

496,282

54.3 (1.8)

112,490

26.5 (2.2)

Unstable Employment

301,597

12.4 (0.8)

228,246

25.0 (1.6)

129,583

30.6 (2.5)

Always Employed

368,547

15.1 (0.9)

189,398

20.7 (1.4)

182,191

42.9 (2.9)

1,931,797

79.3 (1.8)

721,532

78.9 (1.9)

0.880

344,287

81.1 (2.7)

0.494

SSI/TANF

1,012,240

41.5 (1.3)

154,157

16.9 (1.3)

<0.001

41,212

9.7 (1.6)

<0.001

Medicaid HMO/MCO

1,424,726

61.3 (1.5)

459,330

50.5 (2.0)

<0.001

233,429

55.0 (3.0)

0.048

MSA
MEDICAID-RELATED
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Table 3-4.

(Continued)

Characteristics
HEALTH-RELATED

Continuous Medicaid
Weighted N
% (SE)

Discontinuous–Uninsured
Weighted N % (SE)
P-value†
0.162

Perceived Health Status
Fair to Poor

1,314,794

53.9 (1.2)

467,555

51.2 (1.9)

Perceived Mental Health
Fair to Poor

<0.001
170,598

40.2 (2.5)

<0.001
821,318

33.7 (1.2)

234,931

25.7 (1.7)

<0.001
84,716

20.0 (2.2)

0.775

CVD or high-risk
conditions for CVD
<1

Discontinuous–Insured
Weighted N % (SE)
P-value††

0.037

1,678,222

68.9 (1.1)

640,242

70.1 (1.8)

321,685

75.8 (2.3)

2

444,995

18.2 (0.8)

163,062

17.8 (1.4)

65,581

15.5 (2.2)

>3

314,160

12.9 (0.8)

110,621

12.1 (1.3)

37,000

8.7 (1.5)

Mental/Substance Abuse
Illnesses

751,357

30.8 (1.2)

227,885

24.9 (1.6)

0.003

115,891

27.3 (2.4)

0.176

Respiratory Illnesses

479,702

19.7 (1.1)

117,992

12.9 (1.1)

<0.001

39,380

9.3 (1.5)

<0.001

Arthritis/Joint Pain

830,408

34.1 (1.3)

267,358

29.3 (1.7)

0.009

107,575

25.4 (2.4)

0.002

CCI Score Mean (SE)

1.2 (0.0)

0.079

0.9 (0.1)

Population Size

2,437,378

1.1 (0.1)
64.6 (1.0)

913,926
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24.2 (0.8)

424,265

0.003
11.2 (0.7)

Table 3-4.

(Continued)

Study population includes MEPS respondents from the years 2002-2011, aged 18-64 years, who either reported being diagnosed with or
having an event (prescription medication, or inpatient, emergency, outpatient, or office-based provider visits) associated with CVD or highrisk conditions for CVD, had <1 month of Medicaid coverage during the survey year.
†
P-value for the difference between Discontinuous–Uninsured and Continuous Medicaid groups. ††P-value for the difference between
Discontinuous–Insured and Continuous Medicaid groups. P-values in bold indicate statistically significant difference below the threshold
value of P<0.05. SE: Standard error; GED: General educational development; FPL: Federal poverty level; MSA: Metropolitan Statistical
Area; SSI: Supplementary Security Income due to disability; TANF: Temporary Assistance to Needy Families program participation; HMO:
Health maintenance organization; MCO: Managed care organization; CCI: Charlson Comorbidity Index score (D’Hoore adapted CCI score
was calculated in this study using the 3-digit ICD-9-CM codes in MEPS).
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(P<0.001). Among the socioeconomic covariates, this study found that individuals in the
Discontinuous–Insured group were more likely to complete high school/GED or college
(P<0.001), more likely to have higher family income levels (P<0.001), and were more
likely to have some form of employment during the year (P<0.001). The Discontinuous–
Insured group was also to be eligible for SSI due to disability or participate in TANF
(P<0.001), however, there was no significant difference between having Medicaid
through an HMO/MCO (P=0.087). Among the health-related covariates, this study found
that the Discontinuous–Insured group was less likely to have respiratory illnesses
(P<0.001), less likely to report having fair to poor health status (P<0.001), or fair to poor
mental health status (P<0.001), and was similar to the Continuous Medicaid coverage
group in terms of having mental/substance abuse illnesses (P=0.428), arthritis/joint pain
(P=0.086), and mean CCI score or burden of disease (P=0.078). Finally, when examining
the medication-related variables, the Discontinuous–Insured group was found to be
prescribed lower number of unique medications on average (P<0.001), and more likely to
have a 90-day supply of medications (P<0.001) than the Continuous Medicaid group.
For the second aim of examining medication utilization, the patterns in the
demographic, socioeconomic, Medicaid -, and health-related characteristics of the study
population were found to be similar to the patterns described above, with some
exceptions. When examining geographic census region, individuals in the Discontinuous
– Uninsured group were found to be more likely to reside in the South, compared to their
counterparts in the Continuous Medicaid group. However, the magnitude the statistical
significance in difference was small (P=0.049). They were also less likely to have
mental/substance abuse illnesses, and arthritis/joint pain. Among the Discontinuous –
Uninsured group, individuals were less likely to participate in Medicaid administered by
an HMO/MCO (P=0.048), less likely to have 2 or more CVD or high-risk conditions for
CVD (P=0.037), less likely to have arthritis/joint pain (P=0.002), and had a lower
disease burden or mean Charlson score (P=0.003), when compared to those with
continuous Medicaid coverage.
Prescription Medication Use in the Study Population
Table 3-5 displays the summary statistics for prescription medication use in the
study population. The distribution of the classes of medications prescribed was similar
among all three groups; the Continuous Medicaid, Discontinuous–Uninsured, and the
Discontinuous–Insured. Statins and thiazolidinediones were the most commonly
prescribed classes of medications, followed by diuretics and anti-hypertensive
combination medications. On average, the Continuous Medicaid group reported higher
number of all-cause prescription fills annually than the Discontinuous–Uninsured (46.0
vs. 30.0 fills, P<0.001), and the Discontinuous–Insured groups (46.0 vs. 30.0 fills,
P<0.001). Similarly, the Continuous Medicaid group reported higher mean diseasespecific (CVD or high-risk conditions for CVD for CVD) prescription fills annually than
the Discontinuous–Uninsured (16.6 vs. 13.5 fills, P<0.001), and the Discontinuous–
Insured groups (16.6 vs. 12.8 fills, P<0.001). The proportion of days during which
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Table 3-5.

Summary Statistics for Prescription Medication Use in the Study Population

Measures

Therapeutic
Drug Classes
ACEI/ARB

Continuous Medicaid
Weighted N
% (SE)
or Mean
or SE
136,818
6.9 (0.7)

Discontinuous–Uninsured
Weighted N
% (SE)
or Mean
or SE
47,265
6.7 (1.0)

Discontinuous–Insured
Weighted N
% (SE)
or Mean
or SE
28,419
8.5 (1.8)

Beta blockers

147,001

7.4 (0.7)

57,759

8.1 (1.2)

37,979

11.4 (2.3)

CCB

125,709

6.3 (0.6)

57,759

6.3 (0.9)

13,328

4.0 (1.1)

Diuretics

288,166

14.5 (1.0)

105,673

14.9 (1.5)

39,934

11.9 (2.2)

Anti-HTN
combinations

197,107

9.9 (0.7)

72,220

10.2 (1.0)

42,047

12.6 (2.0)

Statins

538,014

27.1 (1.1)

167,148

23.6 (1.8)

85,635

25.6 (2.9)

Sulfonylureas

114,938

5.9 (0.6)

43,755

6.2 (1.0)

16,097

4.8 (1.6)

Biguanides

436,045

22.0 (1.1)

170,483

24.0 (2.0)

70,987

21.2 (2.7)

Mean No. of Drug
Classes

2.4

0.02

2.0

0.02

1.6*

0.1

Mean No. of AllCause Drug Fills

46.0

1.1

30.0***

1.3

30.0***

1.5

Mean No. of
Disease-Specific
Drug Fills

16.6

0.5

13.5***

0.6

12.8***

0.8

Study population included MEPS respondents from the years 2002-2011, aged 18-64 years, who either reported being diagnosed with or having an
event (prescription medication, or inpatient, emergency, outpatient, or office-based provider visits) associated with CVD or high-risk conditions
for CVD, and who reported having Medicaid anytime during the year.
Estimates in bold indicate statistical significance at P<0.05.
ACEI: Angiotensin converting enzyme inhibitors, ARB: Angiotensin II converting enzyme receptor blockers, Calcium channel blockers, HTN:
Hypertension; SE: Standard Error. *P<0.05, **P<0.01, ***P<0.001 for comparison between the continuous and discontinuous Medicaid groups.
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respondents had possession of medications was significantly higher among the
Continuous Medicaid group when compared to the Discontinuous–Uninsured (67.8% vs.
64.9%, P<0.001), but was not significantly different from the Discontinuous–Insured
group (67.8% vs. 68.4%, P=0.710) (results not shown).
The results for medication adherence outcomes, both overall and therapeutic
drugclass-specific, are displayed in Table 3-6. When examining overall adherence using
the average MPR measure, this study found that although the Discontinuous–Uninsured
group had about 17% lower odds of being adherent to their medications than the
Continuous Medicaid group, this difference was not statistically significant [Odds Ratio
(OR): 0.83; 95% Confidence Interval (CI): 0.69 – 1.00]. Difference in overall adherence
was found to be highly insignificant when comparing Discontinuous–Insured and
Continuous Medicaid groups (P=0.775). Appendix Table A-1 displays the full model
coefficients exponentiated as odds ratios for the comparisons between Continuous
Medicaid, Discontinuous–Uninsured, and the Discontinuous–Insured Among the
covariates, having fair or poor perceived health status, arthritis/joint pain, and a 90 days’
supply of prescription drugs were associated with higher odds of being adherent to
commonly prescribed medications that are essential for managing CVD or high-risk
conditions for CVD. When examining class-specific medication adherence, this study
found that the Discontinuous–Uninsured group were 41% less likely to be adherent to
sulfonylureas when compared to the Continuous Medicaid group (OR: 0.59; 95% CI:
0.38 – 0.92). Adherence to the remaining classes of medications examined was not
significantly different between these two groups. When examining class-specific
adherence among the Discontinuous–Insured, this study found that this group was 43%
less likely to be adherent to diuretics (OR: 0.57; 95% CI: 0.33 – 0.98), and had almost 3
times higher odds of being adherent to calcium channel blockers (OR: 2.86; 95% CI: 1.44
– 5.69).
Table 3-7 displays the results for the multivariate negative binomial regression
analyses to examine medication utilization. This study found that the incidence of overall
prescription fills (all-cause) was 27% lower among the Discontinuous–Uninsured group
compared to the Continuous Medicaid group, or in other words, the expected number of
all-cause prescription fills among the Discontinuous–Uninsured group were 27% less
when compared to the Continuous Medicaid group [Incidence Rate Ratio (IRR): 0.73;
95% CI: 0.68 – 0.79]. The average incremental difference in overall prescription
medication fills between the Discontinuous–Uninsured and Continuous Medicaid group
was found to be -12.0 fills (Standard Error (SE): 1.4 fills; P<0.001). In other words,
individuals in the Discontinuous–Uninsured group were predicted to have 12 fewer
prescription drug fills per person annually, compared to the Continuous Medicaid group.
Further, it was found that the Discontinuous–Uninsured group had about 12% lower
prescription drug fills annually specific to the CVD or high-risk conditions for CVD for
CVD considered in this study (disease-specific), when compared to the Continuous
Medicaid group (IRR: 0.88; 95% CI: 0.80 – 0.97). When estimating the average marginal
effect of Medicaid discontinuity, the Discontinuous–Uninsured group was predicted to
have about 2.0 fewer disease-specific prescription drug fills per person annually (SE:
0.76 fills; P=0.009), compared to the Continuous Medicaid group.
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Table 3-6.
Association between Medicaid Discontinuity and Prescription
Medication Adherence in the Study Population
Outcome
Average Adherence
(MPR: <0.8 v >0.8)
Therapeutic Class-Specific
Adherence (MPR: <0.8 v
>0.8)
ACEI/ARB

Medicaid Coverage
Continuous
Discontinuous–Uninsured
Discontinuous–Insured

Odds Ratio
(95% Confidence
Interval)
1.00 (Reference)
0.83 (0.69 – 1.00)
1.04 (0.79 – 1.36)

Continuous
Discontinuous–Uninsured
Discontinuous–Insured

1.00 (Reference)
0.97 (0.74 – 1.28)
1.56 (1.02 – 2.39)*

Beta Blockers

Continuous
Discontinuous–Uninsured
Discontinuous–Insured

1.00 (Reference)
0.74 (0.53 – 1.04)
0.84 (0.51 – 1.36)

Calcium Channel Blockers

Continuous
Discontinuous–Uninsured
Discontinuous–Insured

1.00 (Reference)
1.20 (0.86 – 1.66)
3.06 (1.56 – 6.01)**

Diuretics

Continuous
Discontinuous–Uninsured
Discontinuous–Insured

1.00 (Reference)
0.80 (0.60 – 1.08)
0.50 (0.29 – 0.87)*

Anti-HTN Combinations

Continuous
Discontinuous–Uninsured
Discontinuous–Insured

1.00 (Reference)
0.98 (0.65 – 1.50)
1.60 (0.82 – 3.15)

Statins

Continuous
Discontinuous–Uninsured
Discontinuous–Insured

1.00 (Reference)
0.85 (0.63 – 1.16)
1.02 (0.63 – 1.66)

Sulfonylureas

Continuous
Discontinuous–Uninsured
Discontinuous–Insured

1.00 (Reference)
0.60 (0.38 – 0.94)*
0.63 (0.28 – 1.43)

Biguanides

Continuous
Discontinuous–Uninsured
Discontinuous–Insured

1.00 (Reference)
1.02 (0.69 – 1.50)
1.30 (0.63 – 2.67)
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Table 3-6.

(Continued)

Study population included MEPS respondents from the years 2002-2011, aged 18-64
years, who either reported being diagnosed with or having an event (prescription
medication, or inpatient, emergency, outpatient, or office-based provider visits) associated
with CVD or high-risk conditions for CVD, and who reported having Medicaid anytime
during the year. Estimates in bold indicate statistical significance at P<0.05. *P<0.05,
**P<0.01, ***P<0.001. MPR: Medication Possession Ratio. All models were adjusted for
age, gender race/ethnicity, marital status, family size, census region, education, income,
employment, MSA, SSI/TANF, Medicaid HMO/MCO, mental/substance abuse illnesses,
arthritis/joint pain, no. of CVD conditions, perceived health status, perceived mental health
status, Charlson Comorbidity Index score, and survey year.
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Table 3-7.
Association between Medicaid Discontinuity and Prescription
Medication Utilization in the Study Population
Outcome

Prescription
Drug Fills
All-Cause

DiseaseSpecific

Medicaid Coverage

Incidence Rate
Ratio
(95% CI)

Predicted
Difference in
Events

Continuous
Discontinuous–
Uninsured
Discontinuous–Insured

1.00 (Reference)
0.73 (0.68 – 0.79)***

– 12.1 fills***

0.86 (0.76 – 0.97)*

Continuous

– 6.5 fills**

1.00 (Reference)

Discontinuous–
Uninsured
Discontinuous–Insured

0.86 (0.79 – 0.95)**

– 2.3 fills**

0.84 (0.73 – 0.96)*

– 2.8 fills**

Study population included MEPS respondents from the years 2002-2011, aged 18-64
years, who either reported being diagnosed with or having an event (prescription
medication, or inpatient, emergency, outpatient, or office-based provider visits)
associated with CVD or high-risk conditions for CVD, and who reported having
Medicaid anytime during the year.
Two separate covariates-adjusted regression models for each outcome comparing
Continuous to Discontinuous–Uninsured, and to Discontinuous–Insured, respectively.
Estimates in bold indicate statistical significance at P<0.05.
MPR: Medication Possession Ratio
All models were adjusted for age, gender race/ethnicity, marital status, family size,
census region, education, income, employment, MSA, SSI/TANF, Medicaid HMO/MCO,
mental/substance abuse illnesses, arthritis/joint pain, no. of CVD conditions, perceived
health status, perceived mental health status, Charlson Comorbidity Index score, and
survey year.
*P<0.05, **P<0.01, ***P<0.001 for comparison between the continuous and
discontinuous Medicaid groups.
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Medication utilization was similarly lower among the Discontinuous–Insured
group. When examining all-cause medication utilization, this study found that the
Discontinuous–Insured had approximately 14% lower prescription drug fills annually
(IRR: 0.86; 95% CI: 0.76 – 0.97), with a predicted marginal difference of 6.5 fewer
medication fills per person (SE: 2.4; P=0.007), compared to the Continuous Medicaid
group. Similarly, the Discontinuous–Insured had an approximately 14% lower fills of
overall prescription medications annually (IRR: 0.86; 95% CI: 0.74 – 0.99), and a
predicted marginal difference of 2.4 fewer drug fills on average per person annually (SE:
1.1; P=0.023), when compared to the Continuous Medicaid coverage population.
DISCUSSION
Discontinuous Medicaid coverage among adults with CVD or high-risk
conditions for CVD was found to have a negative association with prescription drug
utilization. The effects were more pronounced among individuals with less than full-year
Medicaid coverage and having no other insurance during the year. This Discontinuous–
Uninsured group was predicted to have 12 fewer fills per person on average for all
prescription medications, and about 2 fewer fills per person on average for prescription
drugs specific to CVD or high-risk conditions for CVD, compared to the Continuous
Medicaid group. Similarly, the Discontinuous–Insured group, or individuals with less
than full-year coverage who reported having other sources of insurance coverage during
the year, were found to have an average of about 6 fewer drug fills per person overall,
and about 3 fewer fills per person for disease-specific medications. Adherence to
commonly prescribed medications to manage CVD or high-risk conditions for CVD,
measured as average MPR to determine overall concurrent medication adherence, was
not found to be significantly different between the continuous and discontinuous
Medicaid coverage groups in this study. However, when examining adherence specific to
individual therapeutic drug classes, this study found lower adherence among the
discontinuous Medicaid groups to sulfonylureas and diuretics. Adherence to ACEI/ARB
and calcium channel blockers was found to be higher among the Discontinuous–Insured
groups, and was not significantly different between the Discontinuous–Uninsured and the
Continuous Medicaid groups as well. Being among the first line therapies to treat high
blood pressure that are commonly prescribed, access to these medication classes may not
have been impacted by changes in Medicaid coverage during the year in these population
groups.
Medication adherence is a highly complex phenomena and barriers to adherence
are multifactorial. The World Health Organization (WHO) has done a phenomenal job in
classifying the barriers of adherence that capture a wide range of factors that contribute to
non-adherence.73 As per the WHO classification, barriers to adherence result from: 1)
factors associated with the health care team and system in place, 2) disease-related
factors, 3) patient-related factors, 4) therapy-related factors, and 5) socio-economic
factors. Health system- and health care team-related factors can include lack of access to
health care and prescribed medications, and lack of continuity of care due to changes in
insurance status, among others. Complex chronic debilitating conditions, such as heart
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failure or stroke, or asymptomatic disorders such as hypertension and diabetes may
prevent taking therapies as prescribed or seeking needed medical care. Patient factors
such as younger age, minority race or ethnicity, presence of physical or cognitive
impairments can also be barriers to medication adherence. Complexity of medication
therapy regimen, and side effects of therapies previously undetected in clinical trials can
also hinder appropriate management of conditions through pharmacotherapy.74 Finally,
socioeconomic factors such as low incomes, high medication costs, low literacy, and poor
social support may hinder effective use of medications to manage disease conditions.62
The present study examined the impact of a health system-related barrier of not
having continuous full-year Medicaid coverage on medication adherence after accounting
for several other factors that may hinder or confound medication adherence. Given that
this study found Medicaid discontinuity to be significantly associated with lower
prescription fills, we have strong reasons to believe that having discontinuous Medicaid
coverage has a negative impact on prescription medication utilization, and by estimating
adherence within a limited time frame of one year using an imputed MPR measure due to
absence of complete days’ supply information, this study may have underestimated the
impact of Medicaid discontinuity on adherence. Adherence to certain classes of
antidiabetic and antihypertensive medications was found to be lower among the
discontinuous Medicaid groups which further highlights the negative impact that
discontinuity and disruptions in Medicaid coverage may have on managing high-risk
conditions for CVD.
To our knowledge, there have been no previous studies which have examined the
association between discontinuous Medicaid coverage and prescription medication
adherence, and the paucity of empirical evidence establishing an association between
Medicaid discontinuity and prescription drug utilization, especially among
subpopulations with chronic diseases, warranted an in-depth examination of these
outcomes. Our findings on prescription drug fills are in line with the findings of Banerjee
and colleagues, who examined the impact transitions into and/or out of Medicaid
coverage on prescription drug fills, among other outcome measures.15 They found that
individuals experiencing discontinuity in their Medicaid coverage had lower incidence of
prescription drug refills compared to those without any disruptions in their Medicaid
coverage. Among studies that investigated disease-specific prescription drug utilization,
Smith and Kirking found that individuals with Medicaid coverage disruptions were
associated with significantly lower acquisition of medications for HIV/AIDS (human
immunodeficiency virus infection and acquired immune deficiency syndrome), such as
antiretrovirals.67 Fields and colleagues examined the impact of insurance stability and
residence on several health care utilization measures and found that discontinuously
insured individuals had fewer prescription drug fills, physician office visits, among other
outcome measures, compared to those with continuous insurance coverage.32 Baicker and
colleagues utilized the random assignment of individuals embedded in the Oregon
Medicaid lottery to examine the impact of Medicaid coverage on several outcome
measures, dubbed the Oregon Experiment. They found that although the use of diabetes
medications increased 2 years after the Medicaid lottery to expand Medicaid coverage,
the utilization of medications for hypertension or high cholesterol were not significantly
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different.75 Differences in sampling, study design (observational vs. random assignment),
and duration, besides differences in the study sample may have contributed to the
discrepancies between some of these findings and findings from the present study.
Medicaid, the nation’s primary public health insurance program for the lowincome population, provides much-needed health insurance coverage to an estimated 67
million individuals who meet the eligibility criteria, which include having incomes and
assets below a certain threshold level determined by each State.7 Medicaid enrollees have
very little copays, with most states requiring about $1 – 3 per drug as copay, although
most of them have limits of up to 5 concurrent prescription medications that can be filled
per month.76 Although seemingly restrictive, studies have found Medicaid enrollees to be
more likely to be prescribed medications for certain chronic conditions. Rice and
Colleagues in their analysis of the 2001 California Health Interview Survey found that
California Medicaid enrollees had higher odds of reporting taking medications for heart
disease, high blood pressure, and asthma.77 Nonetheless, continuity of insurance
coverage, especially for low-income populations, is as critical as gaining insurance
coverage, and the findings from this study reinforce the conclusions made by previous
studies that discontinuous Medicaid coverage may have an adverse impact on enrollees’
prescription drug utilization.15,32,67
The literature examining the impact of lack of insurance on health care outcomes
in general, and disease-specific outcomes in particular is exhaustive with studies
highlighting the adverse impact of lacking health insurance. However, there is a lack of
studies examining the impact of discontinuous health insurance on medication outcomes,
especially for certain disease conditions such as cardiovascular diseases that require
prolonged disease management. And although medication adherence as an area of
research has been thoroughly examined with several high-quality robust analyses of
adherence and its impact on health care utilization, research examining the impact of
churning in insurance in general and Medicaid on medication adherence in particular is
limited.
Adherence to medications for CVD or high-risk conditions for CVD varies
significantly depending on the study population, and therapeutic classes examined.
Studies have shown adherence to several therapeutic classes of medications such as
statins, beta blockers, and antiplatelet agents declined following hospitalizations for AMI,
CAD, and stroke, and that the trend in decreased adherence continued over periods of
more than a year after discharge.66,78-80 Using medication event monitoring data, Vrijens
and colleagues found medication annual nonadherence rate of 50% among patients
prescribed antihypertensive drugs, whereas Bramley and colleagues in their examination
of association between adherence and blood pressure control found 75% of patients to be
adherent to antihypertensives.81,82 Bailey and colleagues analyzed Tennessee’s Medicaid
claims data to examine association between antihypertensive medication adherence and
ambulatory visits to hazards of stroke and mortality, and found the mean adherence rate
to antihypertensive medications to be 67%.65 Examinations of medication adherence
among heath failure patients have also found differing estimates of adherence.83,84
Adherence to sulfonylureas was found to be lower among the Discontinuous–Uninsured
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compared to the Continuous Medicaid population. Estimates have found adherence to
oral hypoglycemic agents to be low among Medicaid enrollees, and range from 35 to
about 50%.85,86 Discontinuous Medicaid coverage with no other coverage during the year
may exacerbate the already low levels of adherence to this therapeutic class, which may
have been reflected in these findings. Although nonadherence to cardiovascular
medications is prevalent, the varying methodologies to estimate adherence, data sources,
and study designs, make it difficult to compare results across studies focused on
cardiovascular conditions.
This study is not without limitations. Adherence was calculated using an imputed
MPR measure that approximated days’ supply for medications based on an algorithm
created using quantity of medications dispensed. However, unlike previous empirical
analyses, this study utilized MEPS data itself to impute MPR, using a plausible
assumption that over the 10-year period from 2002, there have not been major changes in
the strengths and dosage frequencies of cardiovascular medications. The quality of the
prescription drug data in MEPS has been found to be comparable to Medicare claims data,
and combined with the high degree of correlation between the imputed and actual days’
supply variables, we believe benchmarking our analysis solely to MEPS data is a credible
approach.87 Additionally, each state establishes their own Medicaid eligibility and
procedures for reenrollment, which were not available in MEPS to explore the complex
and dynamic patterns of discontinuity that may differ based on the state’s eligibility and
reporting criteria. Further, this study only explored associations between individual
characteristics and Medicaid discontinuity, and not causality, and the findings only
explore predictors of within-year discontinuous Medicaid coverage and may not capture
risk factors for secular trends in Medicaid discontinuity. Regression models may not have
adjusted for certain covariates that may confound the relationship between Medicaid
insurance and medication adherence and utilization, or account for unobserved
differences between the study population groups. Finally, MEPS data are self-reported, so
the estimates may not exactly reflect the national estimates of Medicaid discontinuity.
Researchers have speculated that most surveys underestimate the number of Medicaid
enrollees due to a variety of reasons including stigma of public insurance. However, such
misreporting is less of a problem for MEPS compared to other federal health surveys.54
Finally, findings from this study are representative of the non-institutionalized civilian
population and may not be applicable to individuals with prolonged hospitalizations or
admitted to long-term care facilities.
CONCLUSION
The findings from this study suggest that continuous Medicaid coverage is critical
for non-elderly adults with CVD or high-risk conditions for CVD, and having
discontinuous Medicaid coverage was associated with lower prescription drug utilization,
and lower adherence to certain therapeutic classes of medications, which are essential
components of appropriate disease management. Losing Medicaid coverage may increase
the cost sharing burden for former enrollees who have a majority of their maintenance
medications covered with nominal copays, resulting in forgoing needed
pharmacotherapy, and exacerbating already low levels of adherence to medication
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regimens. Further research with more complete prescription drug data to analyze the
impact of Medicaid discontinuity on adherence to important therapeutic classes may
better inform policymakers on the determinants of nonadherence, and optimize the
delivery of interventions to improve adherence to these vulnerable populations.
Discussions on policies to improve retention of and continuity in Medicaid must include
individuals suffering from these chronic and debilitating conditions whose
pharmacotherapy may be adversely impacted due to such coverage instability.
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CHAPTER 4. ASSOCIATIONS BETWEEN MEDICAID DISCONTINUITY,
ACCESS TO CARE, PREVENTIVE CARE, AND HEALTH SERVICES
UTILIZATION AMONG ADULTS WITH CARDIOVASCULAR DISEASE OR
ASSOCIATED HIGH-RISK CONDITIONS
BACKGROUND
Medicaid provides much-needed health insurance coverage to an estimated 67-70
million low-income and disabled children, adults, and elderly at any given point in time,
who meet the eligibility criteria, which include having incomes and assets below a certain
threshold level determined by each State.7,88 Recent estimates indicate that over 28% of
non-elderly adult Medicaid enrollees with family incomes at or below 138 percent of the
federal poverty level (FPL) are diagnosed with cardiovascular disease (CVD), including
heart disease and stroke.20 Conditions such as hypertension, hypercholesterolemia, and
diabetes, among others, are significant risk factors for CVD; however, these conditions
are preventable and manageable. For low-income vulnerable populations having CVD or
high-risk conditions for CVD, accessing needed medical care, prescription drugs, routine
preventive care, and periodic primary care visits are extremely critical to manage their
complex chronic conditions. Failure to do so may exacerbate their cardiovascular
symptoms leading to prolonged morbidity and result in avoidable hospitalizations that
may exert a substantial financial stress on the health care system.
Overwhelming evidence suggests that access to medical care, routine preventive
services, and having a usual source of care for primary care visits are critical in managing
disease conditions, and maintaining good health.89-92 Having stable, continuous health
insurance coverage has been shown to be critical in ensuring that individuals do not have
to forego medical care or have high financial burden, ensure appropriate preventive care
services are accessed on a timely basis, and have regular access to primary care providers
to obtain the medical care necessary for preventing and treating their chronic diseases.2,9395
Poor disease management, resulting from inadequate access to care, lack of adherence
to pharmacotherapy, or lack of sufficient access to primary care physicians may result in
increased risk of hospitalizations that could have been avoided.91,96-98
Low family incomes, assessed as a percentage of the federal poverty level, family
status, residence, and assets test, are some of the criteria used to determine eligibility for
Medicaid coverage, which are specific to each states. Although most states have moved
towards a 12 month coverage renewal for non-elderly adults in recent years, they may
still require certain individuals to periodically report their income and/or other criteria in
order to maintain eligibility. Upward income mobility would render individuals ineligible
for their state’s Medicaid coverage if their incomes cross the eligibility threshold;
however, research has shown that individuals may passively end up not reenrolling into
Medicaid due to a variety of reasons, ranging from lack of awareness to various barriers
faced in reenrollment.99 This results in individuals and families losing Medicaid coverage
within 12 months of enrollment. Instability in Medicaid, characterized by dropouts and
moving back and forth into various sources of coverage or a state of being uninsured, has
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been a long-standing issue that has impacted non-elderly adult Medicaid enrollees due to
stringent administrative regulations governing coverage for this population.9,100 Previous
estimates have shown that about 43% of individuals who are newly enrolled in Medicaid,
end up losing their Medicaid coverage within twelve months.38 Transitions into and out
of Medicaid coverage may adversely impact the ability for low-income populations with
CVD or high-risk conditions for CVD to seek, and maintain continuity in, medical care.
Losing Medicaid coverage to become uninsured would be detrimental, as there is strong
consensus regarding the negative outcomes associated with lack of insurance.10-12,31,32
However, transitioning between Medicaid and other sources of insurance coverage may
also prove to be problematic, as this may lead to moving between different provider
networks, and coverage with different benefit structures that may limit use of previously
covered health care resources.
Estimates of the impact of discontinuous Medicaid coverage on access to care and
utilization of health care services among individuals with CVD or high-risk conditions
for CVD are very few and dated. Findings from state-specific Medicaid data have found
Medicaid coverage discontinuity to be associated with higher inpatient and ER
hospitalizations associated, especially for individuals with heart disease, diabetes, among
other ambulatory care sensitive conditions.14,101 Newer, more comprehensive national
estimates of the impact of discontinuous Medicaid coverage on access to care, preventive
services use, and health care services utilization among individuals with CVD or its risk
factor chronic conditions are critical to determine the outcomes among vulnerable
diseased populations for whom insurance coverage continuity may be even more critical.
The present study aims to obtain national estimates among adults with CVD or high-risk
conditions for CVD of associations between Medicaid discontinuity and (1) access to
care, (2) preventive services use, and (3) utilization of overall (all-cause) and diseasespecific health care services, such as hospital inpatient visits, emergency room (ER)
visits, hospital outpatient visits, and physician office visits. We hypothesized that having
discontinuous Medicaid coverage, relative to full-year continuous Medicaid coverage,
would be associated with significantly poor access to care, lower preventive services use,
lower primary care utilization, and higher hospitalizations in this study population.
METHODS
The present study is a retrospective cross-sectional analysis comparing adult
populations with CVD or high-risk conditions for CVD, with and without continuous
full-year Medicaid coverage. Instability and disruptions in Medicaid coverage may
especially have a detrimental impact on the continuity of care among low-income adults
with CVD or any of its risk factor conditions. We hypothesized that Medicaid
discontinuity would be associated with poor access to care, decreased primary care –
characterized by lower preventive services use and physician visits – and increased
hospitalizations, both overall (all-cause), and those specific to CVD or high-risk
conditions for CVD (disease-specific).
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Data Source
The present study analyzed data from the Medical Expenditure Panel Survey
(MEPS). MEPS is a set of large-scale surveys of families, individuals, their medical
providers and employers across the United States. It is jointly sponsored by the Agency
for Healthcare Research and Quality (AHRQ) and the National Center for Health
Statistics (NCHS), and has been conducted annually since 1996. It has two major
components; the Household Component (HC), the Insurance Component, with data on
medical providers in the HC being supplemented by the Medical Provider Component.
MEPS collects detailed information from a nationally representative sample of the
civilian noninstitutionalized population of the U.S. on health services utilization and
health expenditures, insurance coverage, and sources of payment.
MEPS has an overlapping panel design. Two separate panels of respondents are
interviewed simultaneously during a calendar year. A new panel of sample households is
selected each year, and data for each panel are collected for two calendar years. The two
years of data for each panel are collected in five rounds of interviews that take place over
a two and a half year period. This provides continuous and current estimates of health
care expenditures at both the person and household level for two panels for each calendar
year. By combining data from the overlapping panels, these annual files provide nearly
double the sample size of individual panels and cover the entire calendar year for each
respondent. Although all MEPS data are reported by respondents during computerassisted personal interviewing, further detailed health service use data, including on
prescription drugs, are collected from a sample of providers with respondents’
permission.39
When obtaining national estimates from surveys such as MEPS, appropriate
sample size is critical to obtain reliable estimates, since estimates of some population
subgroups may vary from year to year. The advantage of survey such as MEPS is that
they allow for several years’ of data to be pooled together in order to increase the sample
size and improve the precision of estimates. The pooling of the different years of data
was conducted in accordance with the guidelines provided by MEPS, and data for the
years 2002 – 2011 were pooled together to allow for a sufficiently large sample size to
ensure reliable estimates.
Study Population
The broad classification of “cardiovascular disease (CVD) and associated
comorbidities” in this study consisted for the following disease conditions: acute
myocardial infarction (Clinical Classification code (CCC): 100), coronary artery disease
(CCC: 101), congestive heart failure (CCC: 108), peripheral and visceral atherosclerosis
(CCCs: 114, 115, 116), stroke (CCCs: 109, 112), hypertension (CCC: 098), lipid
disorders (CCC: 053), and diabetes (CCC: 049, 050). CCC aggregates conditions and
procedures into mutually exclusive and clinically homogeneous categories, using Clinical
Classification Software.40 The study population included respondents who were: (1) aged
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18 to 64 years, (2) reported either being diagnosed with CVD or high-risk conditions for
CVD for CVD in their first round of the MEPS survey, or reported having an event (an
inpatient, emergency, outpatient, or office-based provider visits, or a prescription
medication) associated with one or more of the aforementioned disease conditions at any
point of time during the survey, (3) reported having had Medicaid coverage at any point
of time during the survey year, and (4) had positive person weights, and were interviewed
for all five rounds of the 2-year MEPS survey interviews. Respondents who reported
having Medicare, or pregnancy were excluded from this study.
Respondents who reported having Medicare, or pregnancy were excluded from
this study. Pregnant women with incomes at or below 133 percent of the federal poverty
level are eligible for Medicaid coverage throughout the pregnancy; however, the
coverage ceases 60 days postpartum.68 Low-income non-elderly adults with disabilities
are also eligible for Medicare if they have received monthly social security disability
income for two years. Most coverage benefits for prescription drugs for dual eligible
beneficiaries are covered by Medicare Part D, instead of Medicaid. As a result, these two
population groups were excluded from this study.
Individuals with less than a year of Medicaid coverage who experience withinyear Medicaid discontinuity may not be a homogenous group, especially when they
report having other forms of insurance coverage during the year. In order to account for
these differences, individuals in the study population who reported having <12 months of
Medicaid coverage during a survey year were divided into two groups: (1) individuals
with <12 months of Medicaid coverage who did not report any other sources of health
insurance during the survey year, designated in this study as ‘Discontinuous–Uninsured’,
and (2) individuals with <12 months of Medicaid coverage who also reported having
other source(s) of health insurance during the survey year (either private, Tricare, or any
hospital- or physician group-based health insurance), designated in this study as
‘Discontinuous–Insured’. Individuals in the study population who reported having
Medicaid coverage during all 12 months of a survey year were classified as having
continuous Medicaid coverage, which was the comparison group and designated as
‘Continuous Medicaid’ in this study.
Study Variables
Our first objective was to examine whether Medicaid discontinuity was associated
with poor access to care among non-elderly adults with CVD or high-risk conditions for
CVD. The outcomes of interest for this objective were the following three binary
indicators for: (1) having a usual source of care, (2) having difficulty in obtaining
medical care, and (3) having difficulty obtaining prescription medications. When
examining association between Medicaid discontinuity and preventive services use, the
following three binary outcomes were examined: (1) having blood pressure checkup
within the past year, (2) having cholesterol checkup within the past year, and (3) having
routine medical checkup within the past year. For the final objective of examining
associations between Medicaid discontinuity, primary care visits, and hospitalizations, we
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divided the utilization outcome measures into all-cause, i.e. overall utilization during the
survey year irrespective of diagnosis, and disease-specific utilization, i.e. utilization
specific to CVD or high-risk conditions for CVD considered in this study. Specifically,
the total number of inpatient visits, ER visits, hospital outpatient visits, and physician
office visits, were examined, resulting in eight outcome measures (one all-cause, and one
disease-specific for each) that were characterized as discrete counts of the events
All regression models included the following classes of covariates:1) Demographic covariates: age (in years), gender (female vs. male), race/ethnicity
(Non-Hispanic White vs. Non-Hispanic Black, Hispanic, and other races), marital
status (not married vs. married), family size (N), and geographic residence
(Northeast vs. Midwest, South, and West).
2) Socioeconomic covariates: education (less than high school vs. high school/GED,
and Bachelor’s or higher), income as a percentage of the federal poverty level
(FPL) (<100% FPL vs. 100 - <125% FPL, and >125% FPL), employment (always
unemployed vs. intermittent employment, and always employed), binary indicator
for Metropolitan Statistical Area (MSA) residence.
3) Medicaid-related covariates: binary indicator for Supplementary Security Income
(SSI) for disability receipt or participation in the Temporary Assistance for Needy
Families program, and a binary indicator for Medicaid HMO/Managed Care
participation.
4) Health-related covariates: perceived health status (excellent/very good/good vs.
fair/poor), perceived mental health status (excellent/very good/good vs. fair/poor)
binary indicator for mental illness/substance abuse diagnosis, binary indicator for
respiratory diseases diagnosis, binary indicator for arthritis/joint pain diagnosis,
and Charlson Comorbidity Index (CCI) score.
Additionally, all of the multivariate models included the year fixed effects to
capture any macro-level variations during the study period.
Statistical Analysis
Bivariate statistics were conducted to examine the characteristics of the study
population. When examining the binary outcomes for access to care and preventive
services use, adjusted multivariate logistic regression analyses were conducted. As an
example, Equation 4-1 and Equation 4-2 depict the logistic regression models usual
source of care, as part of the access to care measures, among both the Discontinuous–
Uninsured, and the Discontinuous–Insured groups relative to the Continuous Medicaid
insurance group.

Pr[USC=1|x] = F-1(ߙො  ߚመଵ Ǥ  ݏݑݑ݊݅ݐ݊ܿݏ݅ܦെ ܷ݊݅݊ ݀݁ݎݑݏ ୀଵ ߚመ ܺ ) (Eq. 4-1)

Pr[USC=1|x] = F-1(ߙො  ߚመଵ Ǥ  ݏݑݑ݊݅ݐ݊ܿݏ݅ܦെ  ݀݁ݎݑݏ݊ܫ ୀଵ ߚመ ܺ )
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(Eq. 4-2)

Usual source of care is modeled as a dichotomous outcome variable as a function
of Medicaid discontinuity as well as the demographic, socioeconomic, Medicaid-related,
and health-related covariates mentioned above. F-1 denotes the inverse of the cumulative
standard logistic distribution function that relates the outcome on the probability scale to
the covariates. Pr[ ] denotes the population average probability of having a usual source
of care (denoted by 1) that is conditional on the covariates denoted by x. Discontinuous–
Uninsured and Discontinuous–Insured are binary indicator variables for the main
independent variable of interest, that equals one for individuals having discontinuous
annual Medicaid coverage without any other sources of insurance and with other sources
of insurance during the year, respectively, and equals zero for the comparison group of
individuals with continuous Medicaid coverage. X denotes the vector of the
aforementioned individual characteristics that predict Medicaid discontinuity in the two
population groups of interest.
The number of physician office visits data (both all-cause and disease-specific)
displayed overdispersion, however, this count outcome measure did not have excess
zeros. Thus, an adjusted negative binomial regression was utilized. It is a type of
generalized linear model where the dependent variable Y is a count of the number of
times an event occurs (in this case, the number of physician office visits). A convenient
parameterization of the negative binomial distribution is denoted by Equation 4-3.71
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(Eq. 4-3)

In Equation 4-3, μ>0 is the mean of Y, which is the count variable indicating the
number of prescription drug fills (either all-cause, or disease-specific) and α>0 is the
heterogeneity parameter. It can be derived as a Poisson-gamma mixture, or as the number
of failures before the (1/α)th success. A simpler depiction of the traditional negative
binomial regression model, the NB2 model is depicted is depicted in Equation 4-4 and
Equation 4-5 as follows,
 Ɋି௨௦ ൌ ߚ  ߚଵ  ݏݑݑ݊݅ݐ݊ܿݏ݅ܦെ ܷ݊݅݊ ݀݁ݎݑݏ ߚଶ Ǥ ݔଶ   ڮ ߚ Ǥ ݔ (Eq. 4-4)
 Ɋௗ௦௦ି௦ ൌ ߚ  ߚଵ  ݏݑݑ݊݅ݐ݊ܿݏ݅ܦെ ܷ݊݅݊ ݀݁ݎݑݏ ߚଶ Ǥ ݔଶ   ڮ ߚ Ǥ ݔ
(Eq. 4-5)
where, apart from the main indicator variables for the Discontinuous–Uninsured
group, the covariates ݔଶ to ݔ are known, and the population regression coefficients ߚ to
ߚ are to be estimated. The two equations above depict the negative binomial regression
models to estimate the differences in overall (Equation 4-4), and disease-specific
physician office visits (Equation 4-5) between the Continuous Medicaid, and
Discontinuous–Uninsured groups. Similar regression models (not shown here) were run
to estimate differences in the number of physician office visits between the Continuous
Medicaid and Discontinuous–Insured groups.
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When analyzing the discrete count data for the number of all-cause and diseasespecific inpatient visits, ER visits, and hospital outpatient visits, it was important to
account for the overdispersion in the data characterized by the presence of an excessive
number of zeros, a problem that is commonly known as zero inflation (ZI). Appendix B,
Figures B-1 to B-16, display the distribution of the all-cause and disease-specific
outcome variables examined in this study. The distribution of the ZI data is often rightskewed, with a huge peak at zero, representing the individuals with zero health care
consumption, and a skewed tail representing the rest of the study population with varying
amounts of non-zero consumption. ZI data are often analyzed using a two-part mixture
models combining a point mass at zero with a proper count distribution. These models
assume an initial process to determine membership into one of two latent groups,
generally referred to the ‘susceptible’ and ‘non-susceptible’ population groups.102 The
approach for ZI models uses two regression models, one is usually a logit regression (or
probit) modeling the susceptible probability, and the other is either a Poisson or negative
binomial model, modeling the mean for the susceptible population (Equation 4-6).
Explanatory variables are allowed to have a different impact for the two processes, and
the two models are fit simultaneously using maximum likelihood estimation.102 The
outcomes measures with excess zeros were therefore analyzed using zero inflated
negative binomial regression models, mathematically represented as follows:
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(Eq. 4-6)

Having a mean E(Y) = (1 – p)μ, and a variance Var(Y) = (1 – p)μ(1 + pμ + αμ).
Research has shown zero-inflated negative binomial models to provide superior fit when
compared to zero-inflated Poisson regression.103 For the binary model estimating the
susceptible probability, the following variables were included
The coefficient of interest for the Discontinuous–Uninsured is the measure of
differences in the utilization of overall, and disease-specific drug utilization. Because of
the functional form of the negative binomial regression, the effect size of a factor is the
antilog of its coefficient. This estimated coefficients are transformed to obtain the
incidence rate ratio (IRR). An IRR of less than one for the discontinuous Medicaid
groups would suggest lower hospital outpatient utilization for instance, among them
when compared to their counterparts with continuous Medicaid coverage.
In addition to obtaining IRRs, this study further estimated the average marginal
effect to determine the predicted difference in the number of all-cause and diseasespecific prescription drug fills between the continuous and discontinuous Medicaid
groups. The marginal effects measure the discrete change in the outcome variable, i.e. for
a binary independent variable, how do predicted probabilities change as the binary
independent variable changes from 0 (Continuous Medicaid) to 1 (Discontinuous–
Uninsured, or Discontinuous–Insured).72 In order to obtain these marginal effects, after
developing and running the multivariate negative binomial regression model, the
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estimated coefficients of the model were used to calculate two predicted event visits for
all individuals in the study population. The first predicted utilization assumed all
individuals had discontinuous Medicaid coverage (by setting the Medicaid discontinuity
indicator variable to 1), and the second predicted utilization assumed all individual to
have continuous full-year Medicaid coverage (by setting the Medicaid discontinuity
indicator variable to 0). The average per-person difference in the event visits attributable
to Medicaid coverage was estimated by obtaining the difference in predicted drug
utilization for each person and computing the weighted average of the difference across
the entire study sample.
The proportion of missing data was around 6% in this study, as a result, the
listwise deletion approach was used to account for missing values. Multicollinearity was
assessed for all the regression models, and the variance inflation factor was found to be
less than 5, which was lower than the widely accepted threshold of 10 for existence of
multicollinearity. The Hosmer-Lemeshow tests for goodness-of-fit were highly
insignificant for all the logistic regression models indicating that the model fit the data.
All data analyses were conducted using SAS 9.3 and STATA 13 to account for the
complex survey design of MEPS.
RESULTS
Characteristics of the Study Populations
Table 4-1 displays the characteristics of the study population. The study sample
included 3,926 respondents in the Continuous Medicaid coverage group (nationally
representative of about 2.4 million individuals), 1,407 individuals in the Discontinuous–
Uninsured group (nationally representative of over 900,000 individuals), and 493
individuals in the Discontinuous–Insured group (nationally representative of over
400,000 individuals).
When compared to the Continuous Medicaid group, individuals in the
Discontinuous–Uninsured group were less likely to belong to other race groups
(P<0.001), more likely to be married (P<0.001), and were more likely to reside in the
South region (P=0.049). Among the socioeconomic covariates, this study found that
respondents were more likely to have completed high school/GED or college (P=0.001),
were more likely to have family incomes >125% FPL (P<0.001), and more likely to have
intermittent, as well as continuous full-year employment (P<0.001). Respondents were
less likely to be eligible for SSI due to disability or participate in TANF (P<0.001), and
less likely to report being Medicaid managed care enrollees (P<0.001). Among the
health-related variables, respondents were less likely to report having fair or poor
perceived mental health status (P<0.001), less likely to report having mental/substance
abuse illnesses (P=0.003), less likely to report having respiratory illnesses (P<0.001), and
less likely to report having arthritis/joint pain (P=0.009). The mean CCI score was not
significantly different between the two groups (P=0.181).
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Table 4-1.

Characteristics of the Study Population (2002 – 2011)

Characteristics
DEMOGRAPHIC

Continuous Medicaid
Weighted N
% (SE)

Discontinuous–Uninsured
Weighted N
% (SE) P-value†

Discontinuous–Insured
Weighted N
% (SE)
P-value††

0.385

Age

0.013

18 – 34 years

388,425

15.9 (1.0)

165,340

18.1 (1.3)

98,188

23.1 (2.3)

35 – 49 years

875,809

35.9 (1.2)

324,653

35.5 (1.8)

141,109

33.3 (2.7)

50 – 64 years

1,173,144

48.2 (1.3)

423,933

46.4 (2.0)

184,968

43.6 (3.0)

0.491

Gender
Female

1,632,006

67.0 (1.2)

624,410

68.3 (1.8)

Race/Ethnicity

0.169
267,502

63.1 (2.8)

<0.001

<0.001

Non-Hispanic White

1,094,002

44.9 (1.8)

442,534

48.4 (2.1)

256,231

60.4 (3.2)

Non-Hispanic Black

666,358

27.3 (1.5)

219,033

24.0 (1.6)

79,936

18.8 (2.0)

Hispanic

445,601

18.3 (1.2)

202,106

22.1 (1.5)

50,704

12.0 (1.6)

Others

231,416

9.5 (0.9)

50,253

5.5 (0.9)

37,393

8.8 (1.7)

Marital Status
Married

<0.001
727,457

29.9 (1.3)

344,150

37.7 (1.8)

Region

<0.001
184,414

43.5 (3.2)

0.049

0.023

Northeast

608,070

25.0 (1.6)

187,785

20.5 (1.7)

104,394

24.6 (2.9)

Midwest

477,401

19.6 (1.4)

184,710

20.2 (1.7)

115,146

27.2 (3.2)

South

727,520

29.8 (1.6)

315,073

34.5 (1.8)

98,072

23.1 (2.3)

West

624,386

25.6 (1.7)

226,358

24.8 (1.9)

106,652

25.1 (3.0)

Family Size Mean (SE)

2.8 (0.1)

2.9 (0.1)
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0.409

2.8 (0.1)

0.976

Table 4-1.

(Continued)

Characteristics

Continuous Medicaid
Weighted
% (SE)
N

Discontinuous–Uninsured
Weighted N % (SE)
P-value†

Discontinuous–Insured
Weighted N % (SE)
P-value††

SOCIOECONOMIC
Education
<High School
High School/GED
College Degree

0.001
971,041

40.2 (1.4)

298,300

32.9 (1.8)

67,896

16.0 (1.9)

1,215,968

50.4 (1.4)

498,289

54.9 (2.0)

232,334

54.9 (3.2)

227,668

9.4 (0.7)

111,300

12.2 (1.4)

123,109

29.1 (3.2)

Income
<100% FPL

<0.001

<0.001

<0.001

1,384,551

56.8 (1.2)

428,540

46.9 (1.7)

104,719

24.7 (2.3)

100 – <125% FPL

227,591

9.3 (0.6)

91,940

10.1 (1.1)

28,783

6.8 (1.3)

>125% FPL

825,236

33.9 (1.1)

393,445

43.0 (1.8)

290,763

68.5 (2.6)

Employment
Always Unemployed

<0.001

<0.001

1,767,234

72.5 (1.2)

496,282

54.3 (1.8)

112,490

26.5 (2.2)

Unstable Employment

301,597

12.4 (0.8)

228,246

25.0 (1.6)

129,583

30.6 (2.5)

Always Employed

368,547

15.1 (0.9)

189,398

20.7 (1.4)

182,191

42.9 (2.9)

1,931,797

79.3 (1.8)

721,532

78.9 (1.9)

0.880

344,287

81.1 (2.7)

0.494

SSI/TANF

1,012,240

41.5 (1.3)

154,157

16.9 (1.3)

<0.001

41,212

9.7 (1.6)

<0.001

Medicaid HMO/MCO

1,424,726

61.3 (1.5)

459,330

50.5 (2.0)

<0.001

233,429

55.0 (3.0)

0.048

MSA
MEDICAID-RELATED
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Table 4-1.

(Continued)

Characteristics
HEALTH-RELATED

Continuous Medicaid
Weighted N
% (SE)

Discontinuous–Uninsured
Weighted N % (SE)
P-value†
0.162

Perceived Health Status
Fair to Poor

1,314,794

53.9 (1.2)

467,555

51.2 (1.9)

Perceived Mental Health
Fair to Poor

Discontinuous–Insured
Weighted N % (SE)
P-value††
<0.001
170,598

40.2 (2.5)

<0.001
821,318

33.7 (1.2)

234,931

25.7 (1.7)

<0.001
84,716

20.0 (2.2)

0.775

CVD or high-risk
conditions for CVD

0.037

<1

1,678,222

68.9 (1.1)

640,242

70.1 (1.8)

321,685

75.8 (2.3)

2

444,995

18.2 (0.8)

163,062

17.8 (1.4)

65,581

15.5 (2.2)

>3

314,160

12.9 (0.8)

110,621

12.1 (1.3)

37,000

8.7 (1.5)

Mental/Substance Abuse
Illnesses

751,357

30.8 (1.2)

227,885

24.9 (1.6)

0.003

115,891

27.3 (2.4)

0.176

Respiratory Illnesses

479,702

19.7 (1.1)

117,992

12.9 (1.1)

<0.001

39,380

9.3 (1.5)

<0.001

Arthritis/Joint Pain

830,408

34.1 (1.3)

267,358

29.3 (1.7)

0.009

107,575

25.4 (2.4)

0.002

CCI Score Mean (SE)

1.2 (0.0)

0.079

0.9 (0.1)

Population Size

2,437,378

1.1 (0.1)
64.6 (1.0)

913,926

24.2 (0.8)

424,265

0.003
11.2 (0.7)

Study population includes MEPS respondents from the years 2002-2011, aged 18-64 years, who either reported being diagnosed with or having an
event (prescription medication, or inpatient, emergency, outpatient, or office-based provider visits) associated with CVD or high-risk conditions
for CVD, had <1 month of Medicaid coverage during the survey year. †P-value for the difference between Discontinuous–Uninsured and
Continuous Medicaid groups. ††P-value for the difference between Discontinuous–Insured and Continuous Medicaid groups. P-values in bold
indicate statistically significant difference at P<0.05. SE: Standard error; GED: General educational development; FPL: Federal poverty level;
MSA: Metropolitan Statistical Area; SSI: Supplementary Security Income.
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When comparing the Discontinuous–Insured group to the Continuous Medicaid
group in the above table, this study found that among the demographic covariates,
individuals in the Discontinuous–Insured group were more likely to be younger
(P=0.013), were less likely to belong to minority race/ethnicity groups (P<0.001), more
likely to be married (P<0.001), and were more likely to reside in the Midwest (P=0.023).
Among the socioeconomic covariates, this study found that individuals in the
Discontinuous–Insured group were more likely to complete high school/GED or college
(P<0.001), more likely to have higher family income levels (P<0.001), and were more
likely to have some form of employment during the year (P<0.001). The Discontinuous–
Insured group was also less likely to be eligible for SSI due to disability or participate in
TANF (P<0.001), and less likely to report having Medicaid through an HMO/MCO
(P=0.048). Among the health-related covariates, this study found that the Discontinuous–
Insured group was less likely to report having self-perceived health status (P<0.001), and
self-perceived mental health status (P<0.001), more likely to report fewer CVD or highrisk conditions for CVD (P=0.037), were less likely to report having respiratory illnesses
(P<0.001), less likely to report having arthritis/joint pain (P=0.002), and lower chronic
disease burden (P=0.003).
Medicaid Enrollment among the Discontinuous Medicaid Coverage Groups
Table 4-2 shows the summary statistics for Medicaid enrollment among the
discontinuous Medicaid insurance groups. The average duration of enrollment for the
undivided discontinuous Medicaid population was 6.0 months. The Discontinuous–
Uninsured group was enrolled in Medicaid for a longer period on average compared to
the Discontinuous–Insured group (6.5 vs. 5.0 months, P<0.001). Additionally, this study
examined the average duration of no insurance and found individuals in the
Discontinuous–Insured group were uninsured for a little over a month (5.5 vs. 1.2
months, P<0.001). This study also examined Medicaid enrollment status after 12 months
of initial Medicaid enrollment. Overall, a total of 4,898 individuals were enrolled in the
month of January of the survey year, of which 85.3% were still enrolled in Medicaid
during the month of December in the survey year, 3.5% had some other form of
insurance coverage, and 10.2% were uninsured (results not shown). Of the 621
individuals in the Discontinuous–Uninsured group who had Medicaid in the beginning of
the year, 78.1% were uninsured while 21.9% still had Medicaid coverage at the end of the
year. Of the 200 individuals in the Discontinuous–Insured group who had Medicaid in the
beginning of the survey year, only 8.0% still had Medicaid, 6.0% were uninsured, and the
remaining 86% had some other source of health insurance coverage at the end of the year.
Finally, when examining the number of transitions into and/or out of Medicaid coverage,
this study found that overall 17.6% of individuals in this study population had more than
one transitions, and the proportion of multiple transitions was similar between the two
discontinuous Medicaid subgroups (17.7% vs. 17.3%, P=0.875).
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Table 4-2.
Groups

Patterns of Medicaid Coverage among Discontinuous Medicaid

Coverage
Components
Mean Duration of
Medicaid
Mean Duration of No
Insurance

Discontinuous–Uninsured
Mean or
SE or %
Weighted N
(SE)
6.5 months
0.1

Discontinuous–Insured
Mean or
SE or %
Weighted N
(SE)
5.0 months***
0.2
1.2 months***

5.5 months

0.1

0.1

Insurance Status
After 12 Months†
Still in Medicaid
Uninsured
Other Insurance

83,125
297,045
--

21.9 (2.2)
78.1 (2.2)
--

11,647***
10,058***
147,896

8.0 (2.0)
6.0 (2.0)
86.0 (2.0)

Medicaid Coverage
Transitions
1
>2

752,311
161,615

82.3 (1.4)
17.7 (1.4)

350,803
73,462

82.7 (2.0)
17.3 (2.0)

Sample consisted of 380,171 individuals in the Discontinuous–Uninsured group and 169,600
individuals in the Discontinuous–Insured group who either reported being diagnosed with or
having an event (prescription medication, or inpatient, emergency, hospital outpatient, or
office-based provider visits) associated with CVD or high-risk conditions for CVD, and who
reported having Medicaid at the beginning of the year.
***P<0.001; **P<0.01; *P<0.05 for difference from the Discontinuous–Uninsured group.
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Access to Care
In comparison to the Continuous Medicaid group, individuals in the
Discontinuous–Uninsured group were less likely to report having a usual source of care
(93.6% vs. 84.5%; P<0.001), and more likely to report having difficulties in obtaining
medical care (5.6% vs. 19.1%; P<0.001), and prescription medications (5.8% vs. 15.8%;
P<0.001). When compared to the Continuous Medicaid group, those in the
Discontinuous–Insured group were less likely to report having a usual source of care
(93.6% vs. 88.6%; P=0.002), and more likely to report having difficulty in obtaining
prescription medications (5.8% vs. 11.3%; P<0.001); however, there were no differences
between the two groups in facing difficulty in obtaining medical care (P=0.094). Results
of these bivariate analyses are not displayed. Table 4-3 displays the results of the
multivariate logistic regression examining association between Medicaid discontinuity
and access to care, among adults with CVD or high-risk conditions for CVD. In
comparison to the Continuous Medicaid group, the Discontinuous–Uninsured group were
found to have almost 60% lower odds of having a usual source of care [Odds Ratio (OR):
0.41; 95% Confidence Interval (CI): 0.32 – 0.52]. Additionally, the odds were a
staggering 4 times higher of reporting having difficulty in obtaining in obtaining medical
care (OR: 4.20; 95% CI: 3.14 – 5.62), and were more than 3 times higher of reporting
having difficulty in obtaining prescription medications (OR: 3.32; 95% CI: 2.50 – 4.40)
when compared to those with continuous Medicaid coverage. Among the Discontinuous–
Insured group, the odds of having a usual source of care were 43% lower when compared
to the Continuous Medicaid group (0.57; 95% CI: 0.37 – 0.88). The odds of reporting
having difficulty in obtaining medical care were 74% higher (OR: 1.74; 95% CI: 1.02 –
2.98), and the odds of reporting having difficulty in obtaining prescription medications
were more than twice, when compared to the Continuous Medicaid group (OR: 2.16;
95% CI: 1.42 – 3.27).
Preventive Services Use
When examining the bivariate statistics between the Continuous Medicaid and
Discontinuous–Uninsured groups, this study found no significant differences between the
two when reporting about the routine BP checkup (P=0.073) and routine cholesterol
checkup (P=0.140); however, the Discontinuous–Uninsured group was less likely to
report having had a medical checkup within the past year (P=0.004). When comparing
the Continuous Medicaid and Discontinuous–Insured groups, this study found that those
in the Discontinuous–Insured group were less likely to report having routine BP checkup
(96.9% vs. 94.5%; P=0.023), whereas differences in routine cholesterol checkup (P=
0.897) and medical checkup (P= 0.146) were insignificant (results not displayed). Table
4-4 displays the results of the multivariate logistic regression examining association
between Medicaid discontinuity and preventive services use, among adults with CVD or
high-risk conditions for CVD. When examining routine blood pressure checkup and
routine blood cholesterol checkup, there were no significant differences between the
continuous and discontinuous Medicaid populations. However, the Discontinuous–
Uninsured were found to have 22% lower odds of having had a medical checkup within
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Table 4-3.
Association between Medicaid Discontinuity and Access to Care in the
Study Population
Outcome

Medicaid Coverage

Odds Ratio
(95% Confidence Interval)
1.00 (Reference)
0.41 (0.32 – 0.52)***
0.57 (0.37 – 0.88)*

Have Usual Source of Care

Continuous
Discontinuous–Uninsured
Discontinuous–Insured

Difficulty in Obtaining
Necessary Medical Care

Continuous
Discontinuous–Uninsured
Discontinuous–Insured

1.00 (Reference)
4.20 (3.14 – 5.62)***
1.74 (1.02 – 2.98)*

Difficulty in Obtaining
Prescription Medications

Continuous
Discontinuous–Uninsured
Discontinuous–Insured

1.00 (Reference)
3.32 (2.50 – 4.40)***
2.16 (1.42 – 3.27)***

Study population included MEPS respondents from the years 2002-2011, aged 18-64 years, who
either reported being diagnosed with or having an event (prescription medication, or inpatient,
emergency, outpatient, or office-based provider visits) associated with CVD or high-risk
conditions for CVD, and who reported having Medicaid anytime during the year.
Two separate covariates-adjusted regression models for each outcome comparing Continuous to
Discontinuous–Uninsured, and to Discontinuous–Insured, respectively. Estimates in bold
indicate statistical significance at P<0.05. *P<0.05, **P<0.01, ***P<0.001 for comparison
between the continuous and discontinuous Medicaid groups.
All models were adjusted for age, gender race/ethnicity, marital status, family size, census region,
education, income, employment, MSA, SSI/TANF, Medicaid HMO/MCO, mental/substance
abuse illnesses, arthritis/joint pain, no. of CVD conditions, perceived health status, perceived
mental health status, Charlson Comorbidity Index score, and survey year.
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Table 4-4.
Associations between Medicaid Discontinuity and Preventive Services
Use in the Study Population
Outcome

Medicaid Coverage

Routine BP Checkup

Continuous
Discontinuous–Uninsured
Discontinuous–Insured

Odds Ratio
(95% Confidence Interval)
1.00 (Reference)
0.90 (0.61 – 1.31)
0.75 (0.42 – 1.33)

Routine Cholesterol Checkup

Continuous
Discontinuous–Uninsured
Discontinuous–Insured

1.00 (Reference)
0.85 (0.64 – 1.13)
1.06 (0.68 – 1.64)

Routine Medical Checkup

Continuous
Discontinuous–Uninsured
Discontinuous–Insured

1.00 (Reference)
0.78 (0.63 – 0.96)*
0.80 (0.56 – 1.13)

Study population included MEPS respondents from the years 2002-2011, aged 18-64 years, who
either reported being diagnosed with or having an event (prescription medication, or inpatient,
emergency, outpatient, or office-based provider visits) associated with CVD or high-risk
conditions for CVD, and who reported having Medicaid anytime during the year.
Two separate covariates-adjusted regression models for each outcome comparing Continuous to
Discontinuous–Uninsured, and to Discontinuous–Insured, respectively. Estimates in bold
indicate statistical significance at P<0.05. *P<0.05, **P<0.01, ***P<0.001 for comparison
between the continuous and discontinuous Medicaid groups.
All models were adjusted for age, gender race/ethnicity, marital status, family size, census region,
education, income, employment, MSA, SSI/TANF, Medicaid HMO/MCO, mental/substance
abuse illnesses, arthritis/joint pain, no. of CVD conditions, perceived health status, perceived
mental health status, Charlson Comorbidity Index score, and survey year.
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the past year when compared to the Continuous Medicaid population (OR: 0.78; 95% CI:
0.63 – 0.96).
Utilization of Health Care Services
The results of the final objective of examining associations between Medicaid
discontinuity and heath care services utilization are displayed in Table 4-5. Overall
inpatient visits were not significantly different between the continuous and discontinuous
Medicaid groups. However, when examining disease-specific inpatient visits, this study
found that the Discontinuous–Uninsured group had about 62% higher inpatient visits
compared to the Continuous Medicaid group [Incidence Rate Ratio (IRR): 1.62; 95% CI:
1.19 – 2.22]. The marginal predicted difference in the number of inpatient visits was
found to be 0.05 visits (P=0.007); in other words, individuals in the Discontinuous–
Uninsured group were predicted to have 0.05 higher inpatient visits per person annually,
compared to the Continuous Medicaid group. Similarly, the incidence of disease-specific
inpatient visits was found to be 95% higher among the Discontinuous–Insured population
(IRR: 1.95; 95% CI: 1.23 – 3.10), which at the margins was predicted to be 0.08 higher
inpatient visits per person (P=0.029) when compared to the Continuous Medicaid group.
When examining ER visits, this study did not find significant associations between
Medicaid discontinuity and all-cause ER visits. When examining disease-specific ER
visits, this study found that the incidence of these visits were 52% higher among the
Discontinuous–Uninsured population, and the predicted marginal difference from the
Continuous Medicaid group was found to be 0.05 additional visits per person (P=0.008).
The Discontinuous–Insured too had a 79% higher incidence of disease-specific ER visits
compared to the Continuous Medicaid population, with a predicted difference of 0.07
greater ER visits per person (P=0.034).
Among the primary care utilization outcomes, this study found the
Discontinuous–Uninsured group to have an 86% higher incidence of disease-specific
hospital outpatient visits compared to the Continuous Medicaid insurance group (IRR:
1.86; 95% CI: 1.32 – 2.63), and a predicted marginal difference of 0.21 additional visits
(P=0.007). Finally, the Discontinuous–Uninsured group was found to have
approximately 29% lower incidence of all-cause physician office visits (IRR: 0.71; 95%
CI: 0.64 – 0.80), and were predicted to have 3.4 fewer overall physician office visits per
person annually, when compared to their counterparts with continuous Medicaid
coverage (P<0.001).
DISCUSSION
Adults with CVD or high-risk conditions for CVD who did not have continuous
full-year Medicaid coverage, due to either loss of coverage, or disruptions/gaps, reported
significantly worse health care and medication access, and routine healthcare checkup
visits. Additionally, those in with discontinuous Medicaid coverage reported lower
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Table 4-5.

Associations between Medicaid Discontinuity and Health Care Resources Utilization in the Study Population

Outcome
Inpatient Visits
All-Cause

Disease-Specific

Emergency Room Visits
All-Cause

Disease-Specific

Hospital Outpatient Visits
All-Cause

Disease-Specific

Medicaid Coverage

Incidence Rate Ratio
(95% Confidence Interval)

Predicted
Difference in Visits

Continuous
Discontinuous–Uninsured
Discontinuous–Insured

1.00 (Reference)
1.14 (0.95 – 1.37)
1.24 (0.97 – 1.58)

0.05 visits
0.08 visits

Continuous
Discontinuous–Uninsured
Discontinuous–Insured

1.00 (Reference)
1.62 (1.19 – 2.22)**
1.95 (1.23 – 3.10)**

0.05 visits**
0.08 visits*

Continuous
Discontinuous–Uninsured
Discontinuous–Insured

1.00 (Reference)
0.96 (0.79 – 1.17)
1.00 (0.73 – 1.38)

-0.02 visits
0.00 visits

Continuous
Discontinuous–Uninsured
Discontinuous–Insured

1.00 (Reference)
1.52 (1.14 – 2.03)**
1.79 (1.16 – 2.77)**

0.05 visits**
0.07 visits*

Continuous
Discontinuous–Uninsured
Discontinuous–Insured

1.00 (Reference)
0.77 (0.55 – 1.06)
1.20 (0.71 – 2.04)

-0.33 visits
0.28 visits

Continuous
Discontinuous–Uninsured
Discontinuous–Insured

1.00 (Reference)
1.86 (1.32 – 2.63)***
0.86 (0.47 – 1.60)

0.21 visits**
-0.04 visits
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Table 4-5.

(Continued)

Outcome
Physician Office Visits
All-Cause

Disease-Specific

Medicaid Coverage

Incidence Rate Ratio
(95% Confidence Interval)

Predicted
Difference in Visits

Continuous
Discontinuous–Uninsured
Discontinuous–Insured

1.00 (Reference)
0.71 (0.62 – 0.81)***
0.89 (0.77 – 1.11)

-3.37 visits***
-1.27 visits

Continuous
Discontinuous–Uninsured
Discontinuous–Insured

1.00 (Reference)
0.90 (0.80 – 1.02)*
0.86 (0.71 – 1.06)

-0.30 visits
-0.43 visits

Study population included MEPS respondents from the years 2002-2011, aged 18-64 years, who either reported being
diagnosed with or having an event (prescription medication, or inpatient, emergency, outpatient, or office-based provider
visits) associated with CVD or high-risk conditions for CVD, and who reported having Medicaid anytime during the year.
Estimates in bold indicate statistical significance at P<0.05.
All models were adjusted for age, gender race/ethnicity, marital status, family size, census region, education, income,
employment, MSA, SSI/TANF, Medicaid HMO/MCO, mental/substance abuse illnesses, arthritis/joint pain, no. of CVD
conditions, perceived health status, perceived mental health status, Charlson Comorbidity Index score, and survey year.
*P<0.05, **P<0.01, ***P<0.001 for comparison between the continuous and discontinuous Medicaid groups
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physician office visits, and higher inpatient, and ER hospitalizations. In examining these
associations, this study further classified individuals with discontinuous Medicaid
coverage into those who did not report any other coverage (the Discontinuous–
Uninsured), and those who reported having other sources of insurance coverage during
the year (the Discontinuous–Insured), in order to capture the heterogeneity of the
discontinuous Medicaid group. In doing so, we found that the outcomes of Medicaid
discontinuity were not always similar, either in magnitude, directionality, or statistical
significance. For instance, in comparison to the Continuous Medicaid group, among both
the Discontinuous–Uninsured and Discontinuous–Insured groups, the access to care
outcomes were significantly poor; however, the odds of reporting difficulty in obtaining
medical care were over 4 times, and almost 2 times higher, respectively. Similarly, the
Discontinuous–Uninsured population in this study had significantly lower odds of
reporting routine medical checkup within the past year, whereas no significant difference
in this outcome was observed between the Discontinuous–Insured and the Continuous
Medicaid populations.
Nearly three-quarters (74.1%) of the individuals who did not have continuous
full-year Medicaid coverage in this CVD population belonged to the Discontinuous–
Uninsured group. On average, this group was uninsured for over 5 months during the
year, and around 18% of individuals experienced multiple transitions in their Medicaid
coverage, indicating significant churning, and relapses into the state of being uninsured.
Of the roughly 400,000 individuals who had Medicaid at the beginning of the year, a
whopping 78% were found to be uninsured by the end of the year. These individuals
collectively had worse outcomes associated with Medicaid discontinuity when compared
to those who reported other sources of insurance coverage during the year, the
Discontinuous–Insured, with significantly fewer physician office visits and higher
incidences of inpatient and ER hospitalizations, when compared to those with continuous
Medicaid coverage. Although preventive services use, and primary care visit outcomes
were not significantly poor among the Discontinuous–Insured, these individuals did
collectively have poor access to medical care and pharmacotherapy, and higher
incidences of hospitalizations when compared to those with continuous Medicaid
coverage. Our study findings indicate that for individuals with CVD or some of its risk
factor conditions that require continuous, prolonged disease management, lacking
continuous Medicaid coverage may adversely impact access to care, and primary care,
and have a strong association with increased incidences of hospitalizations, irrespective
of whether or not they have other sources of coverage during the year. And these
outcomes may worsen among individuals and families for whom Medicaid is the only
source of health insurance coverage.
The increased hospitalizations, both inpatient and ER, were The results of this
study, are in line with previous estimates, however, very few have examined Medicaid
discontinuity outcomes among adults with CVD or high-risk conditions for CVD. Among
the earliest studies, Lurie and colleagues examined access to care among a cohort of
California Medicaid enrollees within a 6-month period after loss of coverage. A
significantly higher proportion of individuals in the lost coverage group (62%) reported
poor access to needed medical care, compared to those still on Medicaid (7%), with the
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discontinuous Medicaid group being more likely to have uncontrolled hypertension.104 In
a follow-up study conducted at one year found no improvements in access to care
between the discontinuous and continuous Medicaid groups.105 Carlson and colleagues
examined the impact of disrupted or lost Medicaid coverage within a year of benefit
structure changes among the Oregon Medicaid program, on unmet medical care or
pharmacotherapy needs, utilization, and medical debt.106 They found that enrollees with
discontinuous Medicaid coverage were more likely to report unmet medical care,
prescription medication needs (lost Medicaid coverage group), and were less likely to
report having primary care visits, when compared to those enrolled continuously in the
program.
Harman and colleagues examined associations between interruptions in a state
Medicaid program coverage and inpatient psychiatric services among persons with
schizophrenia.10 They found an 86% increase in the incidence of hospitalizations,
representing 0.63 more psychiatric hospitalizations per beneficiary, and longer hospital
stays to be associated with discontinuous Medicaid coverage. Hall and colleagues
examined the impact of gaps in Florida’s Medicaid coverage on health care utilization
and expenditures among individuals with diabetes.101 That study found that gaps in
coverage were associated with higher inpatient and ER utilization, and higher
expenditures, especially in the period after lapse in Medicaid coverage. Banerjee and
colleagues analyzed the MEPS data for the years 2000 – 2004 to examine association
between Medicaid discontinuity and health resource utilization among all Medicaid
enrollees.15 They defined discontinuity as having one or more than one transitions into or
out of Medicaid coverage, which was different from the present study. The
aforementioned study found Medicaid discontinuity to be associated with higher
inpatient, ER, and higher outpatient physician visits. It is unclear whether they examined
hospital outpatient visits and physician office visits separately, or combined the two
outcomes together. Nonetheless, the results from this study are broadly in agreement with
the study of Banerjee and colleagues, indicating that Medicaid discontinuity, either due to
coverage loss or disruptions in coverage continuity have detrimental outcomes, both
overall, and among individuals with chronic conditions. Alternatively, it may be possible
that the results obtained in the analyses of Medicaid enrollees in general, may in
particular be contributed by individuals with chronic, debilitating conditions, such as
CVD or conditions that are high risk factors for CVD, as this study has shown.
Medicaid provides much-needed health care coverage to the poor and disabled
vulnerable populations who often are unable to afford private health insurance. Medicaid
is often referred to as a “Cadillac” health insurance program, which provides a rich
benefits package at very little or even no cost to the enrollees.107 A substantial body of
research has shown that low-income Medicaid enrollees have comparable access to
physician care, preventive services, and unmet medical care needs when compared to
their counterparts with private health insurance.107 Even low-income mothers on
Medicaid report similar preventive services use and access to care compared to those
with private insurance.108 Together, these and other estimates shown the importance of
Medicaid coverage for low-income populations, and dispel the notion that Medicaid is a
costly, low-quality health coverage program.109,110 Loss of Medicaid coverage may

84

deprive these vulnerable populations suffering from chronic conditions of the ability to
afford and seek much-needed medical care and pharmacotherapy. Such disruptions in
continuity of care may be responsible for respondents reporting lack of usual source of
care and difficulties in obtaining medical care and prescription drugs. The
Discontinuous–Uninsured group also reported lower incidence of physician office visits
overall, which may be precipitated by the lack of usual source of care, and inability of
afford physician visit reimbursements following loss of coverage. This group reported
higher rates of hospital outpatient visits compared to those with continuous Medicaid
coverage, a finding that was puzzling. It may be that these individuals may be more
inclined to seek care in the outpatient setting following loss of Medicaid coverage, and
subsequent inability to afford physician office visits as highlighted earlier. The higher
incidences of disease-specific hospitalizations observed in this study could have been
precipitated by poor access to care, lower likelihood of getting routine medical checkups,
lower primary care office visits, and the disruptions in continuity of care resulting from
loss of Medicaid coverage. A follow-up evaluation of the Oregon Health Experiment,
found higher ER utilization among individuals who gained Medicaid coverage, relative to
those who remained uninsured.111 The present study found increases in CVD or high-risk
conditions for CVD-specific ER visits among the discontinuous Medicaid groups
compared to the Continuous Medicaid group, which may have been precipitated by poor
access to care as observed in our findings, and also due to disruptions in disease
management caused by loss or gaps in Medicaid coverage. Differences in the study
population (diseased vs. general population, and national vs. state-specific) and
estimation techniques may have contributed to the differences in our findings from the
Oregon analysis of ER utilization.
This study has several limitations. State-level Medicaid eligibility data was not
available to explore the complex and dynamic patterns of discontinuity that may differ
based on the state’s eligibility and reporting criteria. This study found strong associations
between Medicaid discontinuity and poor access to care, lower odds of routine medical
checkup, higher disease-specific hospitalizations, and lower all-cause physician office
visits. Nonetheless, temporality between discontinuity and the various outcomes, and the
resulting causality could not be established due to data limitations. The regression
analyses may not have adjusted for unobserved covariates that may have confounded the
impact of certain risk factors on the likelihood of belonging to the Discontinuous–
Uninsured or the Discontinuous–Insured groups. Data in MEPS are self-reported, and the
reasons for discontinuity of Medicaid coverage were not captured, resulting in estimates
that may not exactly reflect the national estimates of the impact of Medicaid discontinuity
on access to care, preventive services use, and health care services utilization.
Researchers have speculated that most surveys underestimate the number of Medicaid
enrollees due to a variety of reasons including stigma of public insurance. However, such
misreporting is less of a problem for MEPS compared to other federal health surveys.54
Finally, findings from this study are representative of the non-institutionalized civilian
population and may not be applicable to individuals with prolonged hospitalizations or
admitted to long-term care facilities.
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Loss of Medicaid coverage has an adverse impact on individuals’ ability to seek
medical care which may in turn lead to poor health outcomes and increased burden on the
health care system resulting from providing care to uninsured individuals. Individuals
eligible for Medicaid may also lose coverage due to the inefficient administrative hurdles
and burdensome paperwork requirements, and may be considered a policy failure.34
However, when individuals transition from one source of coverage to another, continuity
of care may still be impacted, especially since different insurance plans have different
network of providers, and differing benefit structures, and may cover different classes of
medications and services. The present study highlighted the adverse impact that Medicaid
discontinuity may have on ability to access needed medical care, and the increased
hospitalizations for CVD or high-risk conditions for CVD associated with coverage
instability. Enabling continuity in Medicaid coverage for low-income populations with
chronic and debilitating conditions would ensure increased effectiveness of the care they
receive to manage these disease, and may prove cost-effective in the long run.
Discontinuity in Medicaid and the Children’s Health Insurance Program (CHIP)
coverage among low-income children is an issue that has gained considerable scrutiny
previously, and the detrimental effects of such a policy failure have been well
established.35,112 Apart from simplification of administrative regulations governing policy
renewals, a policy initiative adopted by most states is the 12 months continuous eligibility
provision. Under this policy, children continue to be enrolled under Medicaid/CHIP
irrespective for 12 months after gaining or renewing coverage, irrespective of any income
or other eligibility midway. Researchers and advocacy groups, such as the Medicaid and
CHIP Payment Access Commission, have advocated for extending such a measure for
non-elderly adults to ensure continuity of Medicaid coverage in this population.8,44 Our
study findings indicate that individuals with chronic conditions requiring prolonged and
continuous disease management, such as CVD or its high-risk conditions, may be
especially adversely impacted by instability in their Medicaid coverage. States can
choose to have a straight-forward option of establishing a minimum guaranteed eligibility
period, such as the 12 month continuous eligibility provision, for subpopulations of nonelderly adults with chronic conditions, such as CVD, or other such as cancers, respiratory
illnesses, mental illnesses, HIV/AIDS, among others, which require prolonged
management of disease symptoms and risk factors. By using annual eligibility
redetermination periods, and guaranteeing enrollment for the period in between, states
can ensure that loss of coverage or churning midway during enrollment can be reduced in
these vulnerable populations.
CONCLUSION
The present study highlighted the significantly worse access to care, preventive
medical checkups, lower primary care office visits, and higher hospitalizations for CVD
or high-risk conditions for CVD, associated with having discontinuous Medicaid
coverage. Policy initiatives to stabilize Medicaid coverage among non-elderly adults may
provide the most benefit for individuals with chronic conditions requiring continuous
long-term medical care interventions, and appropriate disease management. Low-income
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adults managing chronic conditions, especially in regions with stringent Medicaid
eligibility regulations, must be encouraged to ensure continuity of Medicaid coverage.
States may adopt annual eligibility reassessment policies, with continuous eligibility for
the intermittent period, for non-elderly adults with certain chronic conditions among
whom continuous Medicaid coverage would ensure greater effectiveness of disease
management.
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CHAPTER 5.

CONCLUSION

SUMMARY
The present study was aimed at conducting a detailed examination of the impact
of having discontinuous Medicaid coverage on various health care utilization outcomes
and medication consumption behaviors, which are extremely crucial in effectively
preventing and treating chronic diseases of the cardiovascular system along with many of
its risk factor disease conditions. Although previous estimates have characterized general
populations that experience discontinuous Medicaid coverage, and compared them with
their counterparts with continuous Medicaid insurance, none have focused on national
estimates of subpopulations diagnosed with complex chronic conditions requiring
prolonged disease management, such as CVD or chronic conditions which are high risk
factors for CVD. The first aim of this dissertation intended to characterize the populations
of non-elderly adults with CVD or high-risk conditions for CVD who have discontinuous
Medicaid coverage, and compare them to their counterparts with continuous Medicaid
coverage. Another difference between this analyses and previous ones is the classification
of the subpopulations with less than full-year Medicaid coverage. Individuals with
discontinuous Medicaid coverage are not a homogenous population, since although many
individuals may not have any other source of insurance coverage during the year, the
Discontinuous–Uninsured group in this study, this population would also comprise of
individuals with other sources of coverage, ranging from private insurance, Tricare, or
other hospital-, or physician group-based health insurance. Interestingly, this study found
about three-fourths of this population to belong to the Discontinuous–Uninsured group,
and a little over a fourth to belong to the Discontinuous–Insured group.
Hypertension, lipid disorders, and diabetes, significant risk factors for CVD, were
found to be the most prevalent chronic conditions in this study population. These are
diseases that require prolonged, and sometimes lifelong treatment, which includes
adequate preventive care to monitor health or disease progression, getting regular medical
checkups and making regular primary care visits to diagnose and treat these conditions
early, and filling prescription medications regularly and consuming them as prescribed by
health care providers. This finding, coupled with the fact that insurance is a major source
that enables individuals, especially low-income sick populations, to seek needed medical
care and pharmacotherapy, further strengthens our justification for examining the impact
of Medicaid discontinuity among low-income populations with CVD or high-risk
conditions for CVD.
When examining Medicaid coverage patterns among the two discontinuous
Medicaid coverage groups, this study found that on average, the Discontinuous–
Uninsured were uninsured for over 5 months during the year, and the Discontinuous–
Insured too were uninsured on average for a little over a month, despite reporting other
insurance sources. Further, a subsample of individuals who had coverage at the beginning
of the year were examined to determine their coverage patterns by the year end. It was
observed that among the Discontinuous–Uninsured who had Medicaid coverage at the
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start of the year, 78% were uninsured by the year end. Among the DiscontinuousInsured, only 8% had Medicaid, 86% had other insurance, and around 6% were uninsured
by the end of the year. Finally, this study found that almost 18% of both the
discontinuous Medicaid groups had more than one transitions, indicating a decent amount
of churning taking place in these groups, i.e. going back-and-forth from Medicaid to
either a state of being uninsured, or enrolling in another source of insurance coverage, or
vice versa (uninsured – Medicaid – uninsured, or other insurance – Medicaid – other
insurance). These findings highlight the instability in Medicaid coverage encountered by
low-income, chronically diseased, non-elderly adult population, and the disruptions in
continuity of care associated with transitioning from Medicaid to other sources of
coverage, or vice versa, not to mention the difficulties involved with adjusting to
differences in provider networks, services covered, services and resources covered, and
benefit structures.
When examining the population characteristics associated with Medicaid
discontinuity among the Discontinuous–Uninsured relative to the Continuous Medicaid
group, this study found that those who were married, resided in the South, had
intermittent unstable employment, and had fair to poor perceived health status, had higher
odds of having discontinuous Medicaid coverage, whereas men, minorities, those with
higher incomes, SSI/TANF beneficiaries, Medicaid managed care enrollees, and those
with respiratory illnesses had lower odds of experiencing discontinuity in their Medicaid
coverage during the year. Among the Discontinuous–Insured group, married individuals,
those with higher education, higher incomes, and having some form of employment
during the year were the characteristics associated with higher odds of Medicaid
discontinuity, whereas minorities, those who were married, SSI/TANF beneficiaries,
Medicaid managed care enrollees, and those with respiratory illnesses were associated
with lower odds of Medicaid discontinuity. These findings may have highlighted racial
and ethnic differences in Medicaid continuity; for instance, low-income minorities have
been known to have lower incomes and education, and may be more likely to be
unemployed, resulting in greater continuity in their Medicaid coverage compared to their
Caucasian counterparts. An interesting finding was the lower odds of Medicaid
discontinuity among Medicaid managed care enrollees, which may be the result of better
outreach efforts by managed care organizations, although they may be incentivized to do
so given they are paid on a per-member basis by Medicaid.34
When examining the associations between Medicaid discontinuity, medication
adherence, and medication utilization, as part of the second aim of this dissertation, it was
found that although the point estimate for overall average adherence to frequently
prescribed medications was lower for the Discontinuous–Uninsured, the estimate was not
statistically significantly different from the Continuous Medicaid group. This study found
lower adherence to sulfonylureas among the Discontinuous–Uninsured compared to the
Continuous Medicaid, which may result in higher health care costs in this
subpopulation.113 The Discontinuous–Insured were found to have higher odds of
adherence to ACEI/ARB and calcium channel blockers, which could have been
contributed by better access to these medications through other insurance programs. The
odds of clinically adequate adherence to diuretics, however, was found to be significantly
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lower among the Discontinuous–Insured, which is traditionally used as a first-line
antihypertensive therapy. Medication utilization on the other hand, both all-cause and
disease-specific, was found to be significantly lower among both the discontinuous
Medicaid groups compared to the Continuous Medicaid. On average, the Discontinuous–
Uninsured had 12 fewer drug fills per person for all medications, and 2.3 fewer fills per
person for CVD-specific medications. Even the Discontinuous–Insured had 6.5 fewer
fills, and 2.8 fewer fills per person, for all-cause and disease-specific medications,
respectively. Given the significantly lower prescription drug fills among the
discontinuous Medicaid groups, this study may have overestimated adherence to
medications, which may also be lower among populations lacking continuous Medicaid
coverage.
Finally, as part of the third aim, this study examined associations between
Medicaid discontinuity, access to care, preventive services use, and health care
utilization. Access to care was poor among the discontinuous Medicaid populations, with
these groups having lower odds of having usual source of care, and higher odds for
experiencing difficulties in obtaining needed medical care and medications. The odds of
routine medical checkups were also found to be lower among the Discontinuous–
Uninsured, indicating inadequate medical checkups which are critical for early detection
and management of chronic conditions. Incidences of disease-specific hospitalizations,
both inpatient and ER visits, were found to be significantly higher among the
discontinuous Medicaid populations compared to those with continuous Medicaid.
Although ER use has been found to be higher among individuals who gain Medicaid
coverage, as ER may be a usual source of care for certain vulnerable populations even for
conditions that can be managed in outpatient setting, the increased hospitalizations are
more likely due to poor management of CVD or high-risk conditions for CVD resulting
from poor access to care and inadequate pharmacotherapy. The reason being, when
individuals are asked about whether or not they have a usual source of care, the options
include ER as well, apart from provider offices, outpatient and other clinic settings.
Moreover, all-cause office-based provider visits were lower, whereas all-cause hospital
outpatient visits were higher among the Discontinuous–Uninsured, which may indicate
inability to seek care and build patient-provider relationships with a usual source of
primary care physician, and overreliance on the hospital clinical care setting. It may also
be a result of lower acceptance of Medicaid patients by private practice physicians,
however, the comparison group is those with continuous Medicaid coverage, which
would have had worse primary care office visits if lack of acceptance were predominant
and prevalent. These findings indicate that Medicaid discontinuity among low-income
CVD or high risk chronic condition patients is associated with poor access to care,
inadequate medical checkups, lower prescription drug utilization and poor adherence to
certain commonly prescribed therapeutic drug classes, higher CVD-related
hospitalizations and ER visits, lower overall physician office visits to seek primary care,
and a greater reliance on hospital outpatient setting.
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IMPLICATIONS FOR POLICY
Gaps in Medicaid coverage may have deleterious health consequences for lowincome enrollees, and this study found that the health care access, and utilization
outcomes, and medication consumption behaviors among adults with CVD or high-risk
conditions for CVD may be adversely impacted due to instability in Medicaid coverage.
Continuity of Medicaid, especially for those who continue to be eligible for coverage,
represents a cost-effective policy solution, and lead to greater effectiveness of the
prevention and treatment services and resources, especially among low-income diseased
populations. State Medicaid agencies have a policy option of guaranteeing enrollment for
adults in Medicaid until the next reenrollment and eligibility determination cycle, and
have the duration of these cycles to be six months or annual. This would significantly
reduce within enrollment period churning and ensure better continuity of Medicaid
coverage, and in turn the continuity of care afforded by it. On a long term basis, cost
reductions may be realized due to providing better continuity in Medicaid coverage to
non-elderly adults, especially if the administrative costs associated with frequent
reenrollment are higher. The immediate impact of prolonged continuity of Medicaid may
however, result in a higher financial burden on the states, which may be a reason for the
stringent administrative regulations governing Medicaid coverage for none-elderly adults.
If that may be the case, then rather than a blanket policy that provides guaranteed
Medicaid enrollment to all non-elderly adults, state Medicaid agencies may focus on
specific subpopulations suffering from chronic, debilitating disease conditions, who often
require prolonged medical care to manage their conditions and comorbidities, and for
whom having continuous Medicaid coverage may prove to be more effective, and costeffective. Indeed, the present study showed that adults with CVD or high-risk conditions
for CVD had greater access to care problems, substandard medication adherence,
inadequate preventive care and primary care, and higher incidences of hospitalizations
associated Medicaid discontinuity, after adjusting for a host of demographic,
socioeconomic, health-related and Medicaid eligibility-related covariates in order to
obtain robust estimates. And although this study did not examine individuals with other
disease conditions such as respiratory illnesses, HIV/AIDS, mental illnesses, these
subpopulations too may experience similar negative outcomes of poor access to and use
of health care resources. Therefore, policies to stabilize Medicaid coverage among the
low-income population with chronic, debilitating disease conditions, may provide more
bang for the buck.
Instability in insurance, both public and private, have negative impact on health
and well-being of individuals as has been established by studies above. Although there
has not been any positive impact of this loss of and gaps in coverage investigated on
patients and society, there are some aspects or reasons of that contribute to churning in
insurance or Medicaid that are needed for the benefit of the society. One is the need for
deductibles and co-payments for insurance programs. Studies have shown that inability to
afford paying for deductibles and co-payments is one of the reasons that people opt out of
insurance plans, or do not enroll for public health plans. Although high deductibles and
co-pays have a negative effect on individuals’ utilization of needed care, complete
elimination of these payment structures might also be detrimental. This is because with
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“no skin in the game”, there will the likelihood of what economists call “moral hazard”,
that is individuals will consume more health care than what they need resulting in
inefficient allocation and spending of resources and excessive health care burden on the
society. In order to promote rational utilization of health care resources such contribution
from health plan enrollees is needed; the challenge to determining the “sweet spot” or the
right balance that would ensure that it does not exert a tremendous financial burden.
Another aspect is the requirement for sufficient documentation to ensure that meanstested insurance plans enroll individuals who truly qualify for the health plans, and
prevent any fraud which may divert needed health care resources to individuals who may
not need them. Once again, rather than getting rid of documentation requirements, the
process should be made less burdensome, with greater choices or avenues given to
patients, such as online enrollment, and longer time periods, and note having short
periodic reporting requirements to report eligibility. Also, provisions that enable smooth
transitions from public to private health insurance, or vice versa, especially for lowincome population, can also minimize churning and gaps, while still ensuring that
minimum checks and balances of determining eligibility are in place to prevent wastage
of much needed health care resources.
As part of the 2010 PPACA provisions of Medicaid expansion, states have the
option for expanding Medicaid coverage to their non-elderly adult residents with incomes
at or below 138% FPL. As of May 2015, however, 18 states have chosen status quo over
adopting these provisions and expanding Medicaid coverage, which would result in
continuation of these issues of instability of Medicaid in none-elderly adults and the
resulting adverse impact on continuity and quality of care and disease management.49
Even under PPACA provisions, states will be required to have 12 month recertification
periods, meaning individuals will have to reenroll in Medicaid annually; however, even
within this enrolled period, individuals and families may lose coverage midway if their
incomes and other criteria change. For these states, ensuring continuous Medicaid
coverage, at least for the diseased vulnerable populations could be a policy initiative that
can be adopted to ensure better health outcomes among these populations, and possibly
lower financial burden on the health care system due to providing high cost care resulting
from avoidable hospitalizations. Due to competing priorities, and even among the health
care sector, competing health priorities, resources available for management of these
conditions may be limited and policy initiatives to ensure continuity of insurance
coverage among low-income adult populations may be lacking. Failure to address issues
of Medicaid coverage continuity among adults with complex chronic conditions such as
CVD, may lead to large increases in prevalence of avoidable chronic conditions, which
may exert a tremendous burden on the health care system and the economy.
IMPLICATIONS FOR FUTURE RESEARCH
The present study found strong associations between Medicaid discontinuity and
the negative access to care and health care resource utilization outcomes among the lowincome CVD adult population. However, due to data limitations, we were unable to
establish temporality between Medicaid discontinuity and various outcomes under
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investigation. Moreover, the reasons for losing or gaps in Medicaid coverage were not
known. Future research may incorporate these shortcomings to obtain a holistic view of
the outcomes associated, and possibly caused by disruptions in Medicaid coverage. Using
state-specific eligibility would also be able to better control for state-level differences in
observed and unobserved characteristics that may not have been adequately controlled by
geographic region.
Costs associated with Medicaid discontinuity are an important outcome, and may
be of more interest to policymakers. The obvious follow-up to this study would examine
the costs, including total costs and costs specific to each health care services, to provide a
comprehensive picture of the impact of Medicaid discontinuity on health care resources
and costs, from the health care system perspective or payer perspective. Disruptions in
care continuity associated with poor access to care, lack of preventive care and primary
care, and the resulting increased hospitalizations and ER visits may lead to significant
increases in health care costs. And with a significant increase ER use by the uninsured to
obtain their usual care, or due hospitalizations resulting from chronic disease
exacerbations, the financial burden may increase tremendously on the health care
providers and hospitals due to provision of uncompensated care. The insured may end up
subsidizing a significant portion of the uncompensated care costs through their insurance
plans, and related out-of-pocket expenditures due to cost shifting. This vicious cycle may
not only exert a financial strain on providers and payers, but on patients as well.
Examinations of cost implications due to Medicaid discontinuity from not just payer or
provider perspective, but patient perspective may also provide meaningful information of
the impact of Medicaid discontinuity, and produce a complete and comprehensive picture
of the implications of Medicaid discontinuity among the non-elderly adult population, or
subpopulations of these with chronic conditions such as CVD or several of its high-risk
conditions.
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APPENDIX A. SUPPLEMENTAL MATERIALS FOR CHAPTER 3

Figure A-1. Distribution of All-Cause Prescription Drug Fills among Continuous
Medicaid and Discontinuous–Uninsured

Figure A-2. Distribution of All-Cause Prescription Drug Fills among Continuous
Medicaid and Discontinuous–Insured
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Figure A-3. Distribution of Disease-Specific Prescription Drug Fills among
Continuous Medicaid and Discontinuous–Uninsured

Figure A-4. Distribution of Disease-Specific Prescription Drug Fills among
Continuous Medicaid and Discontinuous–Insured
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Table A-1.

Characteristics Associated with Medication Adherence

Characteristics

Discontinuous–Uninsured
Odds Ratio (95% Confidence Interval)

Discontinuous–Insured
Odds Ratio (95% Confidence Interval)

DEMOGRAPHIC
Age
18 – 34 years

1.00 (Reference)

1.00 (Reference)

35 – 49 years

1.25 (0.97 – 1.61)

1.16 (0.90 – 1.49)

50 – 64 years

1.26 (0.97 – 1.63)

1.22 (0.93 – 1.59)

Female

1.00 (Reference)

1.00 (Reference)

Male

1.11 (0.91 – 1.35)

1.09 (0.88 – 1.35)

Non-Hispanic White

1.00 (Reference)

1.00 (Reference)

Non-Hispanic Black

0.83 (0.67 – 1.04)

0.81 (0.65 – 1.01)

Hispanic

0.86 (0.68 – 1.09)

0.79 (0.61 – 1.02)

Others

0.74 (0.53 – 1.02)

0.74 (0.54 – 1.01)

Not Married

1.00 (Reference)

1.00 (Reference)

Married

0.96 (0.79 – 1.17)

1.05 (0.86 – 1.30)

Northeast

1.00 (Reference)

1.00 (Reference)

Midwest

1.12 (0.84 – 1.49)

1.01 (0.76 – 1.37)

South

1.05 (0.83 – 1.34)

1.00 (0.78 – 1.29)

Gender

Race/Ethnicity

Marital Status

Region

105

Table A-1.

(Continued)

Characteristics
West

Discontinuous–Uninsured
Odds Ratio (95% Confidence Interval)
1.02 (0.79 – 1.31)

Discontinuous–Insured
Odds Ratio (95% Confidence Interval)
1.02 (0.79 – 1.32)

0.97 (0.93 – 1.02)

0.95 (0.90 – 1.00)

<High School

1.00 (Reference)

1.00 (Reference)

High School/GED

0.99 (0.84 – 1.18)

0.97 (0.81 – 1.71)

College Degree

0.85 (0.61 – 1.19)

0.85 (0.62 – 1.17)

<100% FPL

1.00 (Reference)

1.00 (Reference)

100 – <125% FPL

0.87 (0.66 – 1.19)

0.84 (0.61 – 1.15)

>125% FPL

1.11 (0.93 – 1.33)

1.04 (0.85 – 1.27)

Always Unemployed

1.00 (Reference)

1.00 (Reference)

Unstable Employment

1.01 (0.72 – 1.40)

1.00 (0.73 – 1.38)

Always Employed

0.97 (0.75 – 1.25)

1.01 (0.79 – 1.30)

Non-MSA

1.00 (Reference)

1.00 (Reference)

MSA

1.00 (0.80 – 1.25)

0.97 (0.77 – 1.22)

Family Size
SOCIOECONOMIC
Education

Income

Employment

MSA
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Table A-1.

(Continued)

Characteristics

Discontinuous–Uninsured
Odds Ratio (95% Confidence Interval)

Discontinuous–Insured
Odds Ratio (95% Confidence Interval)

MEDICAID-RELATED
SSI/TANF
No

1.00 (Reference)

1.00 (Reference)

Yes

1.02 (0.87 – 1.20)

1.01 (0.84 – 1.21)

No

1.00 (Reference)

1.00 (Reference)

Yes

1.15 (0.97 – 1.36)

1.10 (0.92 – 1.31)

Excellent/Very Good/Good

1.00 (Reference)

1.00 (Reference)

Fair to Poor

1.22 (1.01 – 1.48)

1.10 (0.90 – 1.34)

Excellent/Very Good/Good

1.00 (Reference)

1.00 (Reference)

Fair to Poor

1.07 (0.89 – 1.30)

1.11 (0.92 - 1.35)

<1

1.00 (Reference)

1.00 (Reference)

2

0.82 (0.63 – 1.06)

0.93 (0.70 – 1.22)

>3

1.01 (0.76 – 1.34)

1.00 (0.72 – 1.38)

Medicaid HMO/MCO

HEALTH-RELATED
Perceived Health Status

Perceived Mental Health

CVD or High-Risk Conditions for
CVD
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Table A-1.

(Continued)

Characteristics

Discontinuous–Uninsured
Odds Ratio (95% Confidence Interval)

Discontinuous–Insured
Odds Ratio (95% Confidence Interval)

Mental/Substance Abuse Illnesses
No

1.00 (Reference)

1.00 (Reference)

Yes

1.12 (0.91 – 1.38)

0.91 (0.73 – 1.13)

No

1.00 (Reference)

1.00 (Reference)

Yes

0.88 (0.70 – 1.10)

0.81 (0.63 – 1.04)

No

1.00 (Reference)

1.00 (Reference)

Yes

1.13 (0.93 – 1.37)

1.30 (1.04 – 1.62)*

CCI Score

1.00 (0.94 – 1.07)

1.03 (0.97 – 1.11)

Respiratory Illnesses

Arthritis/Joint Pain

Study population includes MEPS respondents from the years 2002-2011, aged 18-64 years, who either reported being diagnosed with, or reported
having an event (prescription medication, or inpatient, emergency, outpatient, or office-based provider visits) associated with, 1 or more
cardiovascular disease or associated risk factor comorbidities considered in this study.
***P-value<0.001, **P<0.01, *P<0.05 for the difference between Continuous Medicaid vs Discontinuous–Uninsured and Continuous Medicaid
vs Discontinuous–Insured groups
SE: Standard error; GED: General educational development; FPL: Federal poverty level; MSA: Metropolitan Statistical Area; SSI: Supplementary
Security Income due to disability; TANF: Temporary Assistance to Needy Families program participation; HMO: Health maintenance
organization; MCO: Managed care organization; CCI: Charlson Comorbidity Index score (D’Hoore adapted CCI score was calculated in this study
using the 3-digit ICD-9-CM codes in MEPS).
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APPENDIX B. SUPPLEMENTAL MATERIALS FOR CHAPTER 4

Figure B-1. Distribution of All-Cause Inpatient Visits among Continuous
Medicaid and Discontinuous–Uninsured

Figure B-2. Distribution of All-Cause Inpatient Visits among Continuous
Medicaid and Discontinuous–Insured
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Figure B-3. Distribution of Disease-Specific Inpatient Visits among Continuous
Medicaid and Discontinuous–Uninsured

Figure B-4. Distribution of Disease-Specific Inpatient Visits among Continuous
Medicaid and Discontinuous–Insured
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Figure B-5. Distribution of All-Cause Emergency Room Visits among Continuous
Medicaid and Discontinuous–Uninsured

Figure B-6. Distribution of All-Cause Emergency Room Visits among Continuous
Medicaid and Discontinuous–Insured
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Figure B-7. Distribution of Disease-Specific Emergency Room Visits among
Continuous Medicaid and Discontinuous–Uninsured

Figure B-8. Distribution of Disease-Specific Emergency Room Visits among
Continuous Medicaid and Discontinuous–Insured
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Figure B-9. Distribution of All-Cause Hospital Outpatient Visits among
Continuous Medicaid and Discontinuous–Uninsured

Figure B-10. Distribution of All-Cause Hospital Outpatient Visits among
Continuous Medicaid and Discontinuous–Insured

113

Figure B-11. Distribution of Disease-Specific Hospital Outpatient Visits among
Continuous Medicaid and Discontinuous–Uninsured

Figure B-12. Distribution of Disease-Specific Hospital Outpatient Visits among
Continuous Medicaid and Discontinuous–Insured
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Figure B-13. Distribution of All-Cause Physician Office Visits among Continuous
Medicaid and Discontinuous–Uninsured

Figure B-14. Distribution of All-Cause Physician Office Visits among Continuous
Medicaid and Discontinuous–Insured
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Figure B-15. Distribution of Disease-Specific Physician Office Visits among
Continuous Medicaid and Discontinuous–Uninsured

Figure B-16. Distribution of Disease-Specific Physician Office Visits among
Continuous Medicaid and Discontinuous–Insured
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